A0_Samples	A17_Age	A18_Sex	A19_Height	A1_OS	A20_Weight	A21_BMI	A22_histological_type	A23_Tumor_tissue_site	A2_Event	A3_T	A4_N	A5_M	A6_Stage	A8_New_Event	A8_New_Event_Time	A8_New_Event_Tissue	A8_New_Event_Type	A9_Cancer_Status	additional_studies	age_at_initial_pathologic_diagnosis	anatomic_neoplasm_subdivision	bcr_patient_barcode	bcr_patient_uuid	braf_gene_analysis_performed	braf_gene_analysis_result	circumferential_resection_margin	colon_polyps_present	day_of_form_completion	days_to_birth	days_to_death	days_to_initial_pathologic_diagnosis	days_to_last_followup	days_to_last_known_alive	drugs.drug.bcr_drug_barcode	drugs.drug.bcr_drug_uuid	drugs.drug.clinical_trail_drug_classification	drugs.drug.day_of_form_completion	drugs.drug.days_to_drug_therapy_end	drugs.drug.days_to_drug_therapy_start	drugs.drug.drug_name	drugs.drug.measure_of_response	drugs.drug.month_of_form_completion	drugs.drug.number_cycles	drugs.drug.prescribed_dose	drugs.drug.prescribed_dose_units	drugs.drug.regimen_indication	drugs.drug.regimen_indication_notes	drugs.drug.regimen_number	drugs.drug.route_of_administrations.route_of_administration	drugs.drug.therapy_ongoing	drugs.drug.therapy_types.therapy_type	drugs.drug.therapy_types.therapy_type_notes	drugs.drug.total_dose	drugs.drug.total_dose_units	drugs.drug.tx_on_clinical_trial	drugs.drug.year_of_form_completion	ethnicity	follow_ups.follow_up.bcr_followup_barcode	follow_ups.follow_up.bcr_followup_uuid	follow_ups.follow_up.day_of_form_completion	follow_ups.follow_up.days_to_death	follow_ups.follow_up.days_to_last_followup	follow_ups.follow_up.followup_case_report_form_submission_reason	follow_ups.follow_up.followup_treatment_success	follow_ups.follow_up.lost_follow_up	follow_ups.follow_up.month_of_form_completion	follow_ups.follow_up.new_tumor_events.new_tumor_event.additional_pharmaceutical_therapy	follow_ups.follow_up.new_tumor_events.new_tumor_event.additional_radiation_therapy	follow_ups.follow_up.new_tumor_events.new_tumor_event.days_to_new_tumor_event_additional_surgery_procedure	follow_ups.follow_up.new_tumor_events.new_tumor_event.days_to_new_tumor_event_after_initial_treatment	follow_ups.follow_up.new_tumor_events.new_tumor_event.new_neoplasm_event_type	follow_ups.follow_up.new_tumor_events.new_tumor_event.new_tumor_event_additional_surgery_procedure	follow_ups.follow_up.new_tumor_events.new_tumor_event.residual_disease_post_new_tumor_event_margin_status	follow_ups.follow_up.new_tumor_events.new_tumor_event.site_of_additional_surgery_new_tumor_event_mets	follow_ups.follow_up.new_tumor_events.new_tumor_event_after_initial_treatment	follow_ups.follow_up.person_neoplasm_cancer_status	follow_ups.follow_up.postoperative_rx_tx	follow_ups.follow_up.primary_therapy_outcome_success	follow_ups.follow_up.radiation_therapy	follow_ups.follow_up.vital_status	follow_ups.follow_up.year_of_form_completion	gender	height	histological_type	history_of_colon_polyps	history_of_neoadjuvant_treatment	icd_10	icd_o_3_histology	icd_o_3_site	informed_consent_verified	kras_gene_analysis_performed	kras_mutation_codon	kras_mutation_found	loss_expression_of_mismatch_repair_proteins_by_ihc	loss_expression_of_mismatch_repair_proteins_by_ihc_results.loss_expression_of_mismatch_repair_proteins_by_ihc_result	lymph_node_examined_count	lymphatic_invasion	microsatellite_instability	month_of_form_completion	new_tumor_events.new_tumor_event.additional_pharmaceutical_therapy	new_tumor_events.new_tumor_event.additional_radiation_therapy	new_tumor_events.new_tumor_event.days_to_new_tumor_event_additional_surgery_procedure	new_tumor_events.new_tumor_event.days_to_new_tumor_event_after_initial_treatment	new_tumor_events.new_tumor_event.new_neoplasm_event_type	new_tumor_events.new_tumor_event.new_tumor_event_additional_surgery_procedure	new_tumor_events.new_tumor_event.residual_disease_post_new_tumor_event_margin_status	new_tumor_events.new_tumor_event.site_of_additional_surgery_new_tumor_event_mets	new_tumor_events.new_tumor_event_after_initial_treatment	non_nodal_tumor_deposits	number_of_abnormal_loci	number_of_first_degree_relatives_with_cancer_diagnosis	number_of_loci_tested	number_of_lymphnodes_positive_by_he	number_of_lymphnodes_positive_by_ihc	other_dx	patient_id	perineural_invasion_present	person_neoplasm_cancer_status	postoperative_rx_tx	preoperative_pretreatment_cea_level	primary_lymph_node_presentation_assessment	primary_therapy_outcome_success	race_list.race	radiation_therapy	radiations.radiation.anatomic_treatment_site	radiations.radiation.bcr_radiation_barcode	radiations.radiation.bcr_radiation_uuid	radiations.radiation.course_number	radiations.radiation.day_of_form_completion	radiations.radiation.days_to_radiation_therapy_end	radiations.radiation.days_to_radiation_therapy_start	radiations.radiation.measure_of_response	radiations.radiation.month_of_form_completion	radiations.radiation.numfractions	radiations.radiation.radiation_dosage	radiations.radiation.radiation_treatment_ongoing	radiations.radiation.radiation_type	radiations.radiation.radiation_type_notes	radiations.radiation.regimen_indication	radiations.radiation.regimen_indication_notes	radiations.radiation.units	radiations.radiation.year_of_form_completion	residual_tumor	stage_event.ann_arbor.b_symptoms	stage_event.ann_arbor.extranodal_involvement	stage_event.clinical_stage	stage_event.gleason_grading.gleason_score	stage_event.gleason_grading.primary_pattern	stage_event.gleason_grading.secondary_pattern	stage_event.gleason_grading.tertiary_pattern	stage_event.igcccg_stage	stage_event.masaoka_stage	stage_event.pathologic_stage	stage_event.psa.days_to_psa	stage_event.psa.psa_value	stage_event.serum_markers	stage_event.system_version	stage_event.tnm_categories.clinical_categories.clinical_M	stage_event.tnm_categories.clinical_categories.clinical_N	stage_event.tnm_categories.clinical_categories.clinical_T	stage_event.tnm_categories.pathologic_categories.pathologic_M	stage_event.tnm_categories.pathologic_categories.pathologic_N	stage_event.tnm_categories.pathologic_categories.pathologic_T	synchronous_colon_cancer_present	tissue_prospective_collection_indicator	tissue_retrospective_collection_indicator	tissue_source_site	tumor_tissue_site	venous_invasion	vital_status	weight	year_of_form_completion	year_of_initial_pathologic_diagnosis
TCGA-AG-3893	74	MALE	Not Available	1065	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N1	M0	Stage IIIB	0	1065			WITH TUMOR		74	Rectum	TCGA-AG-3893	add567b7-29ef-4122-8a54-57d36f735e78	NO	Not Available	Not Available	Not Available	18	-27272	Not Applicable	0	30	Not Available	TCGA-AG-3893-D37653;TCGA-AG-3893-D37654	D8A5AC42-4F51-4626-BFAB-BF6CD4C44D3C;1680F252-BB88-454F-B1CC-FE1038F33269	n/a;n/a	5;5	245;245	61;61	Folinic acid;5-Fluorouracil	Complete Response;Complete Response	12;12	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2012	Not Available	TCGA-AG-3893-F38019	2F3D7FD0-D5D2-4D85-8DB3-626B668281D1	8	Not Applicable	1065	Scheduled Follow-up Submission	Complete Remission/Response	NO	12									NO	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2012	MALE	Not Available	Rectal Adenocarcinoma	NO	No	C19	8140/3	C19.9	YES	NO	Not Available	Not Available	NO	Not Available	14	YES	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	1	Not Available	No	3893	Not Available	WITH TUMOR	Not Available	Not Available	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T3	NO	NO	YES	AG	Rectum	Not Available	Alive	Not Available	2010	2009
TCGA-AG-A016	55	MALE	Not Available	276	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N2	M1	Stage IV	0	276			WITH TUMOR		55	Rectum	TCGA-AG-A016	9c7b5e85-5579-4d0f-a7ea-b9d081ac0037	NO	Not Available	Not Available	Not Available	15	-20178	Not Applicable	0	31	Not Available	TCGA-AG-A016-D37670;TCGA-AG-A016-D37671;TCGA-AG-A016-D37672	D17DDE62-D61E-4DC5-B0BD-069B51F864DC;078B47FD-21FB-4FD2-8F32-E9DD57433938;A029C8B8-87C1-462D-B804-E918A20290E6	n/a;n/a;n/a	5;5;5	245;61;245	31;31;61	5-Fluorouracil;Folinic acid;Bevacizumab	Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease	12;12;12	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Targeted Molecular therapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2012;2012;2012	Not Available	TCGA-AG-A016-F38512	2E9CA8A0-0B0B-4B40-88F8-AE3D2B4010FD	16	Not Applicable	276	Scheduled Follow-up Submission	Progressive Disease	NO	12									NO	WITH TUMOR	YES	Progressive Disease	NO	Alive	2012	MALE	Not Available	Rectal Adenocarcinoma	NO	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	19	YES	Not Available	6									Not Available	Not Available	Not Available	0	Not Available	4	Not Available	No	A016	Not Available	WITH TUMOR	Not Available	Not Available	YES	Not Available	Not Available	Not Available																			R2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M1	N2	T3	NO	NO	YES	AG	Rectum	NO	Alive	Not Available	2011	2009
TCGA-AF-3400	54	MALE	177.8	1049	85.4	27.0143397429652	Rectal Mucinous Adenocarcinoma	Rectum	Alive	T3	N0	M0	Stage IIA	0	1049			TUMOR FREE		54	Rectosigmoid Junction	TCGA-AF-3400	cbcb2141-b415-4410-8dd7-2a3cd3980a19	NO	Not Available	Not Available	YES	1	-19826	Not Applicable	0	387	Not Available	TCGA-AF-3400-D2753;TCGA-AF-3400-D2847;TCGA-AF-3400-D2850;TCGA-AF-3400-D2833;TCGA-AF-3400-D2800	3ec1df07-49b6-45d9-abb2-137d5d95525f;2a24fcad-f207-47b7-87cf-f710d38df559;a2e12b5b-e00e-4614-aaa9-973b603d189c;f5420dc8-d394-4f7f-9848-008df8cbc84b;0e287f64-1843-4bfa-a0e8-19be31c3cb81	Not Available;Not Available;Not Available;Not Available;Not Available	3;4;4;4;4	137;358;360;358;358	97;185;185;185;185	5FU;5FU;5-FU;Oxaliplatin;Leucovorin	Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11	6;11;11;11;11	459-470;612-832;3672-4992;130-177;600-850	mg;mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;2;2;2;2	IV;IV;IV;IV;IV	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Other, specify in notes	Not Available;Not Available;Not Available;Not Available;Ancillary	14005;7300;44067;1551;6850	mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010	NOT HISPANIC OR LATINO	TCGA-AF-3400-F2622;TCGA-AF-3400-F38603	1813c9fe-91a4-4dcb-b524-75a8fe9f84f6;B0E9C198-7E07-4627-9CD3-1E1DDF9F2EAD	1;18	Not Applicable;Not Applicable	387;1049	Not Available;Scheduled Follow-up Submission	Not Available;Complete Remission/Response	Not Available;NO	11;12									NO;NO	TUMOR FREE;TUMOR FREE	YES;Not Available	Not Available;Not Available	YES;Not Available	Alive;Alive	2010;2012	MALE	177.8	Rectal Mucinous Adenocarcinoma	NO	No	C19	8480/3	C19.9	YES	NO	Not Available	Not Available	NO	Not Available	32	NO	NO	11									Not Available	NO	0	1	5	0	Not Available	No	3400	Not Available	TUMOR FREE	Not Available	2.8	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-AF-3400-R2623	35b41ef3-8733-4bf5-92d6-7adcadd2c43c	1	3	140	98	Not Available	11	28	5040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	YES	NO	AF	Rectum	NO	Alive	85.4	2010	2009
TCGA-AF-3911	48	MALE	180.3	1148	94.5	29.06968696099955	Rectal Adenocarcinoma	Rectum	Alive	T3	N2	MX	Stage IIIC	1	695.0			TUMOR FREE		48	Rectum	TCGA-AF-3911	17e286b7-7793-446d-b556-1108addb5ba2	NO	Not Available	Not Available	YES	28	-17609	Not Applicable	0	537	Not Available	TCGA-AF-3911-D13481;TCGA-AF-3911-D13480;TCGA-AF-3911-D13478;TCGA-AF-3911-D13479;TCGA-AF-3911-D13456	ac0aeb25-48f3-4491-a888-09bc7cd2757f;763988bf-65bc-4af6-affa-2d62417e581e;9cf10576-9771-4a03-ab78-4c2dc302073e;378a1cdd-b199-4005-b5a8-590fe60c777c;93f15563-e1f4-4df9-98fe-2c058fa1aef0	Not Available;Not Available;Not Available;Not Available;Not Available	28;28;28;28;18	302;300;285;300;106	145;145;145;145;68	5FU;Leucovorin;Oxaliplatin;5FU;5FU	Not Available;Not Available;Not Available;Not Available;Not Available	6;6;6;6;7	12;12;11;12;6	5112-5160;50-850;137-183;852-860;468-477	mg;mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	2;2;2;2;1	IV;IV;IV;IV;IV	NO;NO;NO;NO;NO	Chemotherapy;Other, specify in notes;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	61776;6200;1868;10296;13271	mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011;2011	NOT HISPANIC OR LATINO	TCGA-AF-3911-F13443;TCGA-AF-3911-F19776;TCGA-AF-3911-F39018	c4b40609-531d-4459-a0f4-079e608d5454;117414aa-a9d8-4041-ae93-d60a07ad24f3;7E2DAE1D-5040-4D17-B55D-9F67D65FF61C	28;27;11	Not Applicable;Not Applicable;Not Applicable	537;761;1148	Scheduled Follow-up Submission;Additional New Tumor Event;Scheduled Follow-up Submission	Not Available;Not Available;Progressive Disease	Not Available;Not Available;NO	6;12;1	None;YES;NO	None;NO;NO	None;Not Available;Not Available	None;695;1020	None;Unknown;Unknown	None;NO;NO	None;Not Available;Not Available	None;Not Available;Not Available	NO;YES;YES	TUMOR FREE;WITH TUMOR;WITH TUMOR	YES;Not Available;YES	Not Available;Not Available;Complete Remission/Response	YES;Not Available;YES	Alive;Alive;Alive	2011;2011;2013	MALE	180.3	Rectal Adenocarcinoma	Not Available	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	18	YES	NO	6									Not Available	YES	0	0	5	9	Not Available	No	3911	Not Available	TUMOR FREE	Not Available	1.1	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-AF-3911-R13453	f7c39be5-5c87-4c65-9eec-8b4e30cee14a	1	28	107	68	Not Available	6	28	5040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	N2	T3	NO	YES	NO	AF	Rectum	NO	Alive	94.5	2011	2009
TCGA-EI-6513	59	MALE	175	497	78	25.46938775510204	Rectal Adenocarcinoma	Rectum	Alive	T3	N1	M0	Stage IIIB	0	497			TUMOR FREE		59	Rectosigmoid Junction	TCGA-EI-6513	a8a5553c-bfe1-4d5f-aacc-5549ded3f91f	NO	Not Available	Not Available	YES	16	-21776	Not Applicable	0	210	Not Available																								NOT HISPANIC OR LATINO	TCGA-EI-6513-F28633	DA6A857E-765B-4124-B509-E58E9CC1F4FA	27	Not Applicable	497	Scheduled Follow-up Submission	Not Available	Not Available	2									NO	TUMOR FREE	NO	Not Available	NO	Alive	2012	MALE	175	Rectal Adenocarcinoma	NO	No	C20	8263/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	13	NO	Not Available	5									Not Available	NO	Not Available	0	Not Available	2	0	No	6513	NO	TUMOR FREE	Not Available	1.0	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T3	NO	YES	NO	EI	Rectum	NO	Alive	78	2011	2010
TCGA-AG-3882	66	FEMALE	Not Available	608	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T2	N0	M0	Stage I	0	608			WITH TUMOR		66	Rectum	TCGA-AG-3882	92c65e5a-3f07-49d9-ab69-46a0eb86ae88	NO	Not Available	Not Available	Not Available	18	-24198	Not Applicable	0	0	Not Available																								Not Available	TCGA-AG-3882-F38013	6403B608-FB0D-4B72-A758-FD8225E97E8E	8	Not Applicable	608	Scheduled Follow-up Submission	Complete Remission/Response	NO	12									NO	TUMOR FREE	NO	Not Available	NO	Alive	2012	FEMALE	Not Available	Rectal Adenocarcinoma	NO	No	C18.9	8140/3	C18.9	YES	NO	Not Available	Not Available	NO	Not Available	18	YES	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	No	3882	Not Available	WITH TUMOR	Not Available	.33	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	NO	YES	AG	Rectum	YES	Alive	Not Available	2010	2008
TCGA-AG-3887	68	MALE	Not Available	1124	Not Available		Rectal Mucinous Adenocarcinoma	Rectum	Alive	T3	N0	M0	Stage IIA	1	1064.0			WITH TUMOR		68	Rectum	TCGA-AG-3887	8c7ccdb0-7653-4a8d-86b6-de39afc40765	NO	Not Available	Not Available	Not Available	18	-24960	Not Applicable	0	28	Not Available	TCGA-AG-3887-D37650;TCGA-AG-3887-D37651;TCGA-AG-3887-D37652	B21661DA-72BC-41E0-8FB1-7FD3C9904564;D19E88BF-FD23-407D-8687-8DBC9EF02F86;8EDBD3BB-086B-4166-A971-A245C564BF9C	Not Available;Not Available;Not Available	5;5;5	Not Available;Not Available;Not Available	1095;1095;1095	Irinotecan;Capecitabine;Bevacizumab	Not Applicable;Not Applicable;Not Applicable	12;12;12	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	YES;YES;Not Available	Chemotherapy;Chemotherapy;Targeted Molecular therapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2012;2012;2012	Not Available	TCGA-AG-3887-F38015	E26D0933-7503-4204-A9BC-D2C98C23E183	8	Not Applicable	1124	Scheduled Follow-up Submission	Progressive Disease	NO	12	Unknown	Unknown	Not Available	1064	Unknown	NO	Not Available	Not Available	YES	WITH TUMOR	YES	Not Applicable	YES	Alive	2012	MALE	Not Available	Rectal Mucinous Adenocarcinoma	YES	No	C20	8480/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	14	YES	Not Available	5									Not Available	Not Available	Not Available	1	Not Available	0	Not Available	No	3887	Not Available	WITH TUMOR	Not Available	Not Available	YES	Not Available	Not Available	Not Available	Distant Recurrence	TCGA-AG-3887-R38359	881BDAC4-E4FA-4343-8D79-D38218E4C13F	Not Available	13	Not Available	1095	Not Applicable	12	Not Available	Not Available	YES	External	Not Applicable	Not Available	Not Available	Not Available	2012	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	NO	YES	AG	Rectum	YES	Alive	Not Available	2010	2009
TCGA-AG-3999	61	FEMALE	Not Available	853	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N2	M0	Stage IIIC	1	791.0			WITH TUMOR		61	Rectum	TCGA-AG-3999	60778da8-d99e-4e51-96a2-3e900b3978d9	NO	Not Available	5	NO	18	-22311	Not Applicable	0	31	Not Available	TCGA-AG-3999-D37659	4C69C48C-88A7-428F-85CB-0897E5F61623	Not Available	5	Not Available	Not Available	Not Available	Clinical Progressive Disease	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Chemotherapy	Not Available	Not Available	Not Available	NO	2012	Not Available	TCGA-AG-3999-F38308	2288B663-B051-497A-BDE8-6E66274E268B	12	Not Applicable	853	Scheduled Follow-up Submission	Progressive Disease	NO	12	Unknown	Unknown	Not Available	791	Unknown	NO	Not Available	Not Available	YES	TUMOR FREE	YES	Progressive Disease	NO	Alive	2012	FEMALE	Not Available	Rectal Adenocarcinoma	NO	No	C19	8140/3	C19.9	YES	NO	Not Available	Not Available	NO	Not Available	32	YES	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	20	Not Available	No	3999	Not Available	WITH TUMOR	Not Available	9.67	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T3	NO	NO	YES	AG	Rectum	YES	Alive	Not Available	2010	2008
TCGA-AG-3731	65	MALE	Not Available	1126	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N1	M1	Stage IV	0	1126			WITH TUMOR		65	Rectum	TCGA-AG-3731	72756208-a5ed-47d2-8c4c-19a8d39f7b9d	NO	Not Available	Not Available	Not Available	18	-23923	Not Applicable	0	31	Not Available	TCGA-AG-3731-D37642;TCGA-AG-3731-D37643;TCGA-AG-3731-D37644;TCGA-AG-3731-D37645	89CD8582-B07D-4C29-ABEB-E59268AC7FD7;0050963E-70D9-4754-BD4D-5CB6943EDB8A;D24F50D6-FB52-4277-8AB4-AC5123C639C7;ABCED613-88E1-44F3-8477-B6B2A8C63CF9	n/a;n/a;n/a;n/a	5;5;5;5	914;914;184;914	92;92;92;365	Folinic acid;5-Fluorouracil;Oxaliplatin;Irinotecan	Partial Response;Partial Response;Partial Response;Partial Response	12;12;12;12	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2012;2012;2012;2012	Not Available	TCGA-AG-3731-F38010	C1F2C360-D785-4FC6-B913-948FEB5BD0C8	8	Not Applicable	1126	Scheduled Follow-up Submission	Complete Remission/Response	NO	12									NO	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2012	MALE	Not Available	Rectal Adenocarcinoma	YES	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	34	Not Available	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	3	Not Available	No	3731	Not Available	WITH TUMOR	Not Available	32.08	YES	Not Available	Not Available	Not Available																			R2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M1	N1	T3	NO	NO	YES	AG	Rectum	Not Available	Alive	Not Available	2010	2004
TCGA-AF-6136	72	FEMALE	161.3	741	67.2	25.828580477359825	Rectal Adenocarcinoma	Rectum	Alive	T3	N1b	MX	Stage IIIB	1	199.0			WITH TUMOR		72	Rectosigmoid Junction	TCGA-AF-6136	5bc1db25-3e25-44d7-99cb-e31f00cf1d58	Not Available	Not Available	Not Available	NO	12	-26490	Not Applicable	0	232	Not Available	TCGA-AF-6136-D31526;TCGA-AF-6136-D31527;TCGA-AF-6136-D31528;TCGA-AF-6136-D31529;TCGA-AF-6136-D31525	6a8a2d9a-dceb-4ed9-8bfc-76a4c6c10c28;54ada04a-3ac3-487d-b98b-814256e83be5;1419103a-d51d-4461-bb13-1a18acce6ed3;b031c881-0b3e-4778-bc63-28d0e2bf4c48;e005c38c-40ff-4493-815b-770c79d550ad	Not Available;Not Available;Not Available;Not Available;Not Available	9;9;9;9;11	385;454;454;453;117	209;209;209;209;117	Oxaliplatin;Leucovorin;Fluorouracil;Fluorouracil;Fluorouracil	Stable Disease;Stable Disease;Stable Disease;Stable Disease;Unknown	5;5;5;5;5	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	Chemotherapy;Ancillary;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	2012;2012;2012;2012;2012	NOT HISPANIC OR LATINO	TCGA-AF-6136-F31524;TCGA-AF-6136-F40235	007f8ef2-68fb-4272-b6f6-2c58ca7efbac;A13C75DA-41ED-4FB4-A7E2-EFA73D2C25F5	4;14	Not Applicable;Not Applicable	468;741	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Not Available;Progressive Disease	Not Available;NO	5;2	YES;YES	NO;NO	Not Available;Not Available	199;609	Unknown;Unknown	NO;NO	Not Available;Not Available	Not Available;Not Available	YES;YES	WITH TUMOR;WITH TUMOR	YES;YES	Not Available;Progressive Disease	YES;YES	Alive;Alive	2012;2013	FEMALE	161.3	Rectal Adenocarcinoma	NO	No	C19	8140/3	C19.9	YES	Not Available	Not Available	Not Available	YES	MLH1-Expressed;MSH2-Expressed;PMS2-Expressed;MSH6-Expressed	52	YES	NO	9									Not Available	YES	0	0	5	2	Not Available	No	6136	Not Available	WITH TUMOR	Not Available	18.3	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-AF-6136-R31520	4a90eba2-d186-4ac7-b35f-44996abcf93b	1	4	143	104	Not Available	5	28	5040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N1b	T3	NO	YES	NO	AF	Rectum	YES	Alive	67.2	2011	2011
TCGA-DC-6154	57	FEMALE	162	365	59.4	22.633744855967077	Rectal Adenocarcinoma	Rectum	Alive	T4a	N2b	M1	Stage IVA	0	365			TUMOR FREE		57	Rectosigmoid Junction	TCGA-DC-6154	33e91116-8844-4861-843d-784c70b4a6fc	NO	Not Available	18	NO	25	-21093	Not Applicable	0	273	Not Available	TCGA-DC-6154-D17886;TCGA-DC-6154-D17889;TCGA-DC-6154-D17883;TCGA-DC-6154-D17888	ae7103e5-b431-4be0-b041-09485384352a;ca705d57-a0eb-4310-8628-44af85e60bb9;1535646c-5346-457e-8157-8083e674308f;31ab0762-6f93-45f0-910b-0cc012bfbde4	Not Available;Not Available;Not Available;Not Available	27;27;27;27	242;242;242;242	91;91;91;91	Fluorouracil;Oxaliplatin;Fluorouracil;Leucovorin	Not Available;Not Available;Not Available;Not Available	10;10;10;10	12;12;12;12	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;1	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Other, specify in notes	Not Available;Not Available;Not Available;Ancillary	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	NOT HISPANIC OR LATINO	TCGA-DC-6154-F17762;TCGA-DC-6154-F21437	7da860da-477a-48aa-bc61-3b50676654c3;5c00e450-c8e6-46a0-b0b7-b468f96693dd	25;13	Not Applicable;Not Applicable	273;365	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Not Available;Not Available	Not Available;Not Available	10;2									NO;NO	TUMOR FREE;TUMOR FREE	YES;YES	Not Available;Not Available	NO;NO	Alive;Alive	2011;2012	FEMALE	162	Rectal Adenocarcinoma	NO	No	C19	8140/3	C19.9	YES	NO	Not Available	Not Available	NO	Not Available	39	YES	Not Available	10									Not Available	NO	Not Available	0	Not Available	8	Not Available	No	6154	YES	TUMOR FREE	Not Available	16.3	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IVA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M1	N2b	T4a	NO	YES	NO	DC	Rectum	YES	Alive	59.4	2011	2010
TCGA-AG-A02G	66	MALE	Not Available	1185	Not Available		Rectal Adenocarcinoma	Rectum	Dead	T2	N1	M1	Stage IV	1	578.0			WITH TUMOR		66	Rectum	TCGA-AG-A02G	17878cb0-a8f9-43a4-911c-0f94c2a5e3df	NO	Not Available	Not Available	Not Available	15	-24259	Not Applicable	0	0	Not Available	TCGA-AG-A02G-D37682;TCGA-AG-A02G-D37683;TCGA-AG-A02G-D37684;TCGA-AG-A02G-D37685;TCGA-AG-A02G-D37686	7458F01A-6F47-42AC-AB9F-525BFC8D3A2F;A6893A84-4202-474B-9A3D-78E7E865113C;A8310B34-29AD-410D-A5DE-FCDD7CBE7AEE;E6F1FA31-3AF9-45D0-A70B-38EF81B6A288;2DCEA1E6-7D2F-46E0-9D15-4069C8FFC067	n/a;n/a;n/a;n/a;n/a	5;5;5;5;5	1096;1096;242;242;1096	28;28;28;28;851	Folinic acid;5-Fluorouracil;Irinotecan;Bevacizumab;Oxaliplatin	Partial Response;Partial Response;Partial Response;Partial Response;Partial Response	12;12;12;12;12	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	YES;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	2012;2012;2012;2012;2012	Not Available	TCGA-AG-A02G-F38515	76E8C5E1-6AC3-4633-91B8-5DE5EA85A1A2	16	1185	Not Available	Scheduled Follow-up Submission	Partial Remission/Response	NO	12	Unknown	Unknown	Not Available	578	Unknown	NO	Not Available	Not Available	YES	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2012	MALE	Not Available	Rectal Adenocarcinoma	NO	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	16	YES	Not Available	6									Not Available	Not Available	Not Available	0	Not Available	3	Not Available	No	A02G	Not Available	WITH TUMOR	Not Available	2.32	YES	Not Available	Not Available	Not Available																			R2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M1	N1	T2	NO	NO	YES	AG	Rectum	YES	Alive	Not Available	2011	2007
TCGA-EI-6508	48	FEMALE	159	636	66	26.106562240417706	Rectal Adenocarcinoma	Rectum	Alive	T3	N1a	M0	Stage IIIB	0	636			TUMOR FREE		48	Rectosigmoid Junction	TCGA-EI-6508	d8bfcc67-f5c3-42cd-9fc4-bd483f896da1	NO	Not Available	12	NO	9	-17827	Not Applicable	0	66	Not Available	TCGA-EI-6508-D28936	a4922b17-c151-4bac-bd9d-a607e43949e8	Not Available	2	258	76	oxaliplatinum + 5-FU	Not Available	3	12	Not Available	mg/m2/day	ADJUVANT	Not Applicable	Not Available	IV	NO	Chemotherapy	Not Available	Not Available	mg	Not Available	2012	NOT HISPANIC OR LATINO	TCGA-EI-6508-F28935	e969163b-56cb-49f1-a9a4-3a8b44fd676d	1	Not Applicable	636	Scheduled Follow-up Submission	Not Available	Not Available	3									NO	TUMOR FREE	YES	Not Available	NO	Alive	2012	FEMALE	159	Rectal Adenocarcinoma	Not Available	No	C20	8263/3	C20.9	YES	NO	Not Available	Not Available	Not Available	Not Available	15	YES	Not Available	6									Not Available	NO	Not Available	1	Not Available	1	Not Available	No	6508	YES	TUMOR FREE	Not Available	0.6	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1a	T3	Not Available	YES	NO	EI	Rectum	NO	Alive	66	2011	2010
TCGA-AG-3580	67	MALE	Not Available	244	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T1	N0	M0	Stage I	0	244			WITH TUMOR		67	Rectum	TCGA-AG-3580	594a52b0-c929-4e50-ae27-7542e32667ae	NO	Not Available	Not Available	Not Available	18	-24775	Not Applicable	0	0	Not Available																								Not Available	TCGA-AG-3580-F37955	A616BC22-19E3-4565-A5F9-DB08889B9D83	6	Not Applicable	244	Scheduled Follow-up Submission	Complete Remission/Response	NO	12									NO	TUMOR FREE	NO	Not Available	NO	Alive	2012	MALE	Not Available	Rectal Adenocarcinoma	YES	No	C19	8140/3	C19.9	YES	NO	Not Available	Not Available	NO	Not Available	22	NO	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	Yes	3580	Not Available	WITH TUMOR	Not Available	.87	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	NO	YES	AG	Rectum	NO	Alive	Not Available	2010	2007
TCGA-DC-4749	57	MALE	179	762	87.1	27.183920601729035	Rectal Adenocarcinoma	Rectum	Alive	T2	N0	M0	Stage I	0	762			TUMOR FREE		57	Rectosigmoid Junction	TCGA-DC-4749	bf65c2cd-8348-488f-8485-9196ba42d17e	NO	Not Available	Not Available	NO	9	-21092	Not Applicable	0	335	Not Available																								NOT HISPANIC OR LATINO	TCGA-DC-4749-F12834;TCGA-DC-4749-F33821	7c222c08-d934-40c0-ad3a-8b7b2ac286dc;807A6624-CDFD-46FE-AC61-39E0E91C7FF1	9;19	Not Applicable;Not Applicable	335;762	Not Available;Scheduled Follow-up Submission	Not Available;Complete Remission/Response	Not Available;NO	6;7									NO;NO	TUMOR FREE;TUMOR FREE	NO;NO	Not Available;Complete Remission/Response	NO;NO	Alive;Alive	2011;2012	MALE	179	Rectal Adenocarcinoma	NO	No	C19	8140/3	C19.9	YES	NO	Not Available	Not Available	NO	Not Available	16	YES	Not Available	6									Not Available	NO	Not Available	0	Not Available	0	Not Available	No	4749	NO	TUMOR FREE	Not Available	1.3	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	NO	YES	DC	Rectum	YES	Alive	87.1	2011	2010
TCGA-EI-6507	60	MALE	176	607	54	17.43285123966942	Rectal Adenocarcinoma	Rectum	Alive	T3	N0	M0	Stage IIA	0	607			TUMOR FREE		60	Rectum	TCGA-EI-6507	c3f0608b-d493-4c74-930a-d7998a48a659	NO	Not Available	20	NO	13	-22176	Not Applicable	0	5	Not Available																								NOT HISPANIC OR LATINO	TCGA-EI-6507-F28632	6611f712-ecbc-4158-b32a-3d1b7ee59bd3	27	Not Applicable	607	Scheduled Follow-up Submission	Not Available	Not Available	2									NO	TUMOR FREE	NO	Not Available	NO	Alive	2012	MALE	176	Rectal Adenocarcinoma	NO	No	C20	8480/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	25	NO	Not Available	9									Not Available	NO	Not Available	0	Not Available	0	Not Available	No	6507	NO	TUMOR FREE	Not Available	10.7	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	YES	NO	EI	Rectum	NO	Alive	54	2011	2010
TCGA-EI-6882	59	MALE	178	262	108	34.086605226612804	Rectal Mucinous Adenocarcinoma	Rectum	Alive	T3	N0	M0	Stage IIA	0	262			TUMOR FREE		59	Rectosigmoid Junction	TCGA-EI-6882	e3a80e41-2e46-4b04-86c6-fd444d616ab5	NO	Not Available	30	NO	18	-21682	Not Applicable	0	108	Not Available																								NOT HISPANIC OR LATINO	TCGA-EI-6882-F29848	35b07b0e-99b9-45a3-a2e1-b9b38802029b	26	Not Applicable	262	Scheduled Follow-up Submission	Not Available	Not Available	3									NO	TUMOR FREE	NO	Not Available	NO	Alive	2012	MALE	178	Rectal Mucinous Adenocarcinoma	NO	No	C20	8255/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	21	NO	NO	7									Not Available	NO	Not Available	0	Not Available	0	Not Available	No	6882	NO	TUMOR FREE	Not Available	1.3	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	YES	NO	EI	Rectum	NO	Alive	108	2011	2011
TCGA-AF-A56L	48	FEMALE	159	2007	74.3	29.3896602191369	Rectal Adenocarcinoma	Rectum	Alive	T3	N2	M0	Stage IIIC	0	2007			TUMOR FREE		48	Sigmoid Colon	TCGA-AF-A56L	C8FD1040-82A2-4CDA-AC49-C2F82B20CBAB	Unknown	Not Available	Not Available	NO	18	-17734	Not Applicable	0	1760	Not Available	TCGA-AF-A56L-D42409;TCGA-AF-A56L-D42410;TCGA-AF-A56L-D42411;TCGA-AF-A56L-D42412	B297C576-C11B-4810-B6C6-C2859AF3D1DE;C6E884C2-2F25-4791-8E07-CF6A9034F43D;B413308D-C7F5-4902-8FF1-D44C8696D792;7CF68531-04CC-4FC7-B1CA-17DB824739E0	Not Available;Not Available;Not Available;Not Available	18;18;18;18	255;255;255;255	52;52;52;52	Oxaliplatin;Leucovorin;5FU;5FU	Complete Response;Complete Response;Complete Response;Complete Response	4;4;4;4	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Ancillary;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2013;2013;2013;2013	Not Evaluated	TCGA-AF-A56L-F51137	68BC9047-2C54-41C8-84B1-75CAD2DD4DA8	8	Not Applicable	2007	Scheduled Follow-up Submission	Complete Remission/Response	NO	11									NO	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2013	FEMALE	159	Rectal Adenocarcinoma	NO	No	C19	8140/3	C19.9	YES	Unknown	Not Available	Not Available	YES	MLH1-Expressed;MSH2-Expressed;PMS2-Expressed;MSH6-Expressed	23	YES	NO	4									NO	YES	0	0	5	10	Not Available	No	A56L	Unknown	TUMOR FREE	YES	3.2	YES	Complete Remission/Response	BLACK OR AFRICAN AMERICAN	NO																			RX	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T3	NO	NO	YES	AF	Rectum	NO	Alive	74.3	2013	2008
TCGA-AG-4009	83	MALE	Not Available	426	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T2	N0	M0	Stage I	0	426			WITH TUMOR		83	Rectum	TCGA-AG-4009	d63a90d4-730f-4916-af02-d06854221d7a	NO	Not Available	Not Available	Not Available	18	-30559	Not Applicable	0	30	Not Available																								Not Available	TCGA-AG-4009-F38316	5C05C044-9629-4B5D-8E07-FFEB3F38E2C7	12	Not Applicable	426	Scheduled Follow-up Submission	Complete Remission/Response	NO	12									NO	TUMOR FREE	NO	Not Available	NO	Alive	2012	MALE	Not Available	Rectal Adenocarcinoma	YES	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	16	YES	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	No	4009	Not Available	WITH TUMOR	Not Available	Not Available	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	NO	YES	AG	Rectum	YES	Alive	Not Available	2010	2009
TCGA-AG-4005	64	MALE	Not Available	427	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N2	M1	Stage IV	0	427			WITH TUMOR		64	Rectum	TCGA-AG-4005	866de12b-e4df-4f19-b62e-e3fd85d4ec08	NO	Not Available	6	Not Available	18	-23407	Not Applicable	0	0	Not Available	TCGA-AG-4005-D37660;TCGA-AG-4005-D37661;TCGA-AG-4005-D37662	217AFF88-4D43-42A3-9A3E-16D1662C2D28;DB8463A1-4C26-4AC4-9DEE-7392B21B8AA6;380000BA-B2B9-4D32-BA25-4E518DE0341C	n/a;n/a;n/a	5;5;5	213;213;213	61;61;61	Folinic acid;5-Fluorouracil;Oxaliplatin	Complete Response;Complete Response;Complete Response	12;12;12	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2012;2012;2012	Not Available	TCGA-AG-4005-F38310	F203AF61-1DA0-4FFD-9CCE-37CAF0C3A7AB	12	Not Applicable	427	Scheduled Follow-up Submission	Complete Remission/Response	NO	12									NO	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2012	MALE	Not Available	Rectal Adenocarcinoma	NO	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	40	YES	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	7	Not Available	No	4005	Not Available	WITH TUMOR	Not Available	31.52	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M1	N2	T3	NO	NO	YES	AG	Rectum	YES	Alive	Not Available	2010	2007
TCGA-AG-3901	67	FEMALE	Not Available	761	Not Available		Rectal Mucinous Adenocarcinoma	Rectum	Alive	T3	N1	M0	Stage IIIB	0	761			WITH TUMOR		67	Rectum	TCGA-AG-3901	1586cb0a-081a-4364-9470-46f9d0f0167d	NO	Not Available	Not Available	Not Available	18	-24502	Not Applicable	0	0	Not Available																								Not Available	TCGA-AG-3901-F38022	49E1ECE9-A495-4072-B759-530DA98392DC	20	Not Applicable	761	Scheduled Follow-up Submission	Not Applicable	NO	8									Unknown	Unknown	NO	Not Available	NO	Alive	2015	FEMALE	Not Available	Rectal Mucinous Adenocarcinoma	NO	No	C19	8480/3	C19.9	YES	NO	Not Available	Not Available	NO	Not Available	20	YES	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	2	Not Available	No	3901	Not Available	WITH TUMOR	Not Available	0.6	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T3	NO	NO	YES	AG	Rectum	NO	Alive	Not Available	2010	2007
TCGA-DY-A0XA	57	FEMALE	159	3846	64	25.31545429373838	Rectal Adenocarcinoma	Rectum	Alive	T3	N0	M0	Stage IIA	0	3846			Not Available		57	Rectosigmoid Junction	TCGA-DY-A0XA	9df9af6b-00b0-47af-aac7-b52dac399ba5	YES	Normal	Not Available	Not Available	21	-21115	Not Applicable	0	3635	3635	TCGA-DY-A0XA-D30448	3A895248-930E-46DE-99A6-2D6B7732C640	Not Available	10	239	47	Mayo 425-20	Complete Response	4	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2012	NOT HISPANIC OR LATINO	TCGA-DY-A0XA-F17214	3CD987E9-DD78-41B5-950C-F0AA56C3F6D2	25	Not Applicable	3846	Scheduled Follow-up Submission	Not Available	Not Available	10									NO	Not Available	Not Available	Not Available	Not Available	Alive	2011	FEMALE	159	Rectal Adenocarcinoma	NO	No	C19	8140/3	C19.9	YES	YES	Not Available	NO	Not Available	Not Available	14	NO	NO	6									Not Available	Not Available	0	0	6	0	Not Available	No	A0XA	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DY-A0XA-R30542	229799B2-D7A6-4815-B8AF-6CD0244C1015	Not Available	12	142	104	Not Available	4	Not Available	4900	NO	Not Available	Not Applicable	ADJUVANT	Not Available	Not Available	2012	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	NO	YES	DY	Rectum	NO	Alive	64	2011	2001
TCGA-AG-3611	72	MALE	Not Available	424	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N0	M0	Stage IIA	0	424			WITH TUMOR		72	Rectum	TCGA-AG-3611	fb632146-92c7-40d9-acc3-6dc4a2d499be	NO	Not Available	Not Available	Not Available	18	-26420	Not Applicable	0	0	31	TCGA-AG-3611-D37634;TCGA-AG-3611-D37635	40EA7062-DFF9-4BC9-9EBA-7AF603EFA401;0D72C3B9-12DB-45F9-8E9B-575140447392	n/a;n/a	5;5	973;973	850;850	Folinic acid;5-Fluorouracil	Complete Response;Complete Response	12;12	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2012	Not Available	TCGA-AG-3611-F38004	24C1EEB8-9025-45F0-B7DC-61DC856F24A6	8	Not Applicable	424	Scheduled Follow-up Submission	Complete Remission/Response	NO	12									NO	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2012	MALE	Not Available	Rectal Adenocarcinoma	YES	No	C19	8140/3	C19.9	YES	NO	Not Available	Not Available	NO	Not Available	19	NO	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	Yes	3611	Not Available	WITH TUMOR	Not Available	Not Available	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	NO	YES	AG	Rectum	NO	Alive	Not Available	2010	2009
TCGA-AG-3906	67	FEMALE	Not Available	608	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T2	N0	M0	Stage I	0	608			WITH TUMOR		67	Rectum	TCGA-AG-3906	ec2abe34-6566-4c2f-8d06-ade2e858b301	NO	Not Available	Not Available	Not Available	18	-24806	Not Applicable	0	0	Not Available																								Not Available	TCGA-AG-3906-F38024	19513288-4BAC-4556-986C-507799ACAD9F	8	Not Applicable	608	Scheduled Follow-up Submission	Complete Remission/Response	NO	12									NO	TUMOR FREE	NO	Not Available	NO	Alive	2012	FEMALE	Not Available	Rectal Adenocarcinoma	NO	No	C19	8140/3	C19.9	YES	NO	Not Available	Not Available	NO	Not Available	26	NO	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	No	3906	Not Available	WITH TUMOR	Not Available	2.4	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	NO	YES	AG	Rectum	NO	Alive	Not Available	2010	2008
TCGA-AH-6549	66	MALE	Not Available	532	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	NX	MX		0	532			Not Available		66	Rectum	TCGA-AH-6549	107cb92b-6231-4e7a-af05-1f5de5981947	Not Available	Not Available	10	YES	21	-24337	Not Applicable	0	6	Not Available																								Not Available	TCGA-AH-6549-F43206	5BB1A23A-31FC-4468-B638-937E583E37E9	15	Not Applicable	532	Scheduled Follow-up Submission	Complete Remission/Response	NO	5									NO	TUMOR FREE	NO	Complete Remission/Response	NO	Alive	2013	MALE	Not Available	Rectal Adenocarcinoma	YES	No	C20	8140/3	C20.9	YES	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7									Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	No	6549	Not Available	Not Available	Not Available	1.8	NO	Not Available	WHITE	Not Available																			RX	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T3	Not Available	NO	YES	AH	Rectum	Not Available	Alive	Not Available	2011	2010
TCGA-AG-A026	66	MALE	Not Available	59	Not Available		Rectal Adenocarcinoma	Rectum	Dead	T4	N0	M0	Stage II	0	59			WITH TUMOR		66	Rectum	TCGA-AG-A026	31bd8589-378c-40e5-8b7f-3b4c81f304be	NO	Not Available	Not Available	Not Available	15	-24413	59	0	Not Available	Not Available																								Not Available																									MALE	Not Available	Rectal Adenocarcinoma	NO	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	15	YES	Not Available	6									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	No	A026	Not Available	WITH TUMOR	Not Available	9.65	YES	Not Available	Not Available	Not Available																			R1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T4	NO	NO	YES	AG	Rectum	YES	Dead	Not Available	2011	2006
TCGA-AG-3885	71	FEMALE	Not Available	546	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N1	M0	Stage IIIB	0	546			WITH TUMOR		71	Rectum	TCGA-AG-3885	e5e4aa9f-6015-4d62-a088-69920d7f2500	NO	Not Available	0	Not Available	18	-26145	Not Applicable	0	0	Not Available	TCGA-AG-3885-D37648;TCGA-AG-3885-D37649	C4BBC4E0-3D66-4633-A05D-4A68AE87C8A7;78CE6B50-B0DA-403C-A9CF-FFF157A9C0CC	n/a;n/a	5;5	Not Available;Not Available	Not Available;365	Unknown;Zoledronic acid	Complete Response;Not Applicable	12;12	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;YES	Chemotherapy;Ancillary	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2012	Not Available	TCGA-AG-3885-F38014	BCAC2361-83FB-4AD8-B897-24DEAB6DD42A	8	Not Applicable	546	Scheduled Follow-up Submission	Complete Remission/Response	NO	12									NO	TUMOR FREE	YES	Complete Remission/Response	YES	Alive	2012	FEMALE	Not Available	Rectal Adenocarcinoma	NO	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	19	YES	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	3	Not Available	No	3885	Not Available	WITH TUMOR	Not Available	Not Available	YES	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-AG-3885-R38358	F747E175-7B33-42B7-A077-B3581BBCF094	Not Available	13	91	30	Complete Response	12	Not Available	50	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T3	NO	NO	YES	AG	Rectum	YES	Alive	Not Available	2010	2008
TCGA-AF-4110	77	MALE	188	912	92	26.02987777274785	Not Available	Not Available	Alive	T4a	N2b	MX	Stage IVA	0	912			TUMOR FREE		77	Rectosigmoid Junction	TCGA-AF-4110	5f10f8e4-a6f9-4643-b210-390bc8fd32bd	NO	Not Available	Not Available	YES	6	-28289	Not Applicable	0	441	Not Available	TCGA-AF-4110-D13658;TCGA-AF-4110-D13664;TCGA-AF-4110-D13665;TCGA-AF-4110-D13666	8e82086a-6e5b-4fd9-b884-c08049426228;0916a9a1-c34b-4f5f-82d9-bd1d903c605e;ea9270b1-82ca-4900-a127-946f0ec99902;cbc1140c-d519-4b62-90fa-5fe35623fa70	Not Available;Not Available;Not Available;Not Available	7;7;7;7	261;261;261;263	65;65;65;65	Oxaliplatin;5FU;Leucovorin;5FU	Not Available;Not Available;Not Available;Not Available	7;7;7;7	9;9;9;9	185;875;500-875;5200	mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;1	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Other, specify in notes;Chemotherapy	Not Available;Not Available;Leucovorin;Not Available	1665;7875;5875;46800	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	NOT HISPANIC OR LATINO	TCGA-AF-4110-F13614;TCGA-AF-4110-F40320	e5cd0dc2-47f4-4c84-a6a7-49decdbd76e3;CA7ADA59-E99E-4F3C-88C9-6E30E422FDBA	7;15	Not Applicable;Not Applicable	441;912	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Not Available;Complete Remission/Response	Not Available;NO	7;2									NO;NO	TUMOR FREE;TUMOR FREE	YES;YES	Not Available;Complete Remission/Response	NO;NO	Alive;Alive	2011;2013	MALE	188	Not Available	NO	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	34	YES	NO	7									Not Available	YES	0	0	5	21	Not Available	No	4110	Not Available	TUMOR FREE	Not Available	28.7	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IVA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N2b	T4a	NO	YES	NO	AF	Not Available	YES	Alive	92	2011	2010
TCGA-AG-3898	61	MALE	Not Available	1461	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N0	M0	Stage IIA	0	1461			WITH TUMOR		61	Rectum	TCGA-AG-3898	5a7d19f9-6be2-45ac-9ffc-11e28594eeee	NO	Not Available	Not Available	Not Available	18	-22492	Not Applicable	0	0	Not Available																								Not Available	TCGA-AG-3898-F38021	5F29FB6E-D451-492A-A14A-D14512960128	8	Not Applicable	1461	Scheduled Follow-up Submission	Complete Remission/Response	NO	12									NO	WITH TUMOR	NO	Not Available	NO	Alive	2012	MALE	Not Available	Rectal Adenocarcinoma	YES	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	21	NO	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	No	3898	Not Available	WITH TUMOR	Not Available	1.98	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	NO	YES	AG	Rectum	NO	Alive	Not Available	2010	2006
TCGA-AG-3581	63	MALE	Not Available	215	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T2	N0	M0	Stage I	0	215			WITH TUMOR		63	Rectum	TCGA-AG-3581	3124e819-292b-48e7-baac-8c5c4a86dc20	NO	Not Available	Not Available	Not Available	18	-23345	Not Applicable	0	31	Not Available																								Not Available	TCGA-AG-3581-F37957	A3B4E567-D491-41A7-ACAD-05643786269E	6	Not Applicable	215	Scheduled Follow-up Submission	Complete Remission/Response	NO	12									NO	TUMOR FREE	NO	Not Available	NO	Alive	2012	MALE	Not Available	Rectal Adenocarcinoma	NO	No	C19	8140/3	C19.9	YES	NO	Not Available	Not Available	NO	Not Available	33	NO	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	No	3581	Not Available	WITH TUMOR	Not Available	.65	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	NO	YES	AG	Rectum	NO	Alive	Not Available	2010	2007
TCGA-F5-6812	67	MALE	188	1110	90	25.464010864644635	Rectal Adenocarcinoma	Rectum	Alive	T3	N0	M0	Stage IIA	0	1110			TUMOR FREE		67	Rectum	TCGA-F5-6812	e5d7bbd4-4f38-4a5a-9966-f44f8a15a10e	NO	Not Available	Not Available	NO	31	-24490	Not Applicable	0	20	Not Available																								NOT HISPANIC OR LATINO	TCGA-F5-6812-F35402;TCGA-F5-6812-F41123;TCGA-F5-6812-F62653	1B6F4C98-4EE1-43C8-99F8-C34B07598DE1;6AE9B448-631F-489D-A13C-2DB49A5E1107;222B6E6D-A861-4EF8-A14A-04D1383A419C	26;12;23	Not Applicable;Not Applicable;Not Applicable	378;742;1110	Scheduled Follow-up Submission;Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response;Complete Remission/Response	NO;NO;NO	9;3;7									NO;NO;NO	TUMOR FREE;TUMOR FREE;TUMOR FREE	NO;NO;NO	Complete Remission/Response;Complete Remission/Response;Complete Remission/Response	NO;NO;NO	Alive;Alive;Alive	2012;2013;2014	MALE	188	Rectal Adenocarcinoma	NO	No	C49.4	8140/3	C49.4	YES	NO	Not Available	Not Available	NO	Not Available	1	NO	Not Available	8									Not Available	NO	Not Available	Not Available	Not Available	0	0	No	6812	NO	TUMOR FREE	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	YES	NO	F5	Rectum	NO	Alive	90	2011	2011
TCGA-AH-6897	48	MALE	180.5	804	86.4	26.519133524144227	Rectal Adenocarcinoma	Rectum	Alive	T2	N0	M0	Stage I	0	804			TUMOR FREE		48	Rectosigmoid Junction	TCGA-AH-6897	182fe81e-9c96-4824-8a8a-28f7c498020f	Not Available	Not Available	30	NO	22	-17536	Not Applicable	0	140	Not Available																								NOT HISPANIC OR LATINO	TCGA-AH-6897-F45570	A1D2E669-7AF0-442D-92CB-4040F8619C46	17	Not Applicable	804	Scheduled Follow-up Submission	Complete Remission/Response	NO	7									NO	TUMOR FREE	NO	Complete Remission/Response	NO	Alive	2013	MALE	180.5	Rectal Adenocarcinoma	NO	No	C19	8140/3	C19.9	YES	Not Available	Not Available	Not Available	NO	Not Available	14	NO	NO	7									Not Available	NO	Not Available	0	Not Available	0	Not Available	No	6897	NO	TUMOR FREE	Not Available	1.23	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	NO	YES	AH	Rectum	NO	Alive	86.4	2011	2010
TCGA-CL-5918	90	FEMALE	Not Available	0	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N0	MX	Stage IIA	0	0			TUMOR FREE		90	Rectosigmoid Junction	TCGA-CL-5918	f49a8e1e-d247-4c76-ac3b-ad8e5d6b8d18	NO	Not Available	6	NO	Not Available	-32873	Not Applicable	0	0	Not Available																								NOT HISPANIC OR LATINO	TCGA-CL-5918-F39671	1F90F52C-DD81-4DD2-8072-19D77606209D	29	Not Applicable	0	Scheduled Follow-up Submission	Complete Remission/Response	NO	1									NO	TUMOR FREE	NO	Complete Remission/Response	NO	Alive	2013	FEMALE	Not Available	Rectal Adenocarcinoma	NO	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	6									Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Available	No	5918	NO	TUMOR FREE	Not Available	2.2	Not Available	Not Available	WHITE	Not Available																			RX	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T3	NO	Not Available	Not Available	CL	Rectum	NO	Alive	Not Available	2011	2008
TCGA-EI-6885	57	FEMALE	164	415	53	19.70553242117787	Rectal Adenocarcinoma	Rectum	Alive	T3	N1b	M1	Stage IV	1	295.0		Locoregional Disease	WITH TUMOR		57	Rectosigmoid Junction	TCGA-EI-6885	3165bf70-df19-4043-bcfc-9ae92197ef72	NO	Not Available	7	NO	21	-21140	Not Applicable	0	160	Not Available	TCGA-EI-6885-D29907	b055a1f4-d417-4577-9543-dac2a5baa90d	Not Available	30	308	69	oxaliplatinum+5 fluorouracilum	Not Available	3	12	Not Available	mg/m2	ADJUVANT	Not Applicable	Not Available	IV	NO	Chemotherapy	Not Available	Not Available	mg	Not Available	2012	NOT HISPANIC OR LATINO	TCGA-EI-6885-F29906	9c177069-a46e-4a81-b825-1197281fba02	30	Not Applicable	415	Scheduled Follow-up Submission	Not Available	Not Available	3	NO	NO	Not Available	295	Locoregional Disease	YES	Not Available	Not Applicable	YES	WITH TUMOR	YES	Not Available	NO	Alive	2012	FEMALE	164	Rectal Adenocarcinoma	NO	No	C20	8211/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	13	YES	Not Available	7									Not Available	NO	Not Available	0	Not Available	2	Not Available	No	6885	YES	WITH TUMOR	Not Available	7868.0	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M1	N1b	T3	NO	YES	NO	EI	Rectum	NO	Alive	53	2011	2011
TCGA-F5-6863	71	FEMALE	166	361	77	27.94309769197271	Rectal Adenocarcinoma	Rectum	Dead	T4a	N1	M0	Stage IIIB	1	191.0			Not Available		71	Rectum	TCGA-F5-6863	72e640f2-869f-4aef-8ebe-b127f3e7048a	NO	Not Available	Not Available	NO	7	-25936	Not Applicable	0	23	Not Available	TCGA-F5-6863-D35412;TCGA-F5-6863-D35413;TCGA-F5-6863-D35414;TCGA-F5-6863-D35415	52352390-D906-4CD9-A1EF-85A68856259C;C49E0FEE-4847-4946-83B7-457EE6C96D86;A8C20AB5-CB1C-4F37-B128-2926781CD0FF;DDBA0B34-8873-49AE-865D-C33764098442	Not Available;Not Available;Not Available;Not Available	26;26;26;26	251;251;251;289	196;196;196;261	Etoposide;Leucovorin;5-Fluorouracil;Xeloda	Stable Disease;Stable Disease;Stable Disease;Clinical Progressive Disease	9;9;9;9	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2012;2012;2012;2012	NOT HISPANIC OR LATINO	TCGA-F5-6863-F35411	833EDE3F-7468-4A8B-9A54-4618AAA31C3C	26	361	Not Available	Scheduled Follow-up Submission	Progressive Disease	NO	9	YES	NO	Not Available	191	Unknown	NO	Not Available	Not Available	YES	WITH TUMOR	NO	Unknown	NO	Dead	2012	FEMALE	166	Rectal Adenocarcinoma	NO	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	6	NO	Not Available	10									Not Available	NO	Discrepancy	Not Available	Discrepancy	3	0	No	6863	NO	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T4a	NO	YES	NO	F5	Rectum	NO	Alive	77	2011	2011
TCGA-EI-6884	71	MALE	166	328	73	26.49150820148062	Rectal Adenocarcinoma	Rectum	Alive	T3	N1	M0	Stage IIIA	0	328			TUMOR FREE		71	Rectosigmoid Junction	TCGA-EI-6884	b2b125c7-8993-4424-b390-048ccccc9d08	NO	Not Available	Not Available	NO	18	-25995	Not Applicable	0	83	Not Available	TCGA-EI-6884-D29853	36a71370-2d4f-45ac-8144-14a8731a5ce6	Not Available	30	Not Available	52	5 fluorouracilum+leucovorin	Not Available	3	Not Available	Not Available	mg/kg	ADJUVANT	Not Applicable	Not Available	IV	YES	Chemotherapy	Not Available	Not Available	mg	Not Available	2012	NOT HISPANIC OR LATINO	TCGA-EI-6884-F29854	53bb0172-842b-4f3c-85b4-12fa8993d34c	30	Not Applicable	328	Scheduled Follow-up Submission	Not Available	Not Available	3									NO	TUMOR FREE	YES	Not Available	NO	Alive	2012	MALE	166	Rectal Adenocarcinoma	NO	No	C20	8211/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	8	NO	NO	7									Not Available	NO	Not Available	0	Not Available	3	Not Available	No	6884	NO	TUMOR FREE	Not Available	10.7	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T3	NO	YES	NO	EI	Rectum	NO	Alive	73	2011	2011
TCGA-AG-3602	66	FEMALE	Not Available	0	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N2	M0	Stage IIIC	0	0			WITH TUMOR		66	Rectum	TCGA-AG-3602	c69dec57-7a84-481b-bcfe-61a771d0a9d1	NO	Not Available	9	Not Available	18	-24350	Not Applicable	0	0	Not Available																								Not Available																									FEMALE	Not Available	Rectal Adenocarcinoma	YES	No	C19	8140/3	C19.9	YES	NO	Not Available	Not Available	NO	Not Available	31	YES	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	5	Not Available	No	3602	Not Available	WITH TUMOR	Not Available	66.9	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T3	NO	NO	YES	AG	Rectum	NO	Alive	Not Available	2010	2007
TCGA-AG-4008	63	MALE	Not Available	518	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N0	M0	Stage IIA	0	518			WITH TUMOR		63	Rectum	TCGA-AG-4008	72802851-9340-4c5f-a90b-23b7afd7577a	NO	Not Available	Not Available	Not Available	18	-23192	Not Applicable	0	31	Not Available	TCGA-AG-4008-D37663;TCGA-AG-4008-D37664	5DD8AC7E-EEB1-4222-99A5-6B18A6A0B3CD;E2E9F3AE-4CA2-4A37-B87C-AD62DCF39099	n/a;n/a	5;5	92;92	61;61	5-Fluorouracil;Folinic acid	Complete Response;Complete Response	12;12	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2012	Not Available	TCGA-AG-4008-F38314	8D76876D-3055-4BCB-B936-84AD2692A892	12	Not Applicable	518	Scheduled Follow-up Submission	Complete Remission/Response	NO	12									NO	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2012	MALE	Not Available	Rectal Adenocarcinoma	NO	No	C18.9	8140/3	C18.9	YES	NO	Not Available	Not Available	NO	Not Available	15	YES	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	Yes	4008	Not Available	WITH TUMOR	Not Available	Not Available	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	NO	YES	AG	Rectum	YES	Alive	Not Available	2010	2008
TCGA-DC-6156	62	MALE	175	943	86.1	28.114285714285714	Rectal Adenocarcinoma	Rectum	Alive	T4a	N2b	M1a	Stage IVA	1	30.0			Discrepancy		62	Rectosigmoid Junction	TCGA-DC-6156	261925e3-96e4-440c-8e95-c003d44ab2f2	NO	Not Available	5	NO	26	-22706	Not Applicable	0	212	Not Available	TCGA-DC-6156-D15198;TCGA-DC-6156-D15196;TCGA-DC-6156-D15197;TCGA-DC-6156-D15199;TCGA-DC-6156-D21979;TCGA-DC-6156-D21980;TCGA-DC-6156-D29374;TCGA-DC-6156-D29373;TCGA-DC-6156-D29375;TCGA-DC-6156-D44758	c3baaf92-b499-4f7a-9431-70b545c0e8d3;60a99194-92a3-4737-a849-330f061aa523;f501c115-db91-4cde-acb1-35d17cf23bed;609c5cb0-e725-45d6-991d-6064fdca9e45;d409689c-b0f7-406a-bb0d-f9f1dc4b774f;54129ecf-0125-45a8-8506-eb8248500ae8;f4c74905-0f74-43ef-993d-bf84e70f61c1;7924ad55-eb1c-47f3-a2b5-aefe07edff8d;e8158296-a375-4c50-a27d-a7021b3a07d3;45C103CA-FAFA-4BE8-96BB-786E15D2D8CA	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	15;15;15;15;22;22;16;16;16;26	334;269;334;334;Not Available;Not Available;Not Available;Not Available;Not Available;761	92;87;92;92;365;395;365;365;365;395	Fluorouracil;Oxaliplatin;Leucovorin;Fluorouracil;Irinotecan HCL;bevacizumab;Fluorouracil;Fluorouracil;Leucovorin;BEVACIZUmab	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Clinical Progressive Disease	8;8;8;8;2;2;3;3;3;6	17;12;17;17;8;6;8;8;8;Not Available	800;170;210;2400;380;480;320;800;100;Not Available	mg;mg;mg;mg;mg;mg;mg;mg;mg;Not Available	PALLIATIVE;PALLIATIVE;PALLIATIVE;PALLIATIVE;PALLIATIVE;PALLIATIVE;PALLIATIVE;PALLIATIVE;PALLIATIVE;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;1;2;2;2;2;2;Not Available	IV;IV;IV;IV;IV;IV;IV;IV;IV;Not Available	NO;NO;NO;NO;YES;YES;YES;YES;YES;NO	Chemotherapy;Chemotherapy;Other, specify in notes;Chemotherapy;Chemotherapy;Immunotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Ancillary agent;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	13600;1830;3570;35500;2800;2880;2368;5920;740;Not Available	mg;mg;mg;mg;mg;mg;mg;mg;mg;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;NO	2011;2011;2011;2011;2012;2012;2012;2012;2012;2013	NOT HISPANIC OR LATINO	TCGA-DC-6156-F14256;TCGA-DC-6156-F21439;TCGA-DC-6156-F44747	8034c36c-4ea9-4b09-92aa-16a065c07755;88be6466-995e-49fe-ad62-19e57d048337;5A7F2351-C51B-4883-BF17-B89A17225F3F	26;13;26	Not Applicable;Not Applicable;Not Applicable	212;457;943	Scheduled Follow-up Submission;Scheduled Follow-up Submission;Scheduled Follow-up Submission	Not Available;Not Available;Progressive Disease	Not Available;Not Available;NO	7;2;6	None;YES;NO	None;NO;NO	None;Not Available;Not Available	None;30;30	None;Unknown;Unknown	None;NO;NO	None;Not Available;Not Available	None;Not Available;Not Available	NO;YES;YES	WITH TUMOR;WITH TUMOR;WITH TUMOR	YES;YES;YES	Not Available;Not Available;Not Applicable	NO;NO;NO	Alive;Alive;Alive	2011;2012;2013	MALE	175	Rectal Adenocarcinoma	NO	No	C19	8140/3	C19.9	YES	YES	Not Available	NO	NO	Not Available	22	YES	Not Available	7									Not Available	NO	Not Available	1	Not Available	7	Not Available	No	6156	YES	Discrepancy	Not Available	129.7	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IVA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M1a	N2b	T4a	NO	YES	NO	DC	Rectum	YES	Alive	86.1	2011	2010
TCGA-EI-6512	64	FEMALE	170	538	61	21.10726643598616	Rectal Adenocarcinoma	Rectum	Alive	T3	N1	M0	Stage IIIB	0	538			TUMOR FREE		64	Rectosigmoid Junction	TCGA-EI-6512	25b43e40-e1f9-42a0-8052-5138f381eed9	NO	Not Available	Not Available	NO	13	-23537	Not Applicable	0	20	Not Available	TCGA-EI-6512-D28635	b21dc457-7653-4411-931f-6d024c1c33c1	Not Available	27	Not Available	20	FOLFOX	Not Available	2	Not Available	Not Available	mg	ADJUVANT	Not Applicable	Not Available	IV	YES	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2012	NOT HISPANIC OR LATINO	TCGA-EI-6512-F28634	803086c2-dd12-4f44-a330-d862b01edd4c	30	Not Applicable	538	Scheduled Follow-up Submission	Not Available	Not Available	1									NO	TUMOR FREE	YES	Not Available	NO	Alive	2012	FEMALE	170	Rectal Adenocarcinoma	NO	No	C20	8263/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	17	NO	Not Available	5									Not Available	NO	Not Available	0	Not Available	1	00	No	6512	NO	TUMOR FREE	Not Available	1.0	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T3	NO	YES	NO	EI	Rectum	NO	Alive	61	2011	2010
TCGA-AF-3914	39	MALE	172.7	1146	64.2	21.52535650114383	Rectal Adenocarcinoma	Rectum	Alive	T3	N2a	M0	Stage IIIB	1	846.0		Locoregional Disease	TUMOR FREE		39	Rectosigmoid Junction	TCGA-AF-3914	3f2ca278-c74a-4aa7-b029-189d9d0b510c	NO	Not Available	Not Available	NO	28	-14426	Not Applicable	0	265	Not Available	TCGA-AF-3914-D10865;TCGA-AF-3914-D10888;TCGA-AF-3914-D10886;TCGA-AF-3914-D10887;TCGA-AF-3914-D10864;TCGA-AF-3914-D41485;TCGA-AF-3914-D41486;TCGA-AF-3914-D41487;TCGA-AF-3914-D41488;TCGA-AF-3914-D41489	742fb3eb-c8eb-4377-ad4b-8f106d302e97;9f639bf0-67cc-4ca3-a738-c7f03a214b21;caf0a7a9-d006-46fa-9810-3cb754a26c74;70ef1e70-9652-476a-a268-1280652bb1a8;359d8f95-b037-463b-bebb-679c31c0ef3e;AC84D228-12BE-44DA-A004-F09C1B574F03;9BF0B463-F451-4BB4-BB19-1675656AE60F;DB0F22AA-0122-4C85-9E00-07A45715A0B0;E946FC49-AEB3-4A51-B943-CDA7CC4A7A31;A35156FA-AFFB-498C-AE11-E35ECC46908E	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	28;28;28;28;28;19;19;19;19;19	294;296;294;294;105;1134;1022;1022;1022;1024	133;133;133;133;61;924;924;924;924;924	oxaliplatin;5 FU;Leucovorin;5 FU;5 FU;Bevacizumab;Leucovorin;Oxaliplatin;Fluorouracil;Fluorouracil IV Continuous infusion over 46 hours	Not Available;Not Available;Not Available;Not Available;Not Available;Clinical Progressive Disease;Stable Disease;Stable Disease;Stable Disease;Stable Disease	4;4;4;4;4;3;3;3;3;3	12;12;12;12;7;Not Available;Not Available;Not Available;Not Available;Not Available	118-150;3330-4416;50-750;555-736;200-410 daily;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;Not Available;Not Available;Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	2;2;2;2;1;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Other, specify in notes;Chemotherapy;Chemotherapy;Targeted Molecular therapy;Ancillary;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	1643;47,508;3150;7918;12265;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;NO;NO;NO;NO;NO	2011;2011;2011;2011;2011;2013;2013;2013;2013;2013	NOT HISPANIC OR LATINO	TCGA-AF-3914-F10221;TCGA-AF-3914-F41446;TCGA-AF-3914-F41483	2e4c493b-8ab4-4702-9df5-76ab606c57f8;E90AF3AA-E606-4766-8F4E-8E25E398E626;E26202AA-E4B0-4EE7-A8CA-4ED7109D9DA2	3;19;19	Not Applicable;Not Applicable;Not Applicable	390;1146;1146	Not Available;Additional New Tumor Event;Additional New Tumor Event	Not Available;Progressive Disease;Progressive Disease	Not Available;NO;NO	5;3;3	None;YES;YES	None;NO;NO	None;869;Not Available	None;846;846	None;Locoregional Disease;Unknown	None;YES;NO	None;Not Available;Not Available	None;Not Applicable;Not Available	NO;YES;YES	TUMOR FREE;WITH TUMOR;WITH TUMOR	YES;YES;YES	Not Available;Complete Remission/Response;Complete Remission/Response	YES;YES;YES	Alive;Alive;Alive	2011;2013;2013	MALE	172.7	Rectal Adenocarcinoma	NO	No	C19	8140/3	C19.9	YES	NO	Not Available	Not Available	NO	Not Available	55	YES	NO	10									Not Available	NO	0	0	5	5	Not Available	No	3914	Not Available	TUMOR FREE	Not Available	1.4	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-AF-3914-R2587	6db0b8bc-4a5b-422b-bcb1-59a594d938ba	1	28	104	61	Not Available	10	30	5400	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	M0	N2a	T3	NO	YES	NO	AF	Rectum	YES	Alive	64.2	2010	2010
TCGA-CL-4957	79	FEMALE	Not Available	425	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N1	M0		0	425			Not Available		79	Not Available	TCGA-CL-4957	a2e47568-eb43-4c89-ad7c-dfbaa2ba7e27	Not Available	Not Available	Not Available	Not Available	7	-29081	Not Applicable	0	425	Not Available	TCGA-CL-4957-D10094;TCGA-CL-4957-D10096;TCGA-CL-4957-D10097;TCGA-CL-4957-D10095	c60e340b-0248-41fe-80fd-cef4fac101f3;d4aea7da-592a-47ce-ae43-a801599416d4;287ad8e2-f73e-4ece-ab30-2fe789f2d532;001b65f0-aff7-4cb6-bf83-050f9370e6ae	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;7	73;73;73;73	42;42;42;42	Oxaliplatin;Fluorouracil;Leucovorin Calcium;Fluorouracil	Not Available;Not Available;Not Available;Not Available	4;4;4;4	3;3;3;3	65;400;400;1200	mg/m2;mg/m2;mg/m2;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	HISPANIC OR LATINO	TCGA-CL-4957-F10093;TCGA-CL-4957-F68869	6035c913-cd17-4dbb-a96a-7344cabf4d3f;BB9D988B-9616-42C9-97AC-77BAF4223A9E	7;22	Not Applicable;Not Available	Not Available;Not Available	Not Available;Scheduled Follow-up Submission	Not Available;Not Applicable	Not Available;NO	4;12									NO;NO	Not Available;Unknown	YES;YES	Not Available;Complete Remission/Response	NO;NO	Alive;Dead	2011;2014	FEMALE	Not Available	Rectal Adenocarcinoma	Not Available	No	C20	8140/3	C20.9	YES	Not Available	Not Available	Not Available	Not Available	Not Available	14	Not Available	Not Available	4									Not Available	Not Available	Not Available	Not Available	Not Available	2	0	No	4957	Not Available	Not Available	Not Available	Not Available	YES	Not Available	Not Available	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Discrepancy	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	M0	N1	T3	Not Available	Not Available	Not Available	CL	Rectum	Not Available	Alive	Not Available	2011	2008
TCGA-EF-5830	54	MALE	182	106	93	28.076319285110493	Rectal Adenocarcinoma	Rectum	Alive	T4a	N0	M0	Stage IIB	0	106			TUMOR FREE		54	Rectum	TCGA-EF-5830	0b6b1937-4024-4f2c-aeca-46387277755f	NO	Not Available	Not Available	NO	15	-19802	Not Applicable	0	15	Not Available																								NOT HISPANIC OR LATINO	TCGA-EF-5830-F69008	68AE9B17-D82E-4FC6-8CFA-D8798ADEE747	24	Not Applicable	106	Scheduled Follow-up Submission	Not Applicable	YES	12									NO	Not Available	NO	Not Applicable	NO	Alive	2014	MALE	182	Rectal Adenocarcinoma	NO	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	Not Available	NO	NO	7									Not Available	NO	Not Available	1	Not Available	Not Available	Not Available	No	5830	NO	TUMOR FREE	Not Available	Not Available	NO	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T4a	NO	NO	YES	EF	Rectum	NO	Alive	93	2011	2010
TCGA-AG-3608	79	FEMALE	Not Available	485	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N0	M0	Stage IIA	0	485			WITH TUMOR		79	Rectum	TCGA-AG-3608	c3760fb2-3b8a-4251-a189-21d56fba5017	NO	Not Available	0	Not Available	18	-29008	Not Applicable	0	0	Not Available																								Not Available	TCGA-AG-3608-F37999	A5563A17-C406-4C7F-A3B4-06B121205E6F	8	Not Applicable	485	Scheduled Follow-up Submission	Complete Remission/Response	NO	12									NO	TUMOR FREE	NO	Not Available	NO	Alive	2012	FEMALE	Not Available	Rectal Adenocarcinoma	YES	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	16	NO	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	No	3608	Not Available	WITH TUMOR	Not Available	Not Available	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	NO	YES	AG	Rectum	NO	Alive	Not Available	2010	2008
TCGA-AG-3578	76	FEMALE	Not Available	974	Not Available		Rectal Mucinous Adenocarcinoma	Rectum	Alive	T3	N0	M0	Stage IIA	0	974			WITH TUMOR		76	Rectum	TCGA-AG-3578	04178a4f-14b0-45ba-aa3e-f21638e23765	NO	Not Available	Not Available	Not Available	18	-27851	Not Applicable	0	0	Not Available																								Not Available	TCGA-AG-3578-F37953	68DEE803-A0C8-48AE-A74A-C4AFE038FF25	6	Not Applicable	974	Scheduled Follow-up Submission	Complete Remission/Response	NO	12									NO	TUMOR FREE	NO	Not Available	NO	Alive	2012	FEMALE	Not Available	Rectal Mucinous Adenocarcinoma	YES	No	C19	8480/3	C19.9	YES	NO	Not Available	Not Available	NO	Not Available	25	NO	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	No	3578	Not Available	WITH TUMOR	Not Available	1.39	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	NO	YES	AG	Rectum	NO	Alive	Not Available	2010	2007
TCGA-CL-5917	71	FEMALE	Not Available	2376	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N2	MX	Stage IIIC	0	2376			TUMOR FREE		71	Rectosigmoid Junction	TCGA-CL-5917	7a285463-76f4-447d-bb04-336bb5ec1009	NO	Not Available	30	YES	Not Available	-26084	Not Applicable	0	1826	Not Available																								NOT HISPANIC OR LATINO	TCGA-CL-5917-F39667	7E32D4AF-107F-4EFE-AB08-7245987D9E05	29	Not Applicable	2376	Scheduled Follow-up Submission	Complete Remission/Response	NO	1									NO	TUMOR FREE	NO	Complete Remission/Response	NO	Alive	2013	FEMALE	Not Available	Rectal Adenocarcinoma	YES	No	C19	8140/3	C19.9	YES	NO	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	6									Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Available	No	5917	YES	TUMOR FREE	Not Available	0.6	Not Available	Not Available	WHITE	Not Available																			RX	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	N2	T3	NO	Not Available	Not Available	CL	Rectum	YES	Alive	Not Available	2011	2006
TCGA-AG-3902	61	MALE	Not Available	974	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N0	M0	Stage IIA	0	974			WITH TUMOR		61	Rectum	TCGA-AG-3902	bcfe4fe9-d090-49f9-85a7-2b472e0f7453	NO	Not Available	Not Available	Not Available	18	-22492	Not Applicable	0	0	Not Available																								Not Available	TCGA-AG-3902-F38023	6CE120F7-F5D0-406E-8039-7A055E83CBAE	8	Not Applicable	974	Scheduled Follow-up Submission	Complete Remission/Response	NO	12									NO	TUMOR FREE	NO	Not Available	NO	Alive	2012	MALE	Not Available	Rectal Adenocarcinoma	YES	No	C19	8140/3	C19.9	YES	NO	Not Available	Not Available	NO	Not Available	17	NO	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	No	3902	Not Available	WITH TUMOR	Not Available	8.14	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	NO	YES	AG	Rectum	NO	Alive	Not Available	2010	2007
TCGA-F5-6813	70	MALE	174	598	85	28.075042938300964	Rectal Adenocarcinoma	Rectum	Dead	T4a	N2	M0	Stage IIIC	1	65.0			Not Available		70	Rectum	TCGA-F5-6813	99d2c035-06a2-4bc3-8ff9-db875d232c93	NO	Not Available	Not Available	NO	31	-25651	Not Applicable	0	21	Not Available																								NOT HISPANIC OR LATINO	TCGA-F5-6813-F36421;TCGA-F5-6813-F41121	6C771380-606F-4064-8988-2086AF4558F7;27764851-F1F1-4249-90EA-60AECCB1FE9E	30;12	Not Applicable;598	252;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Unknown;Not Applicable	NO;NO	10;3	NO;NO	NO;NO	Not Available;Not Available	65;65	Unknown;Unknown	NO;NO	Not Available;Not Available	Not Available;Liver	YES;YES	WITH TUMOR;WITH TUMOR	NO;NO	Unknown;Unknown	NO;NO	Alive;Dead	2012;2013	MALE	174	Rectal Adenocarcinoma	NO	No	C49.4	8140/3	C49.4	YES	NO	Not Available	Not Available	NO	Not Available	12	NO	Not Available	8									Not Available	NO	Not Available	Not Available	Not Available	12	0	No	6813	NO	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T4a	NO	YES	NO	F5	Rectum	NO	Alive	85	2011	2011
TCGA-AF-6672	43	MALE	172.7	748	93.8	31.44981993469301	Rectal Adenocarcinoma	Rectum	Alive	T4a	N2b	MX	Stage IV	1	279.0		Metastatic	TUMOR FREE		43	Rectosigmoid Junction	TCGA-AF-6672	6221496d-40cc-4071-969f-6fbcba4f573c	NO	Not Available	Not Available	NO	2	-15965	Not Applicable	0	224	Not Available	TCGA-AF-6672-D19805;TCGA-AF-6672-D19807;TCGA-AF-6672-D19804;TCGA-AF-6672-D19806	6ff436f2-b6b7-4a69-a1aa-cbc6fe45a89f;dac0f8bc-2057-4165-bc75-9907572612fc;3bf645a0-d4bb-4afe-85e0-bfbe69b64c7e;5d946f3e-2226-4819-bca2-6f6831cae629	Not Available;Not Available;Not Available;Not Available	27;27;27;27	197;199;183;197	43;43;43;43	Leucovorin;Fluorouracil;Oxaliplatin;Fluorouracil	Not Available;Not Available;Not Available;Not Available	12;12;12;12	12;12;11;12	50-200;3690-4968;100-176;615-828	mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;1	IV;IV;IV;IV	NO;NO;NO;NO	Other, specify in notes;Chemotherapy;Chemotherapy;Chemotherapy	Ancillary;Not Available;Not Available;Not Available	1400;51786;1578;8639	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	NOT HISPANIC OR LATINO	TCGA-AF-6672-F19799;TCGA-AF-6672-F40027	af51da2f-ab70-411f-a7f0-64cfb88801d4;9CC906C8-5B65-4F33-80F9-41A23CAEF708	27;11	Not Applicable;Not Applicable	316;748	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Not Available;Progressive Disease	Not Available;NO	12;2	NO;YES	NO;NO	304;Not Available	279;461	Metastatic;Unknown	YES;NO	Not Available;Not Available	Liver;Not Available	YES;YES	Not Available;WITH TUMOR	YES;YES	Not Available;Progressive Disease	YES;YES	Alive;Alive	2011;2013	MALE	172.7	Rectal Adenocarcinoma	YES	No	C19	8140/3	C19.9	YES	YES	12	YES	NO	Not Available	37	YES	NO	9									Not Available	YES	Not Available	0	5	18	Not Available	No	6672	Not Available	TUMOR FREE	Not Available	9.6	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-AF-6672-R19800	54ae1baa-4e5e-486e-b157-f6717a579ed2	1	27	185	146	Not Available	12	28	5040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N2b	T4a	Not Available	YES	NO	AF	Rectum	NO	Alive	93.8	2011	2011
TCGA-EI-6917	33	MALE	176	531	80	25.826446280991735	Rectal Adenocarcinoma	Rectum	Alive	T3	N1	M0	Stage IIIA	0	531			TUMOR FREE		33	Rectum	TCGA-EI-6917	0cb21fb0-520f-4105-99ec-697a335115b5	NO	Not Available	1	NO	18	-12113	Not Applicable	0	237	Not Available	TCGA-EI-6917-D29855	4e8e5e86-a3d0-4b3d-b936-bc4046da5b55	Not Available	30	145	100	5fluorouracil+oxaciplatina+l-folinian discido	Not Available	3	Not Available	3120+132,6+312	mg/m2	ADJUVANT	Not Applicable	Not Available	IV	NO	Chemotherapy	Not Available	Not Available	mg	Not Available	2012	NOT HISPANIC OR LATINO	TCGA-EI-6917-F29856	4991ad3c-b4a2-43c4-ba38-56e1762b511d	30	Not Applicable	531	Scheduled Follow-up Submission	Not Available	Not Available	3									NO	TUMOR FREE	YES	Not Available	NO	Alive	2012	MALE	176	Rectal Adenocarcinoma	NO	No	C20	8255/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	14	NO	Not Available	7									Not Available	NO	Not Available	Not Available	Not Available	3	Not Available	No	6917	NO	TUMOR FREE	Not Available	2.1	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T3	NO	YES	NO	EI	Rectum	NO	Alive	80	2011	2010
TCGA-EI-6881	60	MALE	176	499	86	27.763429752066116	Rectal Adenocarcinoma	Rectum	Alive	T3	N1	M0	Stage IIIA	0	499			TUMOR FREE		60	Rectosigmoid Junction	TCGA-EI-6881	3aecf83e-c614-4ffa-8c82-1b5dadf6509e	NO	Not Available	15	NO	17	-22057	Not Applicable	0	188	Not Available	TCGA-EI-6881-D29850	b66c7bf1-c626-40ca-b707-a3848b2bdd0b	Not Available	30	250	42	5 fluorouracil+leucovorin	Not Available	3	6	Not Available	mg/m2	ADJUVANT	Not Applicable	Not Available	IV	NO	Chemotherapy	Not Available	Not Available	mg	Not Available	2012	NOT HISPANIC OR LATINO	TCGA-EI-6881-F29849	f8458cea-739e-40d1-a783-c5b08fe1e40d	30	Not Applicable	499	Scheduled Follow-up Submission	Not Available	Not Available	3									NO	TUMOR FREE	YES	Not Available	NO	Alive	2012	MALE	176	Rectal Adenocarcinoma	NO	No	C20	8263/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	18	NO	NO	7									Not Available	NO	Not Available	0	Not Available	1	Not Available	No	6881	NO	TUMOR FREE	Not Available	60.3	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T3	Not Available	YES	NO	EI	Rectum	NO	Alive	86	2011	2010
TCGA-AG-3883	69	MALE	Not Available	31	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T2	N0	M0	Stage I	0	31			WITH TUMOR		69	Rectum	TCGA-AG-3883	b6e6e715-ccc5-474f-860a-a10bf1962936	NO	Not Available	Not Available	Not Available	18	-25415	Not Applicable	0	31	Not Available																								Not Available																									MALE	Not Available	Rectal Adenocarcinoma	NO	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	15	YES	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	No	3883	Not Available	WITH TUMOR	Not Available	2.39	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	NO	YES	AG	Rectum	YES	Alive	Not Available	2010	2008
TCGA-AG-A01N	68	FEMALE	Not Available	943	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T2	N0	M1	Stage IV	0	943			WITH TUMOR		68	Rectum	TCGA-AG-A01N	1118490d-75aa-43cc-b2a2-c2af61829ffc	NO	Not Available	Not Available	Not Available	15	-25049	Not Applicable	0	31	Not Available	TCGA-AG-A01N-D37674;TCGA-AG-A01N-D37675;TCGA-AG-A01N-D37676	8793E6F8-2AE4-419F-82DA-05F1528C6AF6;E059357B-5A89-48CC-B169-E79CDB764464;227136E0-CD9A-4B79-9777-3212A6324483	n/a;n/a;n/a	5;5;5	Not Available;457;Not Available	273;273;273	Capecitabine;Oxaliplatin;Bevacizumab	Not Applicable;Partial Response;Not Applicable	12;12;12	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	YES;NO;YES	Chemotherapy;Chemotherapy;Targeted Molecular therapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2012;2012;2012	Not Available	TCGA-AG-A01N-F38513	5D5D2321-AC02-49D8-90C1-DE6DA5B80533	16	Not Applicable	943	Scheduled Follow-up Submission	Partial Remission/Response	NO	12									NO	WITH TUMOR	YES	Partial Remission/Response	NO	Alive	2012	FEMALE	Not Available	Rectal Adenocarcinoma	YES	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	23	YES	Not Available	6									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	Yes	A01N	Not Available	WITH TUMOR	Not Available	Not Available	YES	Not Available	Not Available	Not Available																			R2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M1	N0	T2	NO	NO	YES	AG	Rectum	NO	Alive	Not Available	2011	2009
TCGA-AG-3612	55	FEMALE	Not Available	608	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N1	M0	Stage IIIB	0	608			WITH TUMOR		55	Rectum	TCGA-AG-3612	1543c1da-bde4-41c1-a510-56b62db8cca8	NO	Not Available	0	Not Available	18	-20242	Not Applicable	0	0	Not Available	TCGA-AG-3612-D37636;TCGA-AG-3612-D37637;TCGA-AG-3612-D37638	C4769825-6F3B-421E-B75C-5FEFBE760F7A;ED6FBE6C-F021-4A62-8F36-809D25748C6B;24C1B6B1-A537-45CC-AFFF-36F91F5F59D9	n/a;n/a;n/a	5;5;5	273;273;212	59;59;59	Folinic acid;5-Fluorouracil;Oxaliplatin	Complete Response;Complete Response;Complete Response	12;12;12	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2012;2012;2012	Not Available	TCGA-AG-3612-F38007	BF9872B6-16F1-4EDD-8D92-607EB0C962EC	8	Not Applicable	608	Scheduled Follow-up Submission	Complete Remission/Response	YES	12									NO	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2012	FEMALE	Not Available	Rectal Adenocarcinoma	NO	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	32	NO	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	1	Not Available	Yes	3612	Not Available	WITH TUMOR	Not Available	Not Available	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T3	NO	NO	YES	AG	Rectum	NO	Alive	Not Available	2010	2009
TCGA-AF-A56K	56	MALE	182.5	2635	145.5	43.6854944642522	Rectal Adenocarcinoma	Rectum	Alive	T3	N0	M0	Stage IIA	1	1217.0		Locoregional Disease	TUMOR FREE		56	Sigmoid Colon	TCGA-AF-A56K	BD818AE4-B31A-4616-9303-B8AEE56A848F	NO	Not Available	0	NO	18	-20527	Not Applicable	0	2396	Not Available																								NOT HISPANIC OR LATINO	TCGA-AF-A56K-F51084	49EF5BDD-8904-4FB6-ABA5-E17D5074611B	7	Not Applicable	2635	Scheduled Follow-up Submission	Complete Remission/Response	NO	11									NO	TUMOR FREE	NO	Complete Remission/Response	NO	Alive	2013	MALE	182.5	Rectal Adenocarcinoma	NO	No	C19	8140/3	C19.9	YES	NO	Not Available	Not Available	Not Available	Not Available	44	NO	Unknown	4	YES	YES	1458	1217	Locoregional Disease	YES	R1	Not Applicable	YES	NO	Not Available	0	Not Available	0	Not Available	No	A56K	Unknown	TUMOR FREE	NO	0.5	YES	Complete Remission/Response	BLACK OR AFRICAN AMERICAN	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	NO	YES	AF	Rectum	NO	Alive	145.5	2013	2006
TCGA-DY-A1DF	73	FEMALE	156	734	75	30.81854043392505	Rectal Adenocarcinoma	Rectum	Dead	T3	N2	M0	Stage IIIC	0	734			Not Available		73	Rectosigmoid Junction	TCGA-DY-A1DF	b1a787b6-8e94-4b1b-b063-3338c80eef78	YES	Normal	Not Available	Not Available	Not Available	-26763	734	0	734	734																								NOT HISPANIC OR LATINO																									FEMALE	156	Rectal Adenocarcinoma	Not Available	No	C19	8140/3	C19.9	YES	YES	13	YES	Not Available	Not Available	15	Not Available	NO	5									Not Available	Not Available	0	0	5	5	Not Available	No	A1DF	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	M0	N2	T3	NO	NO	YES	DY	Rectum	Not Available	Dead	75	2011	2001
TCGA-AF-2691	48	FEMALE	167.6	1309	52.4	18.65448476597878	Rectal Adenocarcinoma	Rectum	Alive	T1	N0	M0	Stage I	0	1309			TUMOR FREE		48	Rectum	TCGA-AF-2691	830fd359-abd4-4c99-89e4-2d6bb9ce5637	NO	Not Available	Not Available	NO	28	-17759	Not Applicable	0	323	Not Available																								NOT HISPANIC OR LATINO	TCGA-AF-2691-F2590;TCGA-AF-2691-F41268	ab8576f5-091c-4624-a05c-fe23bb47d532;7020FFED-888A-4FB5-AF5E-D23B31E38E6A	28;14	Not Applicable;Not Applicable	323;1309	Not Available;Scheduled Follow-up Submission	Not Available;Complete Remission/Response	Not Available;NO	10;3									NO;NO	TUMOR FREE;TUMOR FREE	NO;NO	Not Available;Complete Remission/Response	NO;NO	Alive;Alive	2010;2013	FEMALE	167.6	Rectal Adenocarcinoma	NO	No	C19	8140/3	C19.9	YES	NO	Not Available	Not Available	NO	Not Available	17	NO	Not Available	10									Not Available	NO	Not Available	0	Not Available	0	Not Available	No	2691	Not Available	TUMOR FREE	Not Available	1.3	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	NO	AF	Rectum	NO	Alive	52.4	2010	2009
TCGA-F5-6864	74	FEMALE	157	379	78	31.64428577224228	Rectal Adenocarcinoma	Rectum	Alive	T3	N2a	M0	Stage IIIB	0	379			TUMOR FREE		74	Rectum	TCGA-F5-6864	3546a93b-b279-4615-9d5f-5baa787e487e	Not Available	Not Available	Not Available	Not Available	7	-27058	Not Applicable	0	14	Not Available	TCGA-F5-6864-D33874;TCGA-F5-6864-D33875	A7C58EE8-6D8E-465B-879A-863167346D8A;591BBBE2-4B58-48F4-B353-932C79B86C0F	Not Available;Not Available	23;23	191;191	17;17	5-Fluorouracil;Leucovorin	Complete Response;Complete Response	7;7	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Ancillary	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2012	NOT HISPANIC OR LATINO	TCGA-F5-6864-F33873;TCGA-F5-6864-F63126	12027E4A-E5E6-4DEC-8470-5B1CEC99A5A1;AA29FC62-BE82-4DD6-8C0A-13EE5B35EB9D	23;30	Not Applicable;Not Applicable	379;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Not Available	NO;YES	7;9									NO;Not Available	TUMOR FREE;Not Available	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Not Available	2012;2014	FEMALE	157	Rectal Adenocarcinoma	Not Available	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	Not Available	Not Available	4	NO	Not Available	10									Not Available	NO	Not Available	0	Not Available	4	Not Available	No	6864	NO	TUMOR FREE	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N2a	T3	Not Available	YES	NO	F5	Rectum	NO	Alive	78	2011	2011
TCGA-F5-6861	60	FEMALE	162	1160	64	24.386526444139612	Rectal Adenocarcinoma	Rectum	Alive	T3	N0	M0	Stage IIA	0	1160			TUMOR FREE		60	Rectum	TCGA-F5-6861	78499f63-fe28-4b99-9f0e-6002203c4596	NO	Not Available	Not Available	NO	7	-21936	Not Applicable	0	34	Not Available																								NOT HISPANIC OR LATINO	TCGA-F5-6861-F35080;TCGA-F5-6861-F59744	D07B8AE6-9626-434B-BF8B-9ECEA00202FB;26091CBA-9898-45A7-B585-33DDE431C3BA	14;20	Not Applicable;Not Applicable	449;1160	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Unknown;Complete Remission/Response	NO;NO	9;5									NO;NO	TUMOR FREE;TUMOR FREE	NO;NO	Unknown;Complete Remission/Response	NO;NO	Alive;Alive	2012;2014	FEMALE	162	Rectal Adenocarcinoma	NO	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	8	NO	Not Available	10									Not Available	NO	Not Available	Not Available	Not Available	0	0	No	6861	NO	TUMOR FREE	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	YES	NO	F5	Rectum	NO	Alive	64	2011	2011
TCGA-G5-6233	74	MALE	176.9	556	97.7	31.220431263762794	Rectal Adenocarcinoma	Rectum	Dead	T3	N2	M0		1	92.0			WITH TUMOR		74	Sigmoid Colon	TCGA-G5-6233	ff427104-0727-483c-8513-243dec80db9d	NO	Not Available	Not Available	NO	14	-27190	556	0	Not Available	Not Available	TCGA-G5-6233-D21974;TCGA-G5-6233-D21976;TCGA-G5-6233-D21971	5646f05f-fd36-42e5-8ff3-7e36ff7ad118;de57c88f-e829-4be0-8365-eee4b531dd1d;8151e8a5-d1e3-4f9f-b00c-c87ca2e13f6b	Not Available;Not Available;Not Available	6;6;6	270;270;270	117;117;117	Fluorouracil;Leucovorin;Oxaliplatin	Not Available;Not Available;Not Available	2;2;2	9;9;9	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	PROGRESSION;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable	1;1;1	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2012;2012;2012	NOT HISPANIC OR LATINO	TCGA-G5-6233-F21970	5c011f74-6014-40d4-a124-169001c5d838	3	556	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	2	YES	NO	Not Available	92	Unknown	NO	Not Available	Not Available	YES	WITH TUMOR	NO	Not Available	NO	Dead	2012	MALE	176.9	Rectal Adenocarcinoma	NO	No	C20	8140/3	C20.9	YES	YES	12	YES	NO	Not Available	72	YES	Not Available	7									Not Available	YES	Not Available	0	Not Available	27	Not Available	Yes	6233	YES	WITH TUMOR	Not Available	0.5	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Discrepancy	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T3	NO	NO	YES	G5	Rectum	YES	Dead	97.7	2011	2009
TCGA-EI-6509	53	MALE	178	517	82	25.88057063502083	Rectal Adenocarcinoma	Rectum	Alive	T3	N2b	M0	Stage IIIC	1	90.0		Metastatic	TUMOR FREE		53	Rectosigmoid Junction	TCGA-EI-6509	652e503a-1be8-445b-96d6-ff114f911e76	NO	Not Available	60	NO	13	-19666	Not Applicable	0	250	Not Available	TCGA-EI-6509-D28629	04e8bf95-c20c-4276-a4ca-0acf83597ea1	Not Available	27	Not Available	395	FOLFOX	Not Available	2	Not Available	Not Available	mg	ADJUVANT	Not Applicable	Not Available	IV	YES	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2012	NOT HISPANIC OR LATINO	TCGA-EI-6509-F28628	5912c28c-8a8c-470b-9957-574b055f17d6	27	Not Applicable	517	Scheduled Follow-up Submission	Not Available	Not Available	2	NO	NO	127	90	Metastatic	YES	R0	Liver	YES	WITH TUMOR	YES	Not Available	NO	Alive	2012	MALE	178	Rectal Adenocarcinoma	NO	No	C20	8263/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	10	YES	Not Available	5									Not Available	NO	Not Available	Not Available	Not Available	7	0	No	6509	NO	TUMOR FREE	Not Available	2.8	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N2b	T3	NO	YES	NO	EI	Rectum	NO	Alive	82	2011	2010
TCGA-AG-3591	66	FEMALE	Not Available	1035	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N0	M0	Stage IIA	0	1035			WITH TUMOR		66	Rectum	TCGA-AG-3591	a2b6246d-2b80-49c5-968b-694b4e8171dc	NO	Not Available	2	Not Available	18	-24167	Not Applicable	0	0	Not Available	TCGA-AG-3591-D37628	08A34556-1CC3-4842-91F9-25E1D7455F1E	n/a	5	Not Available	Not Available	Unknown	Complete Response	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Chemotherapy	Not Available	Not Available	Not Available	NO	2012	Not Available	TCGA-AG-3591-F37962	517F641F-615B-49DF-9E92-D15E5A102F03	6	Not Applicable	1035	Scheduled Follow-up Submission	Complete Remission/Response	NO	12									NO	TUMOR FREE	YES	Complete Remission/Response	YES	Alive	2012	FEMALE	Not Available	Rectal Adenocarcinoma	YES	No	C19	8140/3	C19.9	YES	NO	Not Available	Not Available	NO	Not Available	16	NO	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	No	3591	Not Available	WITH TUMOR	Not Available	15.72	YES	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-AG-3591-R38352	F8AD5111-4DB0-47DE-9147-176C61D00915	Not Available	13	92	31	Complete Response	12	Not Available	50	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	NO	YES	AG	Rectum	NO	Alive	Not Available	2010	2007
TCGA-AG-3599	70	MALE	Not Available	366	Not Available		Not Available	Rectum	Alive	T2	N0	M0	Stage I	0	366			WITH TUMOR		70	Rectum	TCGA-AG-3599	2a7903cc-345d-48f7-9fec-b4a5f09f8002	NO	Not Available	Not Available	Not Available	18	-25749	Not Applicable	0	30	Not Available																								Not Available	TCGA-AG-3599-F37992	6576F8BC-A53A-45B0-A285-E2C6B99040F4	8	Not Applicable	366	Scheduled Follow-up Submission	Complete Remission/Response	NO	12									NO	TUMOR FREE	NO	Not Available	NO	Alive	2012	MALE	Not Available	Not Available	NO	No	C19	8480/3	C19.9	YES	NO	Not Available	Not Available	NO	Not Available	12	NO	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	No	3599	Not Available	WITH TUMOR	Not Available	3.36	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	NO	YES	AG	Rectum	NO	Alive	Not Available	2010	2007
TCGA-EI-6506	78	FEMALE	162	625	65	24.767565919829295	Rectal Adenocarcinoma	Rectum	Alive	T3	N0	M0	Stage IIA	0	625			TUMOR FREE		78	Rectosigmoid Junction	TCGA-EI-6506	bcb21cdd-2f57-4df0-bbbe-a74fa5a654d6	NO	Not Available	23	NO	9	-28587	Not Applicable	0	232	Not Available																								NOT HISPANIC OR LATINO	TCGA-EI-6506-F28939	7f26f1a0-f9c3-4fbf-813d-e7667f4d9233	2	Not Applicable	625	Scheduled Follow-up Submission	Not Available	Not Available	3									NO	TUMOR FREE	NO	Not Available	NO	Alive	2012	FEMALE	162	Rectal Adenocarcinoma	NO	No	C20	8211/3	C20.9	YES	NO	Not Available	Not Available	Not Available	Not Available	19	NO	Not Available	6									Not Available	NO	Not Available	0	Not Available	0	Not Available	No	6506	YES	TUMOR FREE	Not Available	2.8	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	Not Available	YES	NO	EI	Rectum	NO	Alive	65	2011	2010
TCGA-CI-6624	53	FEMALE	Not Available	1466	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T2	N0	M0	Stage I	0	1466			Not Available		53	Rectosigmoid Junction	TCGA-CI-6624	398da5c2-d9f2-4eb4-9813-21009d3ad048	Not Available	Not Available	Not Available	Not Available	15	-19419	Not Applicable	0	144	Not Available																								NOT HISPANIC OR LATINO	TCGA-CI-6624-F69599	62F4B30E-B9F2-43DD-A3B0-2706A54C4A74	14	Not Applicable	1466	Scheduled Follow-up Submission	Unknown	NO	1									Unknown	Unknown	Unknown	Unknown	Unknown	Alive	2015	FEMALE	Not Available	Rectal Adenocarcinoma	Not Available	No	C20	8140/3	C20.9	YES	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	9									Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6624	NO	Not Available	Not Available	7.0	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	Not Available	NO	YES	CI	Rectum	NO	Alive	Not Available	2011	2011
TCGA-DY-A1DG	75	MALE	175	1566	86	28.081632653061224	Rectal Adenocarcinoma	Rectum	Dead	T3	N1	M1	Stage IVA	1	592.0			Not Available		75	Rectum	TCGA-DY-A1DG	89e4905e-31bb-4125-9262-93f600aed7e5	YES	Normal	Not Available	YES	Not Available	-27396	1566	0	Not Available	Not Available																								NOT HISPANIC OR LATINO	TCGA-DY-A1DG-F19044	FF271A21-AF76-4913-9379-E64D89FC2DE0	2	1566	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	12	Not Available	Not Available	Not Available	592	Unknown	NO	Not Available	Not Available	YES	Not Available	Not Available	Not Available	Not Available	Dead	2011	MALE	175	Rectal Adenocarcinoma	NO	No	C20	8140/3	C20.9	YES	YES	Not Available	NO	Not Available	Not Available	8	Not Available	NO	5									Not Available	Not Available	0	0	5	2	Not Available	No	A1DG	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IVA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	M1	N1	T3	NO	NO	YES	DY	Rectum	Not Available	Dead	86	2011	2000
TCGA-AG-A020	57	FEMALE	Not Available	31	Not Available		Rectal Mucinous Adenocarcinoma	Rectum	Alive	T3	N1	M0	Stage III	0	31			WITH TUMOR		57	Rectum	TCGA-AG-A020	19e46a3d-18c5-4927-8501-2265e2d617b8	NO	Not Available	Not Available	Not Available	15	-20851	Not Applicable	0	31	Not Available	TCGA-AG-A020-D37679;TCGA-AG-A020-D37680;TCGA-AG-A020-D37681	AD098A28-2DA7-4BED-A331-5AA7358A8D28;3881A04C-1D82-4DD6-B894-53A283C12CBE;D2ADA08C-069D-430C-9642-E1F7DCC0513E	n/a;n/a;n/a	5;5;5	212;212;212	31;31;31	Folinic acid;5-Fluorouracil;Oxaliplatin	Complete Response;Complete Response;Complete Response	12;12;12	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2012;2012;2012	Not Available																									FEMALE	Not Available	Rectal Mucinous Adenocarcinoma	NO	No	C20	8480/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	12	YES	Not Available	6									Not Available	Not Available	Not Available	0	Not Available	1	Not Available	No	A020	Not Available	WITH TUMOR	Not Available	1.43	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage III	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T3	NO	NO	YES	AG	Rectum	Not Available	Alive	Not Available	2011	2005
TCGA-BM-6198	73	MALE	Not Available	646	119		Rectal Adenocarcinoma	Rectum	Alive	T3	N1		Stage IIIB	0	646			Not Available		73	Rectum	TCGA-BM-6198	a46be4e1-260c-4ce9-8b0f-1326d90c697f	NO	Not Available	Not Available	NO	14	-26837	Not Applicable	0	310	Not Available	TCGA-BM-6198-D13221	50c06958-f062-4dd4-8af3-2e20727551da	Not Available	21	261	78	Xeloda	Not Available	6	Not Available	Not Available	Not Available	ADJUVANT	Not Applicable	1	PO	NO	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2011	NOT HISPANIC OR LATINO	TCGA-BM-6198-F13216;TCGA-BM-6198-F34043	a02c3a99-0e40-4502-9e84-7146dbd94644;125975C5-0D45-4255-8A2B-D2B4A609AA24	21;26	Not Applicable;Not Applicable	310;646	Not Available;Scheduled Follow-up Submission	Not Available;Complete Remission/Response	Not Available;NO	6;7									NO;NO	TUMOR FREE;TUMOR FREE	YES;NO	Not Available;Complete Remission/Response	YES;NO	Alive;Alive	2011;2012	MALE	Not Available	Rectal Adenocarcinoma	NO	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	11	NO	Not Available	4									Not Available	NO	Not Available	0	Not Available	0	Not Available	Yes	6198	NO	Not Available	Not Available	81.3	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-BM-6198-R13217	4e30045a-d2c1-4b50-9a10-295cb58133bd	1	21	174	139	Not Available	6	23	4140	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Available	N1	T3	NO	YES	NO	BM	Rectum	NO	Alive	119	2011	2010
TCGA-AG-A008	50	FEMALE	Not Available	424	Not Available		Rectal Mucinous Adenocarcinoma	Rectum	Alive	T2	N0	M0	Stage I	0	424			WITH TUMOR		50	Rectum	TCGA-AG-A008	e7503a51-6647-4cc2-80dd-645d0df4db43	NO	Not Available	Not Available	Not Available	15	-18416	Not Applicable	0	0	Not Available																								Not Available	TCGA-AG-A008-F38306	DC1D0381-ED7B-4C3C-9EED-323B032E6057	12	Not Applicable	424	Scheduled Follow-up Submission	Complete Remission/Response	NO	12									NO	TUMOR FREE	NO	Complete Remission/Response	NO	Alive	2012	FEMALE	Not Available	Rectal Mucinous Adenocarcinoma	YES	No	C20	8480/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	28	NO	Not Available	6									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	No	A008	Not Available	WITH TUMOR	Not Available	Not Available	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	NO	YES	AG	Rectum	NO	Alive	Not Available	2011	2009
TCGA-AG-A002	35	MALE	Not Available	638	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T2	N0	M0	Stage I	0	638			WITH TUMOR		35	Rectum	TCGA-AG-A002	cb005c69-7301-41ce-b534-c9751f1436c5	NO	Not Available	Not Available	Not Available	15	-13090	Not Applicable	0	31	Not Available																								Not Available	TCGA-AG-A002-F38304	E0E9D11D-F3C1-41AF-A770-76308215647B	12	Not Applicable	638	Scheduled Follow-up Submission	Complete Remission/Response	NO	12									NO	TUMOR FREE	NO	Complete Remission/Response	NO	Alive	2012	MALE	Not Available	Rectal Adenocarcinoma	NO	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	34	Not Available	Not Available	6									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	No	A002	Not Available	WITH TUMOR	Not Available	Not Available	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	NO	YES	AG	Rectum	Not Available	Alive	Not Available	2011	2009
TCGA-AF-3913	60	MALE	180	316	95.5	29.47530864197531	Rectal Adenocarcinoma	Rectum	Dead	T3	N1	M1	Stage IV	0	316			WITH TUMOR		60	Rectosigmoid Junction	TCGA-AF-3913	03a9dd9d-62ae-4acd-9272-389274858f3d	NO	Not Available	Not Available	YES	8	-21970	316	0	Not Available	Not Available	TCGA-AF-3913-D15342;TCGA-AF-3913-D15339	37cd71bc-2e4e-467d-8695-ebb6dae9c2e0;55dec849-87fa-4e9d-b34a-25d3f86fd865	Not Available;Not Available	19;19	313;313	231;231	Xeloda;Oxaliplatin	Not Available;Not Available	9;9	3;3	Not Available;Not Available	Not Available;Not Available	PALLIATIVE;PALLIATIVE	Not Applicable;Not Applicable	1;1	PO;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2011;2011	NOT HISPANIC OR LATINO	TCGA-AF-3913-F4474	b71024aa-c00c-4044-b065-106e1a7e4755	7	316	Not Available	Not Available	Not Available	Not Available	12									NO	WITH TUMOR	YES	Not Available	NO	Dead	2010	MALE	180	Rectal Adenocarcinoma	NO	No	C19	8140/3	C19.9	YES	YES	Not Available	NO	NO	Not Available	26	YES	Not Available	11									Not Available	NO	Not Available	Not Available	Not Available	1	Not Available	Yes	3913	Not Available	WITH TUMOR	Not Available	41.5	YES	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	M1	N1	T3	YES	YES	NO	AF	Rectum	NO	Dead	95.5	2010	2009
TCGA-AH-6544	60	MALE	177.8	1173	91	28.785771857258	Rectal Adenocarcinoma	Rectum	Alive	T3	N1	M1		0	1173			WITH TUMOR		60	Rectosigmoid Junction	TCGA-AH-6544	835cbd02-4dbb-4273-9704-4b5d272493d7	NO	Not Available	6	Not Available	21	-21977	Not Applicable	0	15	Not Available	TCGA-AH-6544-D58962;TCGA-AH-6544-D58963;TCGA-AH-6544-D58964;TCGA-AH-6544-D72541;TCGA-AH-6544-D72542	A7E20535-8B56-47B9-9317-056575B2B34A;E0872852-6AFB-4304-9F95-06C0DAE1CC66;26178324-9337-4FDE-9138-4CB722F26575;1ED54217-BFD1-4649-BA20-441ACCFBBF6D;135340EA-B051-4018-8B82-1B4FDE8149C5	Not Available;Not Available;Not Available;Not Available;Not Available	29;29;29;13;13	229;365;365;229;229	68;68;243;68;68	Oxaliplatin;Avastin;Xeloda;5-FU;Leucovorin	Stable Disease;Stable Disease;Stable Disease;Stable Disease;Stable Disease	4;4;4;7;7	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Ancillary	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	2014;2014;2014;2015;2015	Not Available	TCGA-AH-6544-F58961	A7CC21F2-5D55-42F0-8C9E-55E9BD5B1B48	29	Not Applicable	1173	Scheduled Follow-up Submission	Stable Disease	NO	4									NO	WITH TUMOR	YES	Stable Disease	NO	Alive	2014	MALE	177.8	Rectal Adenocarcinoma	YES	No	C19	8140/3	C19.9	YES	YES	12	YES	NO	Not Available	20	Not Available	NO	7									Not Available	Not Available	0	0	5	3	Not Available	No	6544	Not Available	WITH TUMOR	Not Available	2497.4	YES	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M1	N1	T3	Not Available	NO	YES	AH	Rectum	Not Available	Alive	91	2011	2010
TCGA-DY-A1DC	72	FEMALE	Not Available	1258	68		Rectal Adenocarcinoma	Rectum	Dead	T3	N0	M0	Stage IIA	1	630.0		Locoregional Disease	Not Available		72	Rectosigmoid Junction	TCGA-DY-A1DC	205f30ff-fb10-44a8-a1c6-c538de100db5	YES	Normal	Not Available	Not Available	Not Available	-26436	1258	0	Not Available	Not Available	TCGA-DY-A1DC-D30402	1DD51FDD-A9D3-4ECD-B3DF-F74DABB7F28D	Not Available	10	828	771	Capecitabine -xeloda	Partial Response	4	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2012	NOT HISPANIC OR LATINO	TCGA-DY-A1DC-F19043	FD4A2C05-AD6E-44F9-8FCC-7F7A2021A946	2	1258	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	12	Not Available	YES	818	630	Locoregional Disease	YES	Not Available	Not Applicable	YES	Not Available	Not Available	Not Available	Not Available	Dead	2011	FEMALE	Not Available	Rectal Adenocarcinoma	Not Available	No	C19	8140/3	C19.9	YES	YES	Not Available	NO	Not Available	Not Available	16	NO	NO	5									Not Available	Not Available	0	Not Available	5	0	Not Available	No	A1DC	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DY-A1DC-R30532	19D4160B-CB4B-4F90-9B09-F2A04B4E88AB	Not Available	12	169	128	Not Available	4	Not Available	Not Available	NO	Not Available	Not Applicable	ADJUVANT	Not Available	Not Available	2012	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	NO	YES	DY	Rectum	NO	Dead	68	2011	2000
TCGA-DY-A1DD	77	FEMALE	156	1741	42	17.25838264299803	Rectal Adenocarcinoma	Rectum	Dead	T3	N1	M0	Stage IIIB	0	1741			Not Available		77	Rectosigmoid Junction	TCGA-DY-A1DD	813bb368-9389-4528-9b18-387374bc912f	YES	Normal	Not Available	Not Available	Not Available	-28159	1741	0	1741	1741																								NOT HISPANIC OR LATINO	TCGA-DY-A1DD-F19086	58653763-6128-40AA-BCF5-01E1D8EF1CC1	2	1741	1741	Scheduled Follow-up Submission	Not Available	Not Available	12									NO	Not Available	Not Available	Not Available	Not Available	Dead	2011	FEMALE	156	Rectal Adenocarcinoma	Not Available	No	C19	8140/3	C19.9	YES	YES	Not Available	NO	Not Available	Not Available	16	Not Available	NO	5									Not Available	Not Available	0	0	5	1	Not Available	No	A1DD	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	M0	N1	T3	NO	NO	YES	DY	Rectum	Not Available	Dead	42	2011	1999
TCGA-F5-6811	72	FEMALE	165	979	88	32.323232323232325	Rectal Adenocarcinoma	Rectum	Alive	T3	N0	M0	Stage IIA	0	979			TUMOR FREE		72	Rectosigmoid Junction	TCGA-F5-6811	cc2a014b-fb3c-4839-a5fb-6c40e745df1b	Not Available	Not Available	Not Available	Not Available	26	-26575	Not Applicable	0	31	Not Available																								NOT HISPANIC OR LATINO	TCGA-F5-6811-F55510	C955DC30-EE36-47C5-B2B9-FE173D6B4105	8	Not Applicable	979	Scheduled Follow-up Submission	Complete Remission/Response	YES	1									NO	TUMOR FREE	NO	Complete Remission/Response	NO	Alive	2014	FEMALE	165	Rectal Adenocarcinoma	NO	No	C19	8140/3	C19.9	YES	Not Available	Not Available	Not Available	Not Available	Not Available	8	NO	NO	8									Not Available	YES	Not Available	0	Not Available	0	0	No	6811	Not Available	TUMOR FREE	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	Not Available	YES	NO	F5	Rectum	NO	Alive	88	2011	2011
TCGA-AF-2693	75	MALE	180.3	1155	107.6	33.09945308998467	Not Available	Not Available	Alive	T2	N0	MX	Stage I	0	1155			TUMOR FREE		75	Sigmoid Colon	TCGA-AF-2693	2faf928d-453a-4d07-b058-b5d4e1d13845	NO	Not Available	Not Available	NO	6	-27443	Not Applicable	0	581	Not Available																								NOT HISPANIC OR LATINO	TCGA-AF-2693-F13591;TCGA-AF-2693-F38391	f7db3277-60f7-40fe-adb7-15a4068bc2b8;20699C1C-39C6-44B3-ADBA-C5E93E7B1B10	6;13	Not Applicable;Not Applicable	581;1155	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Not Available;Not Applicable	Not Available;NO	7;12									NO;NO	TUMOR FREE;TUMOR FREE	NO;Not Available	Not Available;Not Available	NO;Not Available	Alive;Alive	2011;2012	MALE	180.3	Not Available	NO	No	C19	8140/3	C19.9	YES	NO	Not Available	Not Available	NO	Not Available	30	NO	Not Available	7									Not Available	NO	Not Available	0	Not Available	0	Not Available	No	2693	Not Available	TUMOR FREE	Not Available	4.0	YES	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2	NO	YES	NO	AF	Not Available	NO	Alive	107.6	2011	2009
TCGA-EI-6883	63	MALE	180	350	73	22.530864197530864	Rectal Adenocarcinoma	Rectum	Alive	T3	N0	M0	Stage IIC	0	350			TUMOR FREE		63	Rectosigmoid Junction	TCGA-EI-6883	468c2ecb-a21f-49a7-91f3-63d3ef266cf8	NO	Not Available	21	NO	18	-23268	Not Applicable	0	121	Not Available	TCGA-EI-6883-D29852	f1e06e96-ffc3-4cf9-962b-2e718c64a40e	Not Available	30	111	55	5fluorouracil+leucovorin	Not Available	3	3	Not Available	mg/m2	ADJUVANT	Not Applicable	Not Available	IV	NO	Chemotherapy	Not Available	Not Available	mg	Not Available	2012	NOT HISPANIC OR LATINO	TCGA-EI-6883-F29851	121ec34e-c483-471e-9971-3c0f8c1c5642	30	Not Applicable	350	Scheduled Follow-up Submission	Not Available	Not Available	3									NO	TUMOR FREE	YES	Not Available	NO	Alive	2012	MALE	180	Rectal Adenocarcinoma	NO	No	C20	8211/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	16	NO	NO	7									Not Available	NO	Not Available	0	Not Available	0	Not Available	No	6883	NO	TUMOR FREE	Not Available	1.6	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	YES	NO	EI	Rectum	NO	Alive	73	2011	2011
TCGA-AG-A014	86	MALE	Not Available	485	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T2	N0	M0	Stage I	0	485			WITH TUMOR		86	Rectum	TCGA-AG-A014	51c37449-6a2e-4c3d-a7cc-06f901e1224f	NO	Not Available	Not Available	Not Available	15	-31718	Not Applicable	0	485	Not Available																								Not Available																									MALE	Not Available	Rectal Adenocarcinoma	NO	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	15	NO	Not Available	6									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	Yes	A014	Not Available	WITH TUMOR	Not Available	Not Available	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	NO	YES	AG	Rectum	NO	Alive	Not Available	2011	2009
TCGA-AG-A011	80	MALE	Not Available	1126	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N0	M0	Stage IIA	0	1126			WITH TUMOR		80	Rectum	TCGA-AG-A011	3be106bc-ba42-4c70-9b50-697d89db617d	NO	Not Available	1	Not Available	15	-29463	Not Applicable	0	0	Not Available																								Not Available	TCGA-AG-A011-F38509	1FB047EF-E293-40B1-BA39-EDB3780DCBA0	16	Not Applicable	1126	Scheduled Follow-up Submission	Complete Remission/Response	NO	12									NO	TUMOR FREE	NO	Not Available	NO	Alive	2012	MALE	Not Available	Rectal Adenocarcinoma	NO	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	14	NO	Not Available	6									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	No	A011	Not Available	WITH TUMOR	Not Available	Not Available	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	NO	YES	AG	Rectum	NO	Alive	Not Available	2011	2009
TCGA-CI-6622	74	MALE	Not Available	1362	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T4	N0	M0	Stage IIB	0	1362			TUMOR FREE		74	Rectum	TCGA-CI-6622	bd6877a8-06b4-4b95-bed2-15c524068f21	Not Available	Not Available	Not Available	Not Available	15	-27336	Not Applicable	0	212	Not Available	TCGA-CI-6622-D69594;TCGA-CI-6622-D69595;TCGA-CI-6622-D69596;TCGA-CI-6622-D69597	456BA3A9-364D-4109-AB4E-6E5E75B906F2;852704E9-6A87-4723-A643-5414DEE6DAEC;8DD9165C-7657-44D3-9DB9-AF09646B5A24;7E3E8841-F487-467D-AFFE-BA3623C3803B	Not Available;Not Available;Not Available;Not Available	14;14;14;14	97;269;269;269	65;116;116;116	Fluorouracil;Leuocvorin;Fluorouracil;Oxaliplatin	Unknown;Unknown;Unknown;Unknown	1;1;1;1	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2015;2015;2015;2015	NOT HISPANIC OR LATINO	TCGA-CI-6622-F69592	2C2E61F1-9F41-4D75-93C7-45E441A38817	14	Not Applicable	1362	Scheduled Follow-up Submission	Unknown	NO	1									Unknown	Unknown	YES	Unknown	YES	Alive	2015	MALE	Not Available	Rectal Adenocarcinoma	Not Available	No	C20	8140/3	C20.9	YES	Not Available	Not Available	Not Available	Not Available	Not Available	24	YES	Not Available	9									Not Available	Not Available	Not Available	Not Available	Not Available	0	Not Available	No	6622	YES	TUMOR FREE	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Unknown	TCGA-CI-6622-R69593	019A3A30-B70F-488D-8F91-8CECCDF7ECA7	Not Available	14	97	65	Unknown	1	Not Available	Not Available	NO	Unknown	Not Applicable	Not Available	Not Available	Not Available	2015	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T4	Not Available	NO	YES	CI	Rectum	YES	Alive	Not Available	2011	2010
TCGA-AG-4015	85	FEMALE	Not Available	0	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N0	M0	Stage IIA	0	0			WITH TUMOR		85	Rectum	TCGA-AG-4015	1388bba1-02ba-40df-93e5-c3d58b7bbae0	NO	Not Available	Not Available	Not Available	18	-31291	Not Applicable	0	0	Not Available																								Not Available																									FEMALE	Not Available	Rectal Adenocarcinoma	NO	No	C18.9	8140/3	C18.9	YES	NO	Not Available	Not Available	NO	Not Available	24	YES	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	No	4015	Not Available	WITH TUMOR	Not Available	Not Available	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	NO	YES	AG	Rectum	NO	Alive	Not Available	2010	2009
TCGA-F5-6814	57	MALE	175	1131	61	19.918367346938776	Rectal Adenocarcinoma	Rectum	Alive	T3	N0	M0	Stage IIA	0	1131			TUMOR FREE		57	Rectum	TCGA-F5-6814	8feb0e8f-d09b-437d-8651-0cdecfe776bf	NO	Not Available	Not Available	NO	20	-20828	Not Applicable	0	16	Not Available																								NOT HISPANIC OR LATINO	TCGA-F5-6814-F35048;TCGA-F5-6814-F65816	779F082A-7176-4406-8C98-BD5DB0033D21;8CFF640D-DC67-4DDA-908F-023958D4358C	14;30	Not Applicable;Not Applicable	564;1131	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Unknown;Complete Remission/Response	NO;NO	9;9									NO;NO	TUMOR FREE;TUMOR FREE	NO;NO	Unknown;Complete Remission/Response	NO;NO	Alive;Alive	2012;2014	MALE	175	Rectal Adenocarcinoma	NO	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	Not Available	Not Available	18	NO	Not Available	12									Not Available	NO	Not Available	0	Not Available	0	0	No	6814	NO	TUMOR FREE	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	YES	NO	F5	Rectum	NO	Alive	61	2011	2011
TCGA-AG-4007	87	MALE	Not Available	31	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T4	N2	M1	Stage IV	0	31			WITH TUMOR		87	Rectum	TCGA-AG-4007	8e00e7e7-ffaf-44f0-91a7-172671f18e08	NO	Not Available	2	Not Available	18	-31776	Not Applicable	0	31	Not Available																								Not Available																									MALE	Not Available	Rectal Adenocarcinoma	NO	No	C18.9	8140/3	C18.9	YES	NO	Not Available	Not Available	NO	Not Available	34	YES	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	5	Not Available	No	4007	Not Available	WITH TUMOR	Not Available	3.65	YES	Not Available	Not Available	Not Available																			R2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M1	N2	T4	NO	NO	YES	AG	Rectum	NO	Alive	Not Available	2010	2007
TCGA-DC-6160	68	MALE	175.4	1339	100.1	32.53680461925112	Rectal Adenocarcinoma	Rectum	Alive	T2	N0	M0	Stage I	0	1339			TUMOR FREE		68	Rectosigmoid Junction	TCGA-DC-6160	2bd23664-453b-4fbf-823e-6dbcde0c4a2a	NO	Not Available	12	YES	26	-24990	Not Applicable	0	608	Not Available																								NOT HISPANIC OR LATINO	TCGA-DC-6160-F14254;TCGA-DC-6160-F21436;TCGA-DC-6160-F44764	1d0ea0de-0ee7-4ce1-985a-8ad6279a8170;5acec62e-e1c9-4f91-9be0-ac514b405632;5E71EE91-8CD4-40F6-BE71-22B8F49322BA	26;13;26	Not Applicable;Not Applicable;Not Applicable	608;914;1339	Scheduled Follow-up Submission;Scheduled Follow-up Submission;Scheduled Follow-up Submission	Not Available;Not Available;Not Applicable	Not Available;Not Available;NO	7;2;6									NO;NO;NO	TUMOR FREE;TUMOR FREE;TUMOR FREE	NO;NO;NO	Not Available;Not Available;Not Applicable	NO;NO;NO	Alive;Alive;Alive	2011;2012;2013	MALE	175.4	Rectal Adenocarcinoma	NO	No	C19	8140/3	C19.9	YES	NO	Not Available	Not Available	NO	Not Available	8	NO	Not Available	7									Not Available	NO	Not Available	0	Not Available	0	Not Available	No	6160	YES	TUMOR FREE	Not Available	5.2	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	NO	YES	DC	Rectum	YES	Alive	100.1	2011	2009
TCGA-CI-6621	63	MALE	Not Available	419	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N1	MX	Stage IIIB	0	419			Not Available		63	Rectum	TCGA-CI-6621	156cb6c6-b5d4-4ea9-9495-fc972cf9c84a	Not Available	Not Available	Not Available	Not Available	9	-23240	Not Applicable	0	0	Not Available																								NOT HISPANIC OR LATINO	TCGA-CI-6621-F69555	953D756D-AFF0-4FBE-BF41-2AD8F944E27B	13	Not Applicable	419	Scheduled Follow-up Submission	Unknown	NO	1									Unknown	Unknown	YES	Unknown	Unknown	Alive	2015	MALE	Not Available	Rectal Adenocarcinoma	Not Available	No	C20	8140/3	C20.9	YES	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	1									Not Available	Not Available	Not Available	Not Available	Not Available	0	Not Available	No	6621	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N1	T3	Not Available	NO	YES	CI	Rectum	Not Available	Alive	Not Available	2012	2010
TCGA-CI-6620	41	FEMALE	Not Available	1009	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N1	M1	Stage IVA	1	90.0			WITH TUMOR		41	Rectum	TCGA-CI-6620	b26143d3-d458-4d5c-8446-fd2f05707352	Not Available	Not Available	Not Available	Not Available	30	-15322	Not Applicable	0	184	Not Available	TCGA-CI-6620-D69556;TCGA-CI-6620-D69557;TCGA-CI-6620-D69558	1F45E610-2ED5-4BF2-9A0B-213C8802E4ED;9B427929-3285-4A24-8FDD-0ADFCB371A7B;ED3B3488-DA97-4D97-A0A2-C1E0F5900F16	Not Available;Not Available;Not Available	13;13;13	160;160;160	39;39;39	Leucovorin;Fluorouracil;Oxaliplatin	Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease	1;1;1	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Ancillary;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2015;2015;2015	NOT HISPANIC OR LATINO	TCGA-CI-6620-F69554	0513D499-31F9-4FC8-BFA0-28D6038FA2DC	13	Not Applicable	1009	Scheduled Follow-up Submission	Progressive Disease	NO	1	YES	NO	Not Available	90	Unknown	NO	Not Available	Not Available	YES	WITH TUMOR	YES	Progressive Disease	NO	Alive	2015	FEMALE	Not Available	Rectal Adenocarcinoma	Not Available	Yes	C20	8140/3	C20.9	YES	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11									Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6620	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IVA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M1	N1	T3	Not Available	NO	YES	CI	Rectum	Not Available	Alive	Not Available	2011	2010
TCGA-AG-3728	73	MALE	Not Available	912	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N1	M0	Stage IIIB	0	912			WITH TUMOR		73	Rectum	TCGA-AG-3728	856a490c-c6da-48fe-88b5-9fde0f481365	NO	Not Available	10	Not Available	18	-26906	Not Applicable	0	0	Not Available	TCGA-AG-3728-D37639;TCGA-AG-3728-D37640;TCGA-AG-3728-D37641	53588706-BC6B-405C-A6D2-4C7953641320;73B9ADC4-8BF1-4085-B885-844051A7F688;294E64A4-AE56-42C8-A708-559C0DD9689A	n/a;n/a;n/a	5;5;5	61;61;61	61;61;61	Folinic acid;5-Fluorouracil;Oxaliplatin	Complete Response;Complete Response;Complete Response	12;12;12	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2012;2012;2012	Not Available	TCGA-AG-3728-F38295	577CD483-0C80-4A1F-BAB7-67274F2CB012	12	Not Applicable	912	Scheduled Follow-up Submission	Unknown	NO	12									Unknown	Unknown	YES	Complete Remission/Response	NO	Alive	2012	MALE	Not Available	Rectal Adenocarcinoma	YES	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	19	NO	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	3	Not Available	No	3728	Not Available	WITH TUMOR	Not Available	1.89	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T3	YES	NO	YES	AG	Rectum	NO	Alive	Not Available	2010	2006
TCGA-AH-6547	79	FEMALE	Not Available	76	Not Available		Rectal Adenocarcinoma	Rectum	Dead	T3	N0	MX		0	76			TUMOR FREE		79	Rectosigmoid Junction	TCGA-AH-6547	c7162d11-4bdc-41cd-a964-46fc416829db	NO	Not Available	22	YES	4	-29030	Not Applicable	0	44	Not Available																								Not Available	TCGA-AH-6547-F42779	1B86C4DB-B760-410E-8DE8-AD7E62873CC9	30	76	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	NO	4									NO	TUMOR FREE	NO	Complete Remission/Response	NO	Dead	2013	FEMALE	Not Available	Rectal Adenocarcinoma	YES	No	C19	8140/3	C19.9	YES	NO	Not Available	Not Available	NO	Not Available	21	NO	Not Available	8									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	No	6547	Not Available	TUMOR FREE	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T3	Not Available	NO	YES	AH	Rectum	NO	Alive	Not Available	2011	2010
TCGA-AG-3742	85	FEMALE	Not Available	30	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T1	N0	M0	Stage I	0	30			WITH TUMOR		85	Rectum	TCGA-AG-3742	fbcd7e69-533f-4b6c-9868-162139135b58	NO	Not Available	Not Available	Not Available	18	-31078	Not Applicable	0	30	Not Available																								Not Available																									FEMALE	Not Available	Rectal Adenocarcinoma	NO	No	C18.9	8140/3	C18.9	YES	NO	Not Available	Not Available	NO	Not Available	18	Not Available	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	No	3742	Not Available	WITH TUMOR	Not Available	13.78	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	NO	YES	AG	Rectum	Not Available	Alive	Not Available	2010	2004
TCGA-AG-3881	83	FEMALE	Not Available	579	Not Available		Not Available	Rectum	Alive	T3	N0	M0	Stage IIA	0	579			WITH TUMOR		83	Rectum	TCGA-AG-3881	b6ba7313-8e91-4c39-8629-db3e96f4c556	NO	Not Available	Not Available	Not Available	18	-30467	Not Applicable	0	0	Not Available																								Not Available	TCGA-AG-3881-F38012	CB5CC182-6E3F-4A74-A3A6-AFC8DAF02855	8	Not Applicable	579	Scheduled Follow-up Submission	Complete Remission/Response	NO	12									NO	TUMOR FREE	NO	Not Available	NO	Alive	2012	FEMALE	Not Available	Not Available	NO	No	C80.1	8480/3	C80.9	YES	NO	Not Available	Not Available	NO	Not Available	30	YES	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	No	3881	Not Available	WITH TUMOR	Not Available	16	YES	Not Available	Not Available	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	NO	YES	AG	Rectum	YES	Alive	Not Available	2010	2008
TCGA-AG-3890	62	MALE	Not Available	518	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T2	N0	M0	Stage I	0	518			WITH TUMOR		62	Rectum	TCGA-AG-3890	e2d395f8-bf13-4fe4-8031-683b0eedd875	NO	Not Available	Not Available	Not Available	18	-22950	Not Applicable	0	0	Not Available																								Not Available	TCGA-AG-3890-F38016	5D2BAB20-E659-4551-BAA2-CA11D0084633	8	Not Applicable	518	Scheduled Follow-up Submission	Complete Remission/Response	NO	12									NO	TUMOR FREE	NO	Not Available	NO	Alive	2012	MALE	Not Available	Rectal Adenocarcinoma	YES	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	12	YES	Not Available	5									Not Available	Not Available	Not Available	1	Not Available	0	Not Available	Yes	3890	Not Available	WITH TUMOR	Not Available	Not Available	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	NO	YES	AG	Rectum	YES	Alive	Not Available	2010	2009
TCGA-F5-6464	77	FEMALE	159	303	68	26.89767018709703	Rectal Adenocarcinoma	Rectum	Dead	T4b	N2a	M0	Stage IIIC	0	303			Not Available		77	Rectum	TCGA-F5-6464	8b4383b1-a684-41ea-bfb0-c84e6f5b287d	NO	Not Available	Not Available	NO	20	-28168	Not Applicable	0	0	Not Available																								NOT HISPANIC OR LATINO	TCGA-F5-6464-F29829	3E1AF942-0943-4749-A350-BDEB23F68EAE	29	303	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	3									NO	Not Available	NO	Not Available	NO	Dead	2012	FEMALE	159	Rectal Adenocarcinoma	NO	No	C19	8140/3	C19.9	YES	NO	Not Available	Not Available	NO	Not Available	4	NO	Not Available	6									Not Available	NO	Not Available	Not Available	Not Available	4	0	No	6464	NO	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N2a	T4b	NO	YES	NO	F5	Rectum	NO	Alive	68	2011	2011
TCGA-AG-A01J	59	FEMALE	Not Available	31	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N0	M0	Stage IIA	0	31			WITH TUMOR		59	Rectum	TCGA-AG-A01J	a18acb1d-403a-4802-8efb-9085e006f4c5	NO	Not Available	1	Not Available	15	-21581	Not Applicable	0	31	Not Available																								Not Available																									FEMALE	Not Available	Rectal Adenocarcinoma	NO	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	23	NO	Not Available	6									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	No	A01J	Not Available	WITH TUMOR	Not Available	Not Available	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	NO	YES	AG	Rectum	NO	Alive	Not Available	2011	2009
TCGA-AG-A01L	58	MALE	Not Available	0	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N1	M0	Stage IIIB	0	0			WITH TUMOR		58	Rectum	TCGA-AG-A01L	848a5838-8a06-45a9-a3d6-e4ed47b824ab	NO	Not Available	Not Available	Not Available	15	-21369	Not Applicable	0	0	Not Available	TCGA-AG-A01L-D37673	8D57ECE2-11F5-4F08-8457-0FE7CAE7E643	Not Available	5	212	61	5-Fluorouracil	Complete Response	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2012	Not Available																									MALE	Not Available	Rectal Adenocarcinoma	NO	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	47	YES	Not Available	6									Not Available	Not Available	Not Available	0	Not Available	2	Not Available	No	A01L	Not Available	WITH TUMOR	Not Available	Not Available	YES	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-AG-A01L-R38368	3370ED90-BCDB-4646-9AAB-A38E5438CB38	Not Available	13	91	61	Complete Response	12	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Not Available	2012	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T3	NO	NO	YES	AG	Rectum	NO	Alive	Not Available	2011	2009
TCGA-AG-3600	62	MALE	Not Available	184	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N2	M0	Stage IIIC	0	184			WITH TUMOR		62	Rectum	TCGA-AG-3600	17a8d208-fcf6-4480-945c-848d4234aafd	NO	Not Available	10	Not Available	18	-22767	Not Applicable	0	0	Not Available	TCGA-AG-3600-D37630	69707452-630C-4BFE-A48F-B625078F02D9	Not Available	5	92	31	5-Fluorouracil	Complete Response	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2012	Not Available	TCGA-AG-3600-F37993	962BD6CB-56DF-4352-B79A-FC742A8C6AC0	8	Not Applicable	184	Scheduled Follow-up Submission	Complete Remission/Response	NO	12									NO	TUMOR FREE	YES	Complete Remission/Response	YES	Alive	2012	MALE	Not Available	Rectal Adenocarcinoma	YES	No	C19	8140/3	C19.9	YES	NO	Not Available	Not Available	NO	Not Available	45	YES	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	31	Not Available	No	3600	Not Available	WITH TUMOR	Not Available	48.85	YES	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-AG-3600-R38354	93B78164-CB0A-482C-943D-B5E038F0297F	Not Available	13	92	31	Complete Response	12	Not Available	41	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T3	NO	NO	YES	AG	Rectum	NO	Alive	Not Available	2010	2007
TCGA-AG-A02N	67	MALE	Not Available	1885	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N0	M0	Stage II	0	1885			WITH TUMOR		67	Rectum	TCGA-AG-A02N	8ad1c98b-5395-477e-87a8-19dff3a59c26	NO	Not Available	Not Available	Not Available	15	-24687	Not Applicable	0	1885	Not Available	TCGA-AG-A02N-D37687	EB905BAF-E8D7-417B-AA1A-5FA9303ABF20	Not Available	5	89	28	Folinic acid	Complete Response	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2012	Not Available																									MALE	Not Available	Rectal Adenocarcinoma	NO	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	12	YES	Not Available	6									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	No	A02N	Not Available	WITH TUMOR	Not Available	2.07	YES	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-AG-A02N-R38372	C306E25F-03F1-488D-8A9A-72B559B32875	Not Available	13	89	59	Complete Response	12	Not Available	50	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	NO	YES	AG	Rectum	Not Available	Alive	Not Available	2011	2005
TCGA-DC-5869	62	FEMALE	170	943	62.4	21.591695501730104	Rectal Adenocarcinoma	Rectum	Alive	T3	N1a	M0	Stage IIIB	0	943			TUMOR FREE		62	Rectum	TCGA-DC-5869	cd05d121-f107-4c8e-95a8-153a84f5134a	NO	Not Available	14	NO	26	-22676	Not Applicable	0	153	Not Available																								NOT HISPANIC OR LATINO	TCGA-DC-5869-F14251;TCGA-DC-5869-F20518;TCGA-DC-5869-F44744	77dda678-f40a-4512-8e0e-a1ce30b3bfc9;bafb8fb8-690f-46d8-9155-7527fd6c33f3;B69695AC-9228-44DB-80CB-3DB66991DE1B	26;16;26	Not Applicable;Not Applicable;Not Applicable	153;395;943	Scheduled Follow-up Submission;Scheduled Follow-up Submission;Scheduled Follow-up Submission	Not Available;Not Available;Not Applicable	Not Available;Not Available;NO	7;1;6									NO;NO;NO	TUMOR FREE;TUMOR FREE;TUMOR FREE	NO;NO;NO	Not Available;Not Available;Not Applicable	NO;NO;NO	Alive;Alive;Alive	2011;2012;2013	FEMALE	170	Rectal Adenocarcinoma	NO	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	19	NO	Not Available	7									Not Available	NO	Not Available	0	Not Available	1	Not Available	No	5869	NO	TUMOR FREE	Not Available	3.6	YES	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1a	T3	NO	YES	NO	DC	Rectum	NO	Alive	62.4	2011	2010
TCGA-AG-A032	68	MALE	Not Available	1157	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N1	M0	Stage IIIB	1	792.0			WITH TUMOR		68	Rectum	TCGA-AG-A032	0bb786ee-07cf-4853-9b49-ec95cd14e282	NO	Not Available	Not Available	Not Available	15	-24865	Not Applicable	0	31	Not Available	TCGA-AG-A032-D37688	E547F9F9-E8C7-444D-9948-84C39401718F	n/a	5	Not Available	458	Bevacizumab	Not Applicable	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Targeted Molecular therapy	Not Available	Not Available	Not Available	NO	2012	Not Available	TCGA-AG-A032-F38516	BDFAE041-B1B1-4165-9E13-7DECD1F78D56	16	Not Applicable	1157	Scheduled Follow-up Submission	Partial Remission/Response	NO	12	Unknown	Unknown	Not Available	792	Unknown	NO	Not Available	Not Available	YES	WITH TUMOR	YES	Partial Remission/Response	YES	Alive	2012	MALE	Not Available	Rectal Adenocarcinoma	NO	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	16	YES	Not Available	6									Not Available	Not Available	Not Available	0	Not Available	2	Not Available	No	A032	Not Available	WITH TUMOR	Not Available	7.77	YES	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-AG-A032-R38373	E8E3A0C6-BFF9-4346-B4B4-77958AB2F5DD	Not Available	13	92	61	Partial Response	12	Not Available	50	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T3	NO	NO	YES	AG	Rectum	YES	Alive	Not Available	2011	2007
TCGA-AG-3584	60	MALE	Not Available	730	Not Available		Rectal Adenocarcinoma	Rectum	Dead	T3	N2	M1	Stage IV	0	730			WITH TUMOR		60	Rectum	TCGA-AG-3584	b2c48624-a483-4b1d-9155-c0c80ed2f7a0	NO	Not Available	2	Not Available	18	-22189	Not Applicable	0	0	Not Available	TCGA-AG-3584-D37619;TCGA-AG-3584-D37620;TCGA-AG-3584-D37621;TCGA-AG-3584-D37622;TCGA-AG-3584-D37623;TCGA-AG-3584-D37624;TCGA-AG-3584-D37625;TCGA-AG-3584-D37626;TCGA-AG-3584-D37627	FB261DCE-FD6C-4A15-AA2E-ABE3012E6B22;079392F9-28CE-40D9-8097-908D753F5F41;1B4F9FA3-8976-4771-B187-EAFB66D56DB9;A2894A8C-69C0-42F7-8A2F-F63A9150C893;6B518DAA-0328-44A6-902E-ED9122718F0D;5C31B440-ED68-435C-89C1-337C2C1B9498;C91698E7-82FD-4FD9-B3C7-50E589A064F5;7F381F5C-41AD-4C61-974F-48B497AA77D4;B834783E-DAAC-45FF-9BDC-028EB4A7A879	n/a;n/a;n/a;n/a;n/a;n/a;n/a;n/a;n/a	5;5;5;5;5;5;5;5;5	274;274;274;396;396;396;580;580;580	92;92;92;335;335;335;427;427;427	Folinic acid;5-Fluorouracil;Irinotecan;Folinic acid;5-Fluorouracil;Oxaliplatin;Irinotecan;Irinotecan;Irinotecan	Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease	12;12;12;12;12;12;12;12;12	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO;NO;NO;NO	2012;2012;2012;2012;2012;2012;2012;2012;2012	Not Available	TCGA-AG-3584-F37960	7D8D99F8-7D40-4C9F-A65B-4F1E027C1B12	6	730	Not Available	Scheduled Follow-up Submission	Progressive Disease	NO	12									NO	WITH TUMOR	YES	Progressive Disease	NO	Dead	2012	MALE	Not Available	Rectal Adenocarcinoma	NO	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	34	YES	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	20	Not Available	No	3584	Not Available	WITH TUMOR	Not Available	36.7	YES	Not Available	Not Available	Not Available																			R2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M1	N2	T3	NO	NO	YES	AG	Rectum	YES	Alive	Not Available	2010	2008
TCGA-AG-3594	77	MALE	Not Available	61	Not Available		Rectal Mucinous Adenocarcinoma	Rectum	Dead	T3	N0	M0	Stage IIA	0	61			WITH TUMOR		77	Rectum	TCGA-AG-3594	ca8374a4-ce94-4091-aa9e-44339a7c4b22	NO	Not Available	0	Not Available	18	-28277	Not Applicable	0	0	Not Available																								Not Available	TCGA-AG-3594-F37967	D79BC200-C885-4E23-BFA5-839BD9F3CB14	6	61	Not Available	Scheduled Follow-up Submission	Unknown	NO	12									Unknown	Unknown	NO	Not Available	NO	Dead	2012	MALE	Not Available	Rectal Mucinous Adenocarcinoma	YES	No	C19	8480/3	C19.9	YES	NO	Not Available	Not Available	NO	Not Available	25	NO	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	No	3594	Not Available	WITH TUMOR	Not Available	2.99	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	NO	YES	AG	Rectum	NO	Alive	Not Available	2010	2007
TCGA-EI-7004	37	FEMALE	172	257	88	29.745808545159544	Rectal Mucinous Adenocarcinoma	Rectum	Alive	T4a	N2b	M0		0	257			TUMOR FREE		37	Rectosigmoid Junction	TCGA-EI-7004	b2db7f47-540f-4bd3-81bb-d686b0225201	NO	Not Available	30	NO	18	-13566	Not Applicable	0	62	Not Available	TCGA-EI-7004-D29858	f1a23525-1b5a-4f36-93f3-2c78da97de62	Not Available	30	188	41	xeloda	Not Available	3	7	Not Available	mg/m2	ADJUVANT	Not Applicable	Not Available	IV	NO	Chemotherapy	Not Available	Not Available	mg	Not Available	2012	NOT HISPANIC OR LATINO	TCGA-EI-7004-F29857	24449210-a8d9-453a-a9e6-4b9a490f414f	30	Not Applicable	257	Scheduled Follow-up Submission	Not Available	Not Available	3									NO	TUMOR FREE	YES	Not Available	NO	Alive	2012	FEMALE	172	Rectal Mucinous Adenocarcinoma	NO	No	C19	8480/3	C19.9	YES	NO	Not Available	Not Available	NO	Not Available	30	YES	NO	7									Not Available	NO	Not Available	0	Not Available	30	Not Available	No	7004	NO	TUMOR FREE	Not Available	3.2	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Discrepancy	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N2b	T4a	Not Available	YES	NO	EI	Rectum	NO	Alive	88	2011	2011
TCGA-AG-3894	65	MALE	Not Available	426	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N0	M0	Stage IIA	0	426			WITH TUMOR		65	Rectum	TCGA-AG-3894	065b26fc-6827-44d5-83d8-1100c63fcda6	NO	Not Available	Not Available	Not Available	18	-23954	Not Applicable	0	30	Not Available	TCGA-AG-3894-D37655	E4102A2F-8A6F-4B7C-9E20-3970FC3DD124	Not Available	5	245	61	5-Fluorouracil	Complete Response	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2012	Not Available	TCGA-AG-3894-F38020	2022E30D-185C-4BF5-8602-17AAFAED7CC6	8	Not Applicable	426	Scheduled Follow-up Submission	Complete Remission/Response	NO	12									NO	TUMOR FREE	YES	Complete Remission/Response	YES	Alive	2012	MALE	Not Available	Rectal Adenocarcinoma	YES	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	15	YES	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	No	3894	Not Available	WITH TUMOR	Not Available	Not Available	YES	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-AG-3894-R38360	1D19B143-2456-4A5D-AE81-53C9D60E422D	Not Available	13	92	61	Complete Response	12	Not Available	50	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	NO	YES	AG	Rectum	YES	Alive	Not Available	2010	2009
TCGA-AG-3909	69	FEMALE	Not Available	608	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N1	M0	Stage IIIB	0	608			WITH TUMOR		69	Rectum	TCGA-AG-3909	769880ae-34d9-405e-8ea7-33ba47cf2dd2	NO	Not Available	Not Available	NO	18	-25537	Not Applicable	0	0	Not Available	TCGA-AG-3909-D37656;TCGA-AG-3909-D37657;TCGA-AG-3909-D37658	9844876F-EB16-49BC-86DC-FCCAC4BD3B19;AAB0F90D-B954-464B-9589-2484E0399046;117DFF8F-E037-4B98-8108-AB8562BC27F8	n/a;n/a;n/a	5;5;5	243;243;182	62;62;62	Folinic acid;5-Fluorouracil;Oxaliplatin	Complete Response;Complete Response;Complete Response	12;12;12	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2012;2012;2012	Not Available	TCGA-AG-3909-F38302	F4B63998-15DD-4D28-8F92-0A49CFD46C76	12	Not Applicable	608	Scheduled Follow-up Submission	Complete Remission/Response	NO	12									NO	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2012	FEMALE	Not Available	Rectal Adenocarcinoma	NO	No	C19	8140/3	C19.9	YES	NO	Not Available	Not Available	NO	Not Available	35	YES	Not Available	5									Not Available	Not Available	Not Available	2	Not Available	3	Not Available	No	3909	Not Available	WITH TUMOR	Not Available	Not Available	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T3	NO	NO	YES	AG	Rectum	NO	Alive	Not Available	2010	2008
TCGA-AH-6643	50	MALE	180.5	1314	84.4	25.905264692566817	Rectal Adenocarcinoma	Rectum	Dead	T3	N2b	M0	Stage IIIC	1	1026.0			TUMOR FREE		50	Rectosigmoid Junction	TCGA-AH-6643	bd0ddc1e-ba3b-4719-a2fa-776f0475dd8a	NO	Not Available	4	NO	19	-18273	Not Applicable	0	21	Not Available	TCGA-AH-6643-D57835;TCGA-AH-6643-D57836;TCGA-AH-6643-D57837	A3494B7C-E0B1-4449-A8D8-3C4470AF9AB4;8010F585-8B53-441B-9465-DED992A7E34E;85D44224-0FAD-4FD4-B75C-8AFCAF6CBF8D	Not Available;Not Available;Not Available	27;27;27	202;202;202	41;41;41	Oxaliplatin;5-FU;Leucovorin	Complete Response;Complete Response;Complete Response	3;3;3	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Ancillary	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	Not Available	TCGA-AH-6643-F57833	E55FEF42-0380-4C61-B1DE-B0916442927F	27	1314	Not Available	Scheduled Follow-up Submission	Progressive Disease	NO	3	NO	NO	Not Available	1026	Unknown	NO	Not Available	Not Available	YES	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2014	MALE	180.5	Rectal Adenocarcinoma	NO	No	C19	8140/3	C19.9	YES	NO	Not Available	Not Available	NO	Not Available	15	NO	Not Available	7									Not Available	YES	Not Available	0	Not Available	8	Not Available	No	6643	NO	TUMOR FREE	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N2b	T3	NO	NO	YES	AH	Rectum	NO	Alive	84.4	2011	2010
TCGA-AF-2689	41	FEMALE	163	1201	55.5	20.88900598441793	Rectal Adenocarcinoma	Rectum	Dead	T3	N2	M1	Stage IV	1	301.0			WITH TUMOR		41	Rectosigmoid Junction	TCGA-AF-2689	335d0351-3740-4847-9ff4-be2f078c70f7	NO	Not Available	Not Available	NO	5	-15082	Not Applicable	0	482	Not Available	TCGA-AF-2689-D2997;TCGA-AF-2689-D3030;TCGA-AF-2689-D3028;TCGA-AF-2689-D3029;TCGA-AF-2689-D2996;TCGA-AF-2689-D3001;TCGA-AF-2689-D3007;TCGA-AF-2689-D2991;TCGA-AF-2689-D2998;TCGA-AF-2689-D3024;TCGA-AF-2689-D3308;TCGA-AF-2689-D3309;TCGA-AF-2689-D3307;TCGA-AF-2689-D4053	8675aae4-8055-487a-b80a-4e53c4629f87;22e444fa-7135-4389-bad0-7f7bcdc45420;4d891da7-ccc2-4b3e-b531-0bbd6385e6a6;1dcab074-5ee4-4818-89bf-d7fdd9de8818;772bc81b-8c06-48f0-a915-68df8ceba7eb;6dd36a05-450e-45a0-b0c5-579a3b63651b;bf52814b-2808-468b-9ae6-49608c492c80;5ae8e910-5b3a-4fb0-8bd2-f37b9756c396;0cd90c9e-bd4f-4cbf-ad1d-dd6d457912e7;e843e98b-59be-4d00-b606-7eaf5e9d9ac7;8c673e37-976e-454d-841d-a0888f2d93ed;7eefebc0-11fd-4028-87c6-cab921f47ab3;5df65b50-c401-4ff5-af88-293a113e284a;62a137f0-ba1f-4bfa-a6cc-cfe749a79ca4	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	5;5;5;5;5;5;5;5;5;5;12;12;12;24	267;346;344;344;267;269;344;239;267;344;559;559;559;559	85;316;316;316;85;85;316;85;85;316;379;462;379;379	Oxaliplatin;5FU;Leucovorin;5FU;Leucovorin;5FU;Aflibercept/ Placebo Study;Bevacizumab;5FU;Irinotecan;Camptosar;Avastin;FUDR (Floxuridine);Leucovorin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11;11;11;11;11;11;11;11;11;11	11;3;3;3;12;12;3;10;12;3;Not Available;Not Available;Not Available;Not Available	50-129;3408-3456;568-576;568-576;600;3480-3648;175-180;229.5 - 259.1;580-608;256-259;330-430;500-515;1135-1500;710-760	mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg	PALLIATIVE;PROGRESSION;PROGRESSION;PROGRESSION;PALLIATIVE;PALLIATIVE;PROGRESSION;PALLIATIVE;PALLIATIVE;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;1;1;1;1;1;1;1;2;2;2;2	IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Other, specify in notes;Other, specify in notes;Chemotherapy;Other, specify in notes;Other, specify in notes;Chemotherapy;Other, specify in notes;Targeted Molecular therapy;Chemotherapy;Chemotherapy;Other, specify in notes;Chemotherapy;Targeted Molecular therapy;Chemotherapy;Other, specify in notes	Not Available;Velour 10262 Study- Aflibercept/Placebo (4mg/kg) every 2 weeks with Irinotecan/5FU Combination (FOLFIRI);Other Ancillary-Velour 10262 Study- Aflibercept/Placebo (4mg/kg) every 2 weeks with Irinotecan/5FU Combination (FOLFIRI);Velour 10262 Study- Aflibercept/Placebo (4mg/kg) every 2 weeks with Irinotecan/5FU Combination (FOLFIRI);Ancillary;Not Available;Velour 10262 Study- Aflibercept/Placebo (4mg/kg) every 2 weeks with Irinotecan/5FU Combination (FOLFIRI);Not Available;Not Available;Velour 10262 Study- Aflibercept/Placebo (4mg/kg) every 2 weeks with Irinotecan/5FU Combination (FOLFIRI);Not Available;Not Available;Not Available;Ancillary	707;10296;1716;1716;7200;42192;537;2363.5;7032;772;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010;2010;2010;2010;2010;2010;2010;2010;2010;2010	NOT HISPANIC OR LATINO	TCGA-AF-2689-F3299;TCGA-AF-2689-F34683;TCGA-AF-2689-F34721;TCGA-AF-2689-F34761	67b84c68-c27f-4cca-9a78-97f170fe362a;6062AC06-4371-495B-A7AB-B59EB997DEE2;30BF5D9D-16C0-4348-A146-D06C856FD8FB;836C3D65-5AD5-41BB-9BE8-5D3B9CF0024C	12;28;30;30	Not Applicable;1201;1201;1201	546;Not Available;Not Available;Not Available	Not Available;Additional New Tumor Event;Additional New Tumor Event;Additional New Tumor Event	Not Available;Progressive Disease;Progressive Disease;Progressive Disease	Not Available;NO;NO;NO	11;8;8;8	YES;YES;NO;NO	NO;NO;NO;NO	Not Available;Not Available;Not Available;Not Available	301;461;1134;1134	Unknown;Unknown;Unknown;Unknown	NO;NO;NO;NO	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	YES;YES;YES;YES	WITH TUMOR;WITH TUMOR;WITH TUMOR;WITH TUMOR	YES;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;Not Available;Not Available;Not Available	Alive;Dead;Dead;Dead	2010;2012;2012;2012	FEMALE	163	Rectal Adenocarcinoma	NO	No	C19	8140/3	C19.9	YES	YES	13	YES	NO	Not Available	32	YES	Not Available	11									Not Available	NO	Not Available	Not Available	Not Available	6	Not Available	No	2689	Not Available	WITH TUMOR	Not Available	6.0	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	M1	N2	T3	NO	YES	NO	AF	Rectum	NO	Alive	55.5	2010	2009
TCGA-AG-3593	72	FEMALE	Not Available	1035	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N0	M0	Stage IIA	0	1035			WITH TUMOR		72	Rectum	TCGA-AG-3593	10290e91-9784-4f94-8daa-b5d9a8b0efb9	NO	Not Available	2	Not Available	18	-26480	Not Applicable	0	0	Not Available	TCGA-AG-3593-D37629	F0328A7A-9B62-404F-AC16-CA9495F2E404	Not Available	5	92	61	5-Fluorouracil	Complete Response	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2012	Not Available	TCGA-AG-3593-F37965	4E44995A-B8E7-4642-93AF-4B02C6E1876E	6	Not Applicable	1035	Scheduled Follow-up Submission	Complete Remission/Response	NO	12									NO	TUMOR FREE	YES	Complete Remission/Response	YES	Alive	2012	FEMALE	Not Available	Rectal Adenocarcinoma	NO	No	C19	8140/3	C19.9	YES	NO	Not Available	Not Available	NO	Not Available	38	NO	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	No	3593	Not Available	WITH TUMOR	Not Available	9.76	YES	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-AG-3593-R38353	70576A03-AF1B-4F84-B629-6F9D88A70FAC	Not Available	13	92	61	Complete Response	12	Not Available	50	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	NO	YES	AG	Rectum	NO	Alive	Not Available	2010	2007
TCGA-EI-7002	58	MALE	185	364	93	27.173119065010958	Rectal Adenocarcinoma	Rectum	Alive	T3	N2	M1	Stage IV	0	364			WITH TUMOR		58	Rectum	TCGA-EI-7002	2b1783da-9ede-4590-b96a-6b0eabc8777f	NO	Not Available	9	NO	21	-21192	Not Applicable	0	84	Not Available	TCGA-EI-7002-D29904	cfb19b7d-cb95-4630-a70b-ccae74ce829b	Not Available	30	224	67	IRINOTECAN+5-fluorouracilim	Not Available	3	12	Not Available	mg/m2	ADJUVANT	Not Applicable	Not Available	IV	NO	Chemotherapy	Not Available	Not Available	mg	Not Available	2012	NOT HISPANIC OR LATINO	TCGA-EI-7002-F29903	1189c8c7-3bbd-49d3-9ef1-3c85e6a88838	30	Not Applicable	364	Scheduled Follow-up Submission	Not Available	Not Available	3									NO	TUMOR FREE	YES	Not Available	NO	Alive	2012	MALE	185	Rectal Adenocarcinoma	NO	No	C20	8211/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	13	YES	Not Available	7									Not Available	NO	Not Available	0	Not Available	7	Not Available	No	7002	Not Available	WITH TUMOR	Not Available	140.0	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M1	N2	T3	NO	YES	NO	EI	Rectum	NO	Alive	93	2011	2011
TCGA-EI-6510	77	FEMALE	150	556	59	26.22222222222222	Rectal Adenocarcinoma	Rectum	Alive	T2	N0	MX		0	556			TUMOR FREE		77	Rectosigmoid Junction	TCGA-EI-6510	093ca3a7-f545-468a-85ed-a35c3da03628	NO	Not Available	29	NO	9	-28328	Not Applicable	0	14	Not Available																								NOT HISPANIC OR LATINO	TCGA-EI-6510-F28933	deaacf40-9e9d-4232-bd5d-0ff4ff7bc80d	2	Not Applicable	556	Scheduled Follow-up Submission	Not Available	Not Available	3									NO	TUMOR FREE	NO	Not Available	NO	Alive	2012	FEMALE	150	Rectal Adenocarcinoma	Not Available	No	C20	8263/3	C20.9	YES	NO	Not Available	Not Available	Not Available	Not Available	3	NO	Not Available	6									Not Available	YES	Not Available	0	Not Available	0	Not Available	No	6510	YES	TUMOR FREE	Not Available	11.2	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Discrepancy	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2	Not Available	YES	NO	EI	Rectum	NO	Alive	59	2011	2010
TCGA-F5-6571	62	FEMALE	166	1288	80	29.031789809841776	Rectal Adenocarcinoma	Rectum	Alive	T3	N0	M0	Stage IIA	1	122.0		Metastatic	TUMOR FREE		62	Rectum	TCGA-F5-6571	85947797-54b8-44fb-910b-5cd689542994	NO	Not Available	Not Available	NO	23	-22666	Not Applicable	0	26	Not Available	TCGA-F5-6571-D29834;TCGA-F5-6571-D53525;TCGA-F5-6571-D53527;TCGA-F5-6571-D53530;TCGA-F5-6571-D53531;TCGA-F5-6571-D65905;TCGA-F5-6571-D65907;TCGA-F5-6571-D65909;TCGA-F5-6571-D65922;TCGA-F5-6571-D65923;TCGA-F5-6571-D65924	857CE230-D7C1-4EC3-A8E3-327337A6A5CD;2B9D27E5-E361-4657-8DA6-21B9D8454DFD;2F82A9D7-83B1-4A8F-9EC8-D81BDCBF24B4;08406C00-17CA-42E1-BB5F-919DD9BE7FD8;E3940B66-3CF4-4484-A360-2A1E70F345EB;AF8F3EF6-1533-41EA-9E07-49767EF773FB;752ADA80-5EDC-4F56-AEF4-F64C81591C01;EB1AB997-77FB-4F19-A8CE-2B4F475F4548;BFAF1A47-D8B9-4307-AB33-423277F0B8F8;55F67205-87D7-49DF-85D4-77DBA50B9A0A;82FA8F68-90F5-42E8-8ABF-5A8C488D0F1E	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	29;12;12;12;12;1;1;1;1;1;1	350;813;952;952;952;1157;1157;1157;Not Available;Not Available;Not Available	226;770;847;847;847;1065;1065;1065;1065;1255;1255	Capecitabine;Mitomycin;5-Fluorouracil;Leucovorin;Oxaliplatin;Irinotecan;Leucovorin;5-Fluorouracil;Bevacizumab;Oxaliplatin;Gemcitabine	Not Available;Clinical Progressive Disease;Complete Response;Complete Response;Complete Response;Stable Disease;Stable Disease;Stable Disease;Not Applicable;Not Applicable;Not Applicable	3;12;12;12;12;10;10;10;10;10;10	6;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	4;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	g/day;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	RECURRENCE;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	PO;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO;NO;NO;YES;YES;YES	Chemotherapy;Chemotherapy;Chemotherapy;Ancillary;Chemotherapy;Chemotherapy;Ancillary;Chemotherapy;Targeted Molecular therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	336;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	g/day;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	2012;2013;2013;2013;2013;2014;2014;2014;2014;2014;2014	NOT HISPANIC OR LATINO	TCGA-F5-6571-F29833;TCGA-F5-6571-F53522;TCGA-F5-6571-F53534	2A3B4B12-541A-47F4-A361-7F76C73DF422;B35975A1-4FAD-466A-88DD-3B8E83AE96FB;A2043FB3-CF3D-4C8A-86F7-B8395DCA9B03	29;12;12	Not Applicable;Not Applicable;Not Applicable	392;952;1288	Scheduled Follow-up Submission;Scheduled Follow-up Submission;Scheduled Follow-up Submission	Not Available;Complete Remission/Response;Stable Disease	Not Available;NO;NO	3;12;12	YES;YES;YES	NO;NO;NO	150;Not Available;Not Available	122;660;1059	Metastatic;Unknown;Unknown	YES;NO;NO	RX;Not Available;Not Available	Liver;Liver;Liver	YES;YES;YES	TUMOR FREE;TUMOR FREE;WITH TUMOR	NO;NO;NO	Not Available;Complete Remission/Response;Complete Remission/Response	NO;NO;NO	Alive;Alive;Alive	2012;2013;2013	FEMALE	166	Rectal Adenocarcinoma	NO	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	2	NO	Not Available	8									Not Available	NO	Not Available	Not Available	Not Available	0	0	No	6571	NO	TUMOR FREE	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	YES	NO	F5	Rectum	NO	Alive	80	2011	2011
TCGA-DC-6155	31	FEMALE	163	425	55.3	20.813730287176785	Rectal Adenocarcinoma	Rectum	Alive	T2	N1b	M0	Stage IIIA	0	425			TUMOR FREE		31	Rectosigmoid Junction	TCGA-DC-6155	eb75ca70-e60f-453f-820c-485390abad88	NO	Not Available	15	NO	26	-11381	Not Applicable	0	225	Not Available	TCGA-DC-6155-D15164;TCGA-DC-6155-D15163;TCGA-DC-6155-D15168;TCGA-DC-6155-D15166	0b815912-6451-40de-8bdf-676366ba19f1;c6d39c6c-9b36-4771-9d2b-f7fd8791e5f4;2280d088-6312-4936-90a6-1076aecf0b11;f7f4fe18-913d-4ce0-82a3-d4dc4d4b8759	Not Available;Not Available;Not Available;Not Available	12;12;12;12	239;71;239;239	57;57;57;57	Leucovorin;Oxaliplatin;Fluorouracil;Fluorouracil	Not Available;Not Available;Not Available;Not Available	8;8;8;8	11;2;12;12	160-650;130;1900;650-600	mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;1	IV;IV;IV;IV	NO;NO;NO;NO	Other, specify in notes;Chemotherapy;Chemotherapy;Chemotherapy	Ancillary agent;Not Available;Not Available;Not Available	5970;260;22800;7600	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	NOT HISPANIC OR LATINO	TCGA-DC-6155-F14246;TCGA-DC-6155-F21438	0f656363-f199-4bec-961d-8749f3342458;0782a1e8-9553-4100-bf08-26a519b83272	26;13	Not Applicable;Not Applicable	225;425	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Not Available;Not Available	Not Available;Not Available	7;2									NO;NO	TUMOR FREE;TUMOR FREE	YES;YES	Not Available;Not Available	NO;NO	Alive;Alive	2011;2012	FEMALE	163	Rectal Adenocarcinoma	NO	No	C19	8140/3	C19.9	YES	NO	Not Available	Not Available	YES	Not Available	31	NO	Not Available	7									Not Available	NO	Not Available	1	Not Available	3	Not Available	No	6155	NO	TUMOR FREE	Not Available	1.3	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1b	T2	NO	YES	NO	DC	Rectum	YES	Alive	55.3	2011	2010
TCGA-DC-5337	69	MALE	165	792	69.4	25.49127640036731	Rectal Adenocarcinoma	Rectum	Alive	T1	N0	M0	Stage I	0	792			TUMOR FREE		69	Rectosigmoid Junction	TCGA-DC-5337	016c9c14-4c88-49f5-a11a-dd4bc282f11e	NO	Not Available	35	NO	3	-25202	Not Applicable	0	304	304																								NOT HISPANIC OR LATINO	TCGA-DC-5337-F11065;TCGA-DC-5337-F20427;TCGA-DC-5337-F37186	541a1401-c6ec-4c84-b5db-9db899663e57;07fcffc8-aaff-44af-9e9e-b11080d91515;CB413DCF-CEFD-4662-992F-E2EE74C49E46	3;Not Available;29	Not Applicable;Not Applicable;Not Applicable	304;457;792	Not Available;Scheduled Follow-up Submission;Scheduled Follow-up Submission	Not Available;Not Available;Unknown	Not Available;Not Available;NO	5;1;11									NO;NO;NO	Discrepancy;TUMOR FREE;TUMOR FREE	NO;NO;NO	Not Available;Not Available;Unknown	NO;NO;NO	Alive;Alive;Alive	2011;2012;2012	MALE	165	Rectal Adenocarcinoma	NO	No	C19	8140/3	C19.9	YES	NO	Not Available	Not Available	NO	Not Available	18	NO	Not Available	5									Not Available	NO	Not Available	0	Not Available	0	Not Available	No	5337	NO	TUMOR FREE	Not Available	2	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	NO	DC	Rectum	NO	Alive	69.4	2011	2010
TCGA-AF-6655	66	MALE	173	609	53.2	17.77540178422266	Rectal Adenocarcinoma	Rectum	Alive	T2	N1	M0	Stage IIIA	0	609			TUMOR FREE		66	Rectum	TCGA-AF-6655	ce2e0f1c-60ff-4f93-8bba-4f4d3ccac37c	NO	Not Available	Not Available	NO	15	-24417	Not Applicable	0	194	Not Available																								NOT HISPANIC OR LATINO	TCGA-AF-6655-F19775;TCGA-AF-6655-F39414	5926098b-3927-4026-92ba-6ea25afdda4c;B3B69DDC-12FE-4DCD-826A-C2E517F69848	23;22	Not Applicable;Not Applicable	355;609	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Not Available;Complete Remission/Response	Not Available;NO	12;1									NO;NO	TUMOR FREE;TUMOR FREE	NO;NO	Not Available;Complete Remission/Response	NO;NO	Alive;Alive	2011;2013	MALE	173	Rectal Adenocarcinoma	YES	No	C19	8140/3	C19.9	YES	NO	Not Available	Not Available	YES	MLH1-Expressed;MSH2-Expressed;PMS2-Expressed;MSH6-Expressed	29	YES	NO	8									Not Available	NO	0	0	4	2	Not Available	No	6655	Not Available	TUMOR FREE	Not Available	1.6	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2	NO	YES	NO	AF	Rectum	NO	Alive	53.2	2011	2010
TCGA-AG-3892	57	FEMALE	Not Available	396	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T1	N0	M0	Stage I	0	396			WITH TUMOR		57	Rectum	TCGA-AG-3892	ded3feb2-1079-4520-a7ca-f5b5fc73d7c5	NO	Not Available	Not Available	Not Available	18	-20880	Not Applicable	0	31	Not Available																								Not Available	TCGA-AG-3892-F38018	C50631C8-CD29-4443-970B-3AB492922E7E	8	Not Applicable	396	Scheduled Follow-up Submission	Complete Remission/Response	NO	12									NO	TUMOR FREE	NO	Complete Remission/Response	NO	Alive	2012	FEMALE	Not Available	Rectal Adenocarcinoma	NO	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	17	Not Available	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	No	3892	Not Available	WITH TUMOR	Not Available	Not Available	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	NO	YES	AG	Rectum	Not Available	Alive	Not Available	2010	2009
TCGA-AG-4021	84	FEMALE	Not Available	121	Not Available		Rectal Adenocarcinoma	Rectum	Dead	T3	N2	M1	Stage IV	1				WITH TUMOR		84	Rectum	TCGA-AG-4021	6dafce6c-b2a9-4b23-b9f8-b71e01616389	YES	Not Available	Not Available	Not Available	18	-31015	Not Applicable	0	0	Not Available																								Not Available	TCGA-AG-4021-F38318	3B59F395-585D-48A1-9E25-96B50C5B8380	12	121	Not Available	Scheduled Follow-up Submission	Progressive Disease	NO	12	Unknown	Unknown	Not Available	0	Unknown	NO	Not Available	Not Available	YES	WITH TUMOR	NO	Not Available	NO	Dead	2012	FEMALE	Not Available	Rectal Adenocarcinoma	YES	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	17	YES	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	5	Not Available	No	4021	Not Available	WITH TUMOR	Not Available	3101	YES	Not Available	Not Available	Not Available																			R2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M1	N2	T3	NO	NO	YES	AG	Rectum	YES	Alive	Not Available	2010	2005
TCGA-AG-3891	66	FEMALE	Not Available	548	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T2	N0	M0	Stage I	0	548			WITH TUMOR		66	Rectum	TCGA-AG-3891	d461e83a-7f09-4e4c-ac49-f05766a6051a	NO	Not Available	Not Available	Not Available	18	-24411	Not Applicable	0	30	Not Available																								Not Available	TCGA-AG-3891-F38017	55926AA9-64C6-41AA-9E9C-0A5B1893A549	8	Not Applicable	548	Scheduled Follow-up Submission	Complete Remission/Response	NO	12									NO	TUMOR FREE	NO	Not Available	NO	Alive	2012	FEMALE	Not Available	Rectal Adenocarcinoma	YES	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	13	YES	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	No	3891	Not Available	WITH TUMOR	Not Available	Not Available	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	NO	YES	AG	Rectum	Not Available	Alive	Not Available	2010	2009
TCGA-AG-3592	68	MALE	Not Available	1035	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N0	M0	Stage IIA	0	1035			WITH TUMOR		68	Rectum	TCGA-AG-3592	12f1d449-4da3-460d-b4f3-9e1232440a8b	Not Available	Not Available	Not Available	Not Available	18	-25141	Not Applicable	0	0	Not Available																								Not Available	TCGA-AG-3592-F37964	4F10CE94-C30D-4351-9251-83994FCD1D5D	6	Not Applicable	1035	Scheduled Follow-up Submission	Complete Remission/Response	NO	12									NO	TUMOR FREE	NO	Not Available	NO	Alive	2012	MALE	Not Available	Rectal Adenocarcinoma	YES	No	C19	8140/3	C19.9	YES	NO	Not Available	Not Available	NO	Not Available	32	NO	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	No	3592	Not Available	WITH TUMOR	Not Available	.96	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	NO	YES	AG	Rectum	NO	Alive	Not Available	2010	2007
TCGA-AF-A56N	47	FEMALE	165.1	360	78.1	28.652128310173783	Rectal Adenocarcinoma	Rectum	Alive	T3	N0	M0	Stage IIA	0	360			TUMOR FREE		47	Rectum	TCGA-AF-A56N	811F3FEB-A5A9-48B1-ACDA-FBB23FCBCF16	Unknown	Not Available	Not Available	NO	11	-17480	Not Applicable	0	138	Not Available	TCGA-AF-A56N-D42111;TCGA-AF-A56N-D42114	5A29766B-D0E7-47E8-BB9B-21A9A9E7F331;9BCDA4FD-AF03-4003-9FD6-36343C7BB81C	Not Available;Not Available	11;11	95;347	54;159	xeloda;xeloda	Complete Response;Complete Response	4;4	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	NOT HISPANIC OR LATINO	TCGA-AF-A56N-F51140	0A37BF85-A860-4A9A-A6C8-A44E2786799F	8	Not Applicable	360	Scheduled Follow-up Submission	Complete Remission/Response	NO	11									NO	TUMOR FREE	YES	Complete Remission/Response	YES	Alive	2013	FEMALE	165.1	Rectal Adenocarcinoma	NO	No	C19	8140/3	C19.9	YES	Unknown	Not Available	Not Available	YES	MLH1-Expressed;MSH2-Expressed;PMS2-Expressed;MSH6-Expressed	33	NO	NO	4									NO	NO	0	0	5	0	Not Available	No	A56N	Not Available	TUMOR FREE	YES	9.5	YES	Complete Remission/Response	BLACK OR AFRICAN AMERICAN	YES	Primary Tumor Field	TCGA-AF-A56N-R42108	13C9FA18-FACB-43ED-B9E2-B54D13703B9C	Not Available	11	95	54	Complete Response	4	28	5040	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	YES	NO	AF	Rectum	NO	Alive	78.1	2013	2012
TCGA-F5-6702	71	MALE	172	869	76	25.689561925365062	Rectal Adenocarcinoma	Rectum	Dead	T3	N1	M1	Stage IVA	1	368.0			WITH TUMOR		71	Rectosigmoid Junction	TCGA-F5-6702	f1ce4b5f-55d0-4989-a5f3-6b6e591538b2	Not Available	Not Available	Not Available	NO	31	-26123	Not Applicable	0	66	Not Available	TCGA-F5-6702-D46350;TCGA-F5-6702-D46351;TCGA-F5-6702-D46352	AE38DEA3-6C5A-423C-B49F-86D4DCE40ED9;4A439625-FA84-45EC-817B-67C23AFE1E37;A119CEAA-1B12-4770-B8B6-D4D1D7A38F0F	Not Available;Not Available;Not Available	6;6;6	641;641;551	370;370;340	5-Fluorouracil;Polyplatillen;Oxaliplatin	Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease	8;8;8	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2013;2013;2013	NOT HISPANIC OR LATINO	TCGA-F5-6702-F46648;TCGA-F5-6702-F31161	96B57819-168C-4C4E-A5BB-66664450A232;DE208906-8BA5-4980-BD0B-7EFF18DBA78A	13;6	869;Not Applicable	Not Available;452	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Progressive Disease;Not Available	NO;Not Available	8;8	YES;YES	NO;NO	Not Available;Not Available	368;368	Unknown;Unknown	NO;NO	Not Available;Not Available	Not Available;Not Available	YES;YES	WITH TUMOR;WITH TUMOR	NO;NO	Progressive Disease;Not Available	NO;NO	Dead;Alive	2013;2013	MALE	172	Rectal Adenocarcinoma	Not Available	No	C19	8140/3	C19.9	YES	Not Available	Not Available	Not Available	Not Available	Not Available	12	NO	Not Available	8									Not Available	NO	Not Available	1	Not Available	1	Not Available	No	6702	NO	WITH TUMOR	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IVA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M1	N1	T3	NO	YES	NO	F5	Rectum	NO	Alive	76	2011	2010
TCGA-DC-6681	70	FEMALE	151	790	63.1	27.67422481470111	Rectal Adenocarcinoma	Rectum	Alive	T3	N2a	M1a	Stage IVA	0	790			TUMOR FREE		70	Rectosigmoid Junction	TCGA-DC-6681	3e97286f-8aa8-4b6a-b339-d7a8e30f60c2	YES	Normal	15	NO	Not Available	-25659	Not Applicable	0	181	Not Available	TCGA-DC-6681-D17003;TCGA-DC-6681-D17004;TCGA-DC-6681-D17001;TCGA-DC-6681-D17005	70773b35-24f4-40be-8d08-4e29f9b40993;db7f6761-c134-48ba-b2f3-df57a979b4b1;0389e5fe-ae72-4684-8857-a1786571f0fc;f49b8f63-3f14-47e6-ac92-e3fe637e5299	Not Available;Not Available;Not Available;Not Available	29;29;29;29	136;136;136;136	38;38;38;38	fluorouracil;Leucovorin Calcium;Fluorouracil;Oxaliplatin	Not Available;Not Available;Not Available;Not Available	9;9;9;9	8;8;8;8	1900;160;600;110	mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;1	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Other, specify in notes;Chemotherapy;Chemotherapy	Not Available;Ancillary;Not Available;Not Available	15200;1280;3920;850	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	NOT HISPANIC OR LATINO	TCGA-DC-6681-F15645;TCGA-DC-6681-F30874;TCGA-DC-6681-F44768	7b430910-c285-49df-a62f-c051525a7edb;3708e8da-af41-4b95-a021-6f4905c95963;13C09BEB-2E53-4E36-BE53-633C6FBD9291	Not Available;18;26	Not Applicable;Not Applicable;Not Applicable	181;394;790	Scheduled Follow-up Submission;Scheduled Follow-up Submission;Scheduled Follow-up Submission	Not Available;Not Available;Not Applicable	Not Available;Not Available;NO	8;4;6									NO;NO;NO	TUMOR FREE;TUMOR FREE;TUMOR FREE	YES;YES;YES	Not Available;Not Available;Not Applicable	NO;NO;NO	Alive;Alive;Alive	2011;2012;2013	FEMALE	151	Rectal Adenocarcinoma	NO	No	C19	8140/3	C19.9	YES	YES	12	YES	NO	Not Available	24	YES	Not Available	8									Not Available	NO	Not Available	0	Not Available	7	Not Available	No	6681	YES	TUMOR FREE	Not Available	7.9	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IVA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M1a	N2a	T3	NO	YES	NO	DC	Rectum	YES	Alive	63.1	2011	2011
TCGA-AG-3587	65	MALE	Not Available	1400	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T2	N0	M0	Stage I	1	1216.0			WITH TUMOR		65	Rectum	TCGA-AG-3587	c9632a8b-dcfe-4480-a8ad-482f55b8cfa2	NO	Not Available	Not Available	Not Available	18	-24075	Not Applicable	0	31	Not Available																								Not Available	TCGA-AG-3587-F37961	C944AE17-F197-4B93-B985-B63FC6463C55	6	Not Applicable	1400	Scheduled Follow-up Submission	Unknown	NO	12	Unknown	Unknown	Not Available	1216	Unknown	NO	Not Available	Not Available	YES	TUMOR FREE	NO	Unknown	YES	Alive	2012	MALE	Not Available	Rectal Adenocarcinoma	NO	No	C20	8140/3	C20.9	YES	Not Available	Not Available	NO	NO	Not Available	17	NO	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	No	3587	Not Available	WITH TUMOR	Not Available	1.41	YES	Not Available	Not Available	Not Available	Distant Recurrence	TCGA-AG-3587-R38351	52A5AD86-5B9F-4198-80CE-BCCAC130C028	Not Available	13	1369	1308	Unknown	12	Not Available	63	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	NO	YES	AG	Rectum	NO	Alive	Not Available	2010	2007
TCGA-AG-3605	85	FEMALE	Not Available	30	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N1	M1	Stage IV	0	30			WITH TUMOR		85	Rectum	TCGA-AG-3605	a744d4a3-f99a-46ce-9b3f-8ee8835e67ec	NO	Not Available	Not Available	Not Available	18	-31078	Not Applicable	0	30	Not Available																								Not Available																									FEMALE	Not Available	Rectal Adenocarcinoma	NO	No	C19	8140/3	C19.9	YES	NO	Not Available	Not Available	NO	Not Available	13	YES	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	3	Not Available	No	3605	Not Available	WITH TUMOR	Not Available	23.09	YES	Not Available	Not Available	Not Available																			R2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M1	N1	T3	NO	NO	YES	AG	Rectum	YES	Alive	Not Available	2010	2008
TCGA-AG-3609	65	FEMALE	Not Available	608	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N2	M0	Stage IIIC	0	608			WITH TUMOR		65	Rectum	TCGA-AG-3609	81dac02c-6e5f-4afe-9c90-12b5a4f26594	NO	Not Available	Not Available	Not Available	18	-23925	Not Applicable	0	0	Not Available	TCGA-AG-3609-D37631;TCGA-AG-3609-D37632;TCGA-AG-3609-D37633	DA3F2436-7363-4949-967D-5030F2F0C5D2;5E269C7F-6E92-4C6D-BC05-F089CC7FCA62;AE9AEFB7-BB2B-4B63-B031-2CAF2DB86DC3	Not Available;Not Available;Not Available	5;5;5	212;212;90	31;31;31	Folinic acid;5-Fluorouracil;Oxaliplatin	Complete Response;Complete Response;Complete Response	12;12;12	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2012;2012;2012	Not Available	TCGA-AG-3609-F38002	4079154D-89C9-43B5-8A09-C640D11057AB	8	Not Applicable	608	Scheduled Follow-up Submission	Complete Remission/Response	NO	12									NO	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2012	FEMALE	Not Available	Rectal Adenocarcinoma	NO	No	C19	8140/3	C19.9	YES	NO	Not Available	Not Available	NO	Not Available	42	YES	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	4	Not Available	No	3609	Not Available	WITH TUMOR	Not Available	Not Available	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T3	NO	NO	YES	AG	Rectum	NO	Alive	Not Available	2010	2008
TCGA-AH-6644	73	MALE	Not Available	838	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	NX	MX		0	838			TUMOR FREE		73	Rectosigmoid Junction	TCGA-AH-6644	d9121e5a-88f2-47a6-a0b1-25735c209e54	Not Available	Not Available	30	NO	20	-26892	Not Applicable	0	22	Not Available																								Not Available	TCGA-AH-6644-F42780	05D8E4BD-4800-4F9F-8B8E-3A8692F6FD26	30	Not Applicable	838	Scheduled Follow-up Submission	Complete Remission/Response	NO	4									NO	TUMOR FREE	NO	Complete Remission/Response	NO	Alive	2013	MALE	Not Available	Rectal Adenocarcinoma	YES	No	C19	8140/3	C19.9	YES	Not Available	Not Available	Not Available	Not Available	Not Available	15	NO	Not Available	7									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	No	6644	Not Available	TUMOR FREE	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T3	Not Available	NO	YES	AH	Rectum	NO	Alive	Not Available	2011	2010
TCGA-EI-6511	52	MALE	165	482	69	25.34435261707989	Rectal Adenocarcinoma	Rectum	Alive	T3	N1	M0	Stage IIIB	0	482			TUMOR FREE		52	Rectum	TCGA-EI-6511	d004a083-6dc6-4db6-96d0-88a8ca3b1b93	NO	Not Available	Not Available	YES	9	-19237	Not Applicable	0	121	Not Available	TCGA-EI-6511-D28932	CA39B724-0291-4EB0-87A1-D85C280C3964	Not Available	2	182	161	oxaliplatinum+5-FU	Not Available	3	3	Not Available	mg/m2/day	ADJUVANT	Not Applicable	Not Available	IV	NO	Chemotherapy	Not Available	Not Available	mg	Not Available	2012	NOT HISPANIC OR LATINO	TCGA-EI-6511-F28930	E798707B-0F2C-4F9A-BA35-032DDF99D55D	2	Not Applicable	482	Scheduled Follow-up Submission	Not Available	Not Available	3									NO	TUMOR FREE	YES	Not Available	YES	Alive	2012	MALE	165	Rectal Adenocarcinoma	NO	No	C20	8263/3	C20.9	YES	NO	Not Available	Not Available	Not Available	Not Available	18	YES	Not Available	6									Not Available	NO	Not Available	Not Available	Not Available	4	Not Available	No	6511	YES	TUMOR FREE	Not Available	14.9	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T3	Not Available	YES	NO	EI	Rectum	NO	Alive	69	2011	2010
TCGA-G5-6235	72	MALE	169.0	1696	77.6	27.169917019712194	Rectal Adenocarcinoma	Rectum	Alive	T3	N1	MX	Stage IIIB	1	1042.0			WITH TUMOR		72	Rectosigmoid Junction	TCGA-G5-6235	c2ea7b58-cabd-407e-98ce-6cbf9e4d93e1	NO	Not Available	Not Available	NO	14	-26348	Not Applicable	0	1451	Not Available	TCGA-G5-6235-D21956;TCGA-G5-6235-D21953;TCGA-G5-6235-D21955	b0ca40c0-6174-4371-bf39-12d2ff45d079;b59a484b-cd0a-4482-ab1d-4310539df12e;05fe541d-4408-48c0-88e2-865b333fb9e5	Not Available;Not Available;Not Available	7;7;7	187;187;187	33;89;33	Oxaliplatin;Fluorouracil;Leucovorin	Not Available;Not Available;Not Available	2;2;2	12;8;12	150;740;720	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	1880;5968;8848	mg;mg;mg	Not Available;Not Available;Not Available	2012;2012;2012	NOT HISPANIC OR LATINO	TCGA-G5-6235-F21952	a59aa52d-4943-434b-b870-3dd2e3e46cd4	7	Not Applicable	1696	Scheduled Follow-up Submission	Not Available	Not Available	2	NO	YES	Not Available	1042	Unknown	NO	Not Available	Not Available	YES	TUMOR FREE	YES	Not Available	NO	Alive	2012	MALE	169.0	Rectal Adenocarcinoma	NO	No	C19	8140/3	C19.9	YES	NO	Not Available	Not Available	NO	Not Available	13	NO	Not Available	7									Not Available	NO	Not Available	0	Not Available	1	Not Available	Yes	6235	NO	WITH TUMOR	Not Available	1.7	YES	Not Available	WHITE	Not Available																			R1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	N1	T3	NO	NO	YES	G5	Rectum	NO	Alive	77.6	2011	2007
TCGA-F5-6465	64	FEMALE	170	1506	62	21.453287197231834	Rectal Adenocarcinoma	Rectum	Alive	T3	N0	M0	Stage IIA	0	1506			TUMOR FREE		64	Rectosigmoid Junction	TCGA-F5-6465	d7cb062c-898d-4452-8e87-57262162bafa	Not Available	Not Available	Not Available	NO	21	-23432	Not Applicable	0	103	Not Available																								NOT HISPANIC OR LATINO	TCGA-F5-6465-F39568;TCGA-F5-6465-F30852;TCGA-F5-6465-F70150	386247D2-707A-4CAF-97BB-8B87CADF2848;EDA9775A-A692-425B-AC8B-B3B937ABF832;84A0CBB0-D302-4860-ADA1-B257F0BECEF2	25;24;28	Not Applicable;Not Applicable;Not Applicable	1141;715;1506	Scheduled Follow-up Submission;Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Not Available;Complete Remission/Response	NO;Not Available;NO	1;1;1									NO;NO;NO	TUMOR FREE;TUMOR FREE;TUMOR FREE	NO;NO;NO	Complete Remission/Response;Not Available;Complete Remission/Response	NO;NO;NO	Alive;Alive;Alive	2013;2014;2015	FEMALE	170	Rectal Adenocarcinoma	Not Available	No	C19	8140/3	C19.9	YES	Not Available	Not Available	Not Available	Not Available	Not Available	12	NO	Not Available	6									Not Available	NO	Not Available	0	Not Available	0	0	No	6465	NO	TUMOR FREE	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	YES	NO	F5	Rectum	NO	Alive	62	2011	2010
TCGA-DC-6158	70	MALE	160	334	71.7	28.0078125	Rectal Adenocarcinoma	Rectum	Dead	T2	N0	M0	Stage I	0	334			TUMOR FREE		70	Rectum	TCGA-DC-6158	0011a67b-1ba9-4a32-a6b8-7850759a38cf	NO	Not Available	2	NO	26	-25842	Not Applicable	0	212	Not Available																								NOT HISPANIC OR LATINO	TCGA-DC-6158-F14262;TCGA-DC-6158-F21434	fe0149cd-4f9b-42aa-97a9-5abfde320d0b;c88fb7e8-0aaf-4565-a973-a4103dcc9c79	26;13	Not Applicable;334	216;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Not Available;Not Available	Not Available;Not Available	7;2									NO;NO	TUMOR FREE;TUMOR FREE	NO;NO	Not Available;Not Available	NO;NO	Alive;Dead	2011;2012	MALE	160	Rectal Adenocarcinoma	NO	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	1	NO	Not Available	7									Not Available	NO	Not Available	0	Not Available	0	Not Available	No	6158	YES	TUMOR FREE	Not Available	1.7	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	YES	NO	DC	Rectum	YES	Alive	71.7	2011	2010
TCGA-G5-6641	67	MALE	189.3	804	118.6	33.096606090947574	Rectal Mucinous Adenocarcinoma	Rectum	Alive	T1	N1	MX	Stage IIIA	0	804			TUMOR FREE		67	Rectosigmoid Junction	TCGA-G5-6641	0a2cb2f9-972c-450c-8b7a-115a4cb93658	NO	Not Available	Not Available	NO	4	-24486	Not Applicable	0	636	Not Available	TCGA-G5-6641-D21865;TCGA-G5-6641-D21867;TCGA-G5-6641-D21868	d81354b9-0c34-4fcc-8b3f-e3f107f69534;5bf0d06d-1ace-46e0-a4ca-0994b79721e7;9a002138-e55e-40ed-bc8d-9878e0bdcd74	Not Available;Not Available;Not Available	7;7;7	212;254;254	100;100;100	Oxaliplatin;Fluorouracil;Leucovorin	Not Available;Not Available;Not Available	2;2;2	9;12;12	210;980;980	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	1862;11632;11632	mg;mg;mg	Not Available;Not Available;Not Available	2012;2012;2012	NOT HISPANIC OR LATINO	TCGA-G5-6641-F21862	86156171-7653-4f55-922b-6f7242b3bf5f	7	Not Applicable	804	Scheduled Follow-up Submission	Not Available	Not Available	2									NO	TUMOR FREE	YES	Not Available	NO	Alive	2012	MALE	189.3	Rectal Mucinous Adenocarcinoma	NO	No	C19	8480/3	C19.9	YES	NO	Not Available	Not Available	NO	Not Available	26	NO	Not Available	8									Not Available	NO	Not Available	0	Not Available	1	Not Available	Yes	6641	NO	TUMOR FREE	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	N1	T1	NO	NO	YES	G5	Rectum	NO	Alive	118.6	2011	2009
TCGA-AG-3598	69	MALE	Not Available	1522	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N0	M0	Stage IIA	0	1522			WITH TUMOR		69	Rectum	TCGA-AG-3598	6bc056f2-f06e-428f-aebc-85b780d880ed	NO	Not Available	Not Available	Not Available	18	-25324	Not Applicable	0	0	Not Available																								Not Available	TCGA-AG-3598-F37968	D179A4FD-195C-4D8B-A694-CAFA7C21BCBF	6	Not Applicable	1522	Scheduled Follow-up Submission	Complete Remission/Response	NO	12									NO	TUMOR FREE	NO	Not Available	NO	Alive	2012	MALE	Not Available	Rectal Adenocarcinoma	NO	No	C19	8140/3	C19.9	YES	NO	Not Available	Not Available	NO	Not Available	65	NO	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	No	3598	Not Available	WITH TUMOR	Not Available	4.76	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	NO	YES	AG	Rectum	NO	Alive	Not Available	2010	2007
TCGA-AG-3575	51	MALE	Not Available	365	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N0	M0	Stage II	0	365			Discrepancy		51	Rectum	TCGA-AG-3575	5daa9f6b-eeba-466f-992b-2bd29fa60e93	NO	Not Available	1	Not Available	18	-18932	Not Applicable	0	365	Not Available																								Not Available	TCGA-AG-3575-F37950	C607FFA9-F026-48E8-B561-5437A501D11E	6	Not Applicable	365	Scheduled Follow-up Submission	Complete Remission/Response	NO	12									NO	TUMOR FREE	NO	Not Available	NO	Alive	2012	MALE	Not Available	Rectal Adenocarcinoma	NO	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	31	NO	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	No	3575	Not Available	Discrepancy	Not Available	.83	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	NO	YES	AG	Rectum	NO	Alive	Not Available	2010	2006
TCGA-AG-3878	64	MALE	Not Available	30	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T2	N0	M0	Stage I	0	30			WITH TUMOR		64	Rectum	TCGA-AG-3878	fdeeff8e-1328-42a4-aca0-a03b97421f1e	NO	Not Available	Not Available	Not Available	18	-23527	Not Applicable	0	30	Not Available																								Not Available																									MALE	Not Available	Rectal Adenocarcinoma	YES	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	15	NO	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	No	3878	Not Available	WITH TUMOR	Not Available	1.15	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	NO	YES	AG	Rectum	NO	Alive	Not Available	2010	2007
TCGA-EF-5831	72	MALE	162	127	60	22.86236854138089	Rectal Adenocarcinoma	Rectum	Alive	T3	N0	M0	Stage IIA	0	127			TUMOR FREE		72	Rectum	TCGA-EF-5831	4d5437b3-b6a0-4d17-a7aa-4f2b790e4532	NO	Not Available	Not Available	Not Available	15	-26331	Not Applicable	0	73	Not Available																								NOT HISPANIC OR LATINO	TCGA-EF-5831-F69009	10064861-41E4-4F83-90AE-ABE08AF5958B	24	Not Applicable	127	Scheduled Follow-up Submission	Not Applicable	YES	12									NO	Not Available	NO	Not Applicable	NO	Alive	2014	MALE	162	Rectal Adenocarcinoma	Not Available	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7									Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5831	Not Available	TUMOR FREE	Not Available	Not Available	NO	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	NO	YES	EF	Rectum	Not Available	Alive	60	2011	2010
TCGA-AG-A015	64	FEMALE	Not Available	1096	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T1	N0	M0	Stage I	1	518.0			WITH TUMOR		64	Rectum	TCGA-AG-A015	09daff79-6493-45c1-8cba-9381259e2bea	NO	Not Available	Not Available	Not Available	15	-23496	Not Applicable	0	0	Not Available																								Not Available	TCGA-AG-A015-F38511	929B4674-D970-476F-9968-D98282FC031B	16	Not Applicable	1096	Scheduled Follow-up Submission	Complete Remission/Response	NO	12	Unknown	Unknown	Not Available	518	Unknown	NO	Not Available	Not Available	YES	TUMOR FREE	NO	Not Available	NO	Alive	2012	FEMALE	Not Available	Rectal Adenocarcinoma	YES	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	18	NO	Not Available	6									Not Available	Not Available	Not Available	1	Not Available	0	Not Available	Yes	A015	Not Available	WITH TUMOR	Not Available	Not Available	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	NO	YES	AG	Rectum	NO	Alive	Not Available	2011	2009
TCGA-AG-A01Y	49	FEMALE	Not Available	0	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N0	M0	Stage II	0	0			WITH TUMOR		49	Rectum	TCGA-AG-A01Y	a91f7a8c-e0fe-403a-9ef0-f7679b2761cc	NO	Not Available	Not Available	Not Available	15	-18112	Not Applicable	0	0	Not Available	TCGA-AG-A01Y-D37678	F99733D4-0119-416D-BCC9-791AD546EB61	n/a	5	151	31	5-Fluorouracil	Complete Response	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2012	Not Available																									FEMALE	Not Available	Rectal Adenocarcinoma	NO	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	17	YES	Not Available	6									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	No	A01Y	Not Available	WITH TUMOR	Not Available	5.85	YES	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-AG-A01Y-R38371	0F9BBF5E-5992-4949-8E8C-CD0B31753B6F	Not Available	13	121	62	Complete Response	12	Not Available	50	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	NO	YES	AG	Rectum	Not Available	Alive	Not Available	2011	2004
TCGA-AG-A02X	77	MALE	Not Available	1247	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T2	N0	M0	Stage I	0	1247			WITH TUMOR		77	Rectum	TCGA-AG-A02X	a424bfe7-5518-4c80-83c8-709a34320bc7	NO	Not Available	Not Available	Not Available	15	-28399	Not Applicable	0	1247	Not Available																								Not Available																									MALE	Not Available	Rectal Adenocarcinoma	NO	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	15	YES	Not Available	6									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	No	A02X	Not Available	WITH TUMOR	Not Available	8.14	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	NO	YES	AG	Rectum	YES	Alive	Not Available	2011	2007
TCGA-AG-3725	90	FEMALE	Not Available	0	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N2	M0	Stage III	0	0			WITH TUMOR		90	Rectum	TCGA-AG-3725	fd798ddf-7273-49b8-b13c-d9909c8c87ff	NO	Not Available	Not Available	Not Available	18	-32872	Not Applicable	0	0	Not Available																								Not Available	TCGA-AG-3725-F38008	2217DE25-DDB6-4010-ACF8-2A1D42F8449C	8	Not Applicable	0	Scheduled Follow-up Submission	Partial Remission/Response	NO	12									NO	TUMOR FREE	NO	Not Available	NO	Alive	2012	FEMALE	Not Available	Rectal Adenocarcinoma	YES	No	C19	8140/3	C19.9	YES	NO	Not Available	Not Available	NO	Not Available	18	YES	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	5	Not Available	No	3725	Not Available	WITH TUMOR	Not Available	6.08	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage III	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T3	NO	NO	YES	AG	Rectum	YES	Alive	Not Available	2010	2005
TCGA-AF-2692	54	FEMALE	170	412	64.4	22.283737024221452	Not Available	Not Available	Alive	T3	N0	M0	Stage IIA	1	327.0		Metastatic	WITH TUMOR		54	Not Available	TCGA-AF-2692	71a32fca-d48f-4ea3-8df7-69f9dda8fa91	NO	Not Available	Not Available	YES	10	-19830	Not Applicable	0	412	Not Available	TCGA-AF-2692-D9921	8d16b3a4-228c-430e-a26c-6747b843381d	Not Available	21	384	344	Xeloda	Not Available	12	Not Available	1500	mg	RECURRENCE	Not Applicable	1	PO	NO	Chemotherapy	Not Available	87000	mg	Not Available	2010	NOT HISPANIC OR LATINO	TCGA-AF-2692-F10351	d6a1d481-8e01-4139-9d11-7f3b23f130c1	10	Not Applicable	412	Not Available	Not Available	Not Available	11	YES	YES	396	327	Metastatic	YES	R0	Other	YES	WITH TUMOR	NO	Not Available	NO	Alive	2010	FEMALE	170	Not Available	NO	No	C20	8140/3	C20.9	YES	YES	12	YES	NO	Not Available	12	NO	Not Available	11									Not Available	NO	Not Available	0	Not Available	0	Not Available	No	2692	Not Available	WITH TUMOR	Not Available	10.6	YES	Not Available	WHITE	Not Available	Primary Tumor Field;Distant site	TCGA-AF-2692-R9920;TCGA-AF-2692-R9918	94bd837c-1105-4e0c-b84c-b5392c7ebc8b;3839f8d1-df50-44f5-aec2-31597910f245	1;1	21;21	385;435	350;418	Not Available;Not Available	12;12	25;14	5000;3500	NO;NO	EXTERNAL BEAM;EXTERNAL BEAM	Not Applicable;Not Applicable	RECURRENCE;PALLIATIVE	Not Available;Not Available	cGy;cGy	2010;2010	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	YES	NO	AF	Not Available	NO	Alive	64.4	2010	2009
TCGA-AF-5654	73	FEMALE	165	512	96.6	35.48209366391185	Rectal Adenocarcinoma	Rectum	Dead	T2	N0	M0	Stage I	0	512			TUMOR FREE		73	Rectosigmoid Junction	TCGA-AF-5654	5d4b9087-fa7b-47b8-9b12-adc0dd1cf17c	NO	Not Available	Not Available	NO	16	-26738	Not Applicable	0	257	257																								NOT HISPANIC OR LATINO	TCGA-AF-5654-F12868;TCGA-AF-5654-F32800	f3561c4f-56df-488c-80fc-64cdd590977e;3B0DEBF6-962E-4F3A-91EE-5B2F71D13608	10;12	Not Applicable;512	257;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	6;6									NO;NO	TUMOR FREE;TUMOR FREE	NO;Not Available	Not Available;Not Available	NO;Not Available	Alive;Dead	2011;2012	FEMALE	165	Rectal Adenocarcinoma	NO	No	C19	8140/3	C19.9	YES	NO	Not Available	Not Available	YES	MLH1-Expressed;MSH2-Expressed;PMS2-Expressed;MSH6-Expressed	24	NO	NO	5									Not Available	NO	0	0	5	0	Not Available	No	5654	Not Available	TUMOR FREE	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	YES	NO	AF	Rectum	NO	Alive	96.6	2011	2010
TCGA-AG-A00H	75	MALE	Not Available	790	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N0	M0	Stage IIA	1	790.0			WITH TUMOR		75	Rectum	TCGA-AG-A00H	9f4574ec-a58a-4410-8735-c5e5bc4ca7e0	NO	Not Available	10	Not Available	15	-27485	Not Applicable	0	29	Not Available	TCGA-AG-A00H-D37669	F74BAE20-BD17-4DF8-9A05-AF806FEAA77A	Not Available	5	121	90	5-Fluorouracil	Complete Response	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2012	Not Available	TCGA-AG-A00H-F38315	7CBEB7C0-1EC1-4303-BE70-7C210D667199	12	Not Applicable	790	Scheduled Follow-up Submission	Progressive Disease	NO	12	YES	YES	Not Available	790	Unknown	NO	Not Available	Not Available	YES	WITH TUMOR	YES	Progressive Disease	YES	Alive	2012	MALE	Not Available	Rectal Adenocarcinoma	NO	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	32	NO	Not Available	6									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	Yes	A00H	Not Available	WITH TUMOR	Not Available	1.5	YES	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-AG-A00H-R38355	1390BFF6-8470-476A-A7D3-ED7DCEEFA710	Not Available	13	121	90	Complete Response	12	Not Available	50	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	NO	YES	AG	Rectum	NO	Alive	Not Available	2011	2008
TCGA-AG-3726	63	FEMALE	Not Available	243	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T2	N0	M0	Stage I	0	243			Discrepancy		63	Rectum	TCGA-AG-3726	21e8c2b7-3a80-4b7e-acec-6ff863f15324	NO	Not Available	Not Available	Not Available	18	-23345	Not Applicable	0	243	Not Available																								Not Available	TCGA-AG-3726-F38009	870C0B80-2D08-465E-BE2B-B7C27FD27218	8	Not Applicable	243	Scheduled Follow-up Submission	Complete Remission/Response	NO	12									NO	TUMOR FREE	NO	Not Available	NO	Alive	2012	FEMALE	Not Available	Rectal Adenocarcinoma	NO	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	34	NO	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	No	3726	Not Available	Discrepancy	Not Available	3.98	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	NO	YES	AG	Rectum	NO	Alive	Not Available	2010	2006
TCGA-AG-3727	78	FEMALE	Not Available	30	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N1	M0	Stage III	0	30			WITH TUMOR		78	Rectum	TCGA-AG-3727	e6827400-0d95-46b0-8874-6ce9e9d5011b	NO	Not Available	Not Available	Not Available	18	-28641	Not Applicable	0	30	Not Available																								Not Available																									FEMALE	Not Available	Rectal Adenocarcinoma	NO	No	C19	8140/3	C19.9	YES	NO	Not Available	Not Available	NO	Not Available	25	YES	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	2	Not Available	No	3727	Not Available	WITH TUMOR	Not Available	1.1	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage III	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T3	NO	NO	YES	AG	Rectum	NO	Alive	Not Available	2010	2006
TCGA-CI-6619	41	MALE	Not Available	184	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N1c	M1	Stage IV	0	184			Not Available		41	Rectum	TCGA-CI-6619	3b55aa84-9fdc-4125-8d39-d8949de2a1b3	Not Available	Not Available	Not Available	Not Available	15	-15322	Not Applicable	0	184	Not Available																								NOT HISPANIC OR LATINO	TCGA-CI-6619-F69600	9D955ED0-3230-4E13-A370-2F4C06B5B2D9	14	Not Applicable	Not Available	Scheduled Follow-up Submission	Unknown	YES	1									Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	2015	MALE	Not Available	Rectal Adenocarcinoma	Not Available	No	C20	8140/3	C20.9	YES	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9									Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6619	Not Available	Not Available	Not Available	52.7	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M1	N1c	T3	Not Available	NO	YES	CI	Rectum	Not Available	Alive	Not Available	2011	2010
TCGA-AG-A00Y	68	MALE	Not Available	700	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N0	M0	Stage IIA	1	123.0			WITH TUMOR		68	Rectum	TCGA-AG-A00Y	c7e09161-60d6-4dff-a840-7cec3bb7a30a	NO	Not Available	Not Available	Not Available	15	-24837	Not Applicable	0	0	Not Available																								Not Available	TCGA-AG-A00Y-F38317	9AB30C5D-E8CA-452C-B427-B88A9C1BF474	12	Not Applicable	700	Scheduled Follow-up Submission	Complete Remission/Response	NO	12	Unknown	Unknown	Not Available	123	Unknown	NO	Not Available	Not Available	YES	TUMOR FREE	NO	Complete Remission/Response	NO	Alive	2012	MALE	Not Available	Rectal Adenocarcinoma	YES	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	31	NO	Not Available	6									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	No	A00Y	Not Available	WITH TUMOR	Not Available	4.21	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	YES	NO	YES	AG	Rectum	NO	Alive	Not Available	2011	2008
TCGA-AG-3574	89	FEMALE	Not Available	91	Not Available		Rectal Adenocarcinoma	Rectum	Dead	T3	N0	M0	Stage II	0	91			WITH TUMOR		89	Rectum	TCGA-AG-3574	0eda7373-8335-455f-b90a-8c3540f28088	NO	Not Available	Not Available	NO	18	-32781	Not Applicable	0	0	Not Available																								Not Available	TCGA-AG-3574-F37944	19DCF384-411F-4CA9-B8B8-E2D42800C04A	6	91	Not Available	Scheduled Follow-up Submission	Unknown	NO	12									Unknown	Unknown	NO	Not Available	NO	Dead	2012	FEMALE	Not Available	Rectal Adenocarcinoma	YES	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	18	NO	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	No	3574	Not Available	WITH TUMOR	Not Available	4.59	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	NO	YES	AG	Rectum	NO	Alive	Not Available	2010	2005
TCGA-AG-A025	62	FEMALE	Not Available	1520	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T1	N0	M0	Stage I	0	1520			WITH TUMOR		62	Rectum	TCGA-AG-A025	9d7e0672-0a9e-4dbf-a583-80f4eb086ec6	NO	Not Available	Not Available	Not Available	15	-22952	Not Applicable	0	1520	Not Available																								Not Available																									FEMALE	Not Available	Rectal Adenocarcinoma	NO	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	11	Not Available	Not Available	6									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	No	A025	Not Available	WITH TUMOR	Not Available	0.75	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	NO	YES	AG	Rectum	Not Available	Alive	Not Available	2011	2006
TCGA-AG-3732	78	FEMALE	Not Available	1003	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T2	N0	M0	Stage I	0	1003			WITH TUMOR		78	Rectum	TCGA-AG-3732	a83923fd-276c-4526-9922-5ef741f551fd	NO	Not Available	Not Available	Not Available	18	-28521	Not Applicable	0	0	Not Available	TCGA-AG-3732-D37646;TCGA-AG-3732-D37647	E3DA3054-7188-4C70-B09A-AAE3757CB1F5;F553079B-0B3B-485C-A8D3-B2D83729DB97	n/a;n/a	5;5	1673;1673	1277;1277	Capecitabine;Bevacizumab	Unknown;Unknown	12;12	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Targeted Molecular therapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2012	Not Available	TCGA-AG-3732-F38011	7FD58A13-0001-4312-9E34-59AFD13434C0	8	Not Applicable	1003	Scheduled Follow-up Submission	Complete Remission/Response	NO	12									NO	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2012	FEMALE	Not Available	Rectal Adenocarcinoma	NO	No	C19	8140/3	C19.9	YES	NO	Not Available	Not Available	Not Available	Not Available	12	YES	Not Available	5									Not Available	Not Available	Not Available	1	Not Available	0	Not Available	No	3732	Not Available	WITH TUMOR	Not Available	1.21	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	NO	YES	AG	Rectum	NO	Alive	Not Available	2010	2005
TCGA-AF-3912	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available						0				Not Available		Not Available	Not Available	TCGA-AF-3912	a4faf514-50af-43ed-b294-350ee0756250	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available																								Not Available																									Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available									Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3912	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	AF	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available
TCGA-AG-3896	85	FEMALE	Not Available	31	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T2	N0	M0	Stage I	0	31			WITH TUMOR		85	Rectum	TCGA-AG-3896	9af35239-ffb9-4d4f-889e-f743da271eef	NO	Not Available	Not Available	Not Available	18	-31046	Not Applicable	0	31	Not Available																								Not Available																									FEMALE	Not Available	Rectal Adenocarcinoma	NO	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	12	YES	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	No	3896	Not Available	WITH TUMOR	Not Available	Not Available	Discrepancy	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	NO	YES	AG	Rectum	YES	Alive	Not Available	2010	2009
TCGA-AG-A023	62	FEMALE	Not Available	1581	Not Available		Rectal Adenocarcinoma	Rectum	Dead	T4	N2	M1	Stage IV	1	822.0			WITH TUMOR		62	Rectum	TCGA-AG-A023	3bc6e336-f58e-4dc4-8414-7318e55016ed	NO	Not Available	Not Available	Not Available	15	-22830	Not Applicable	0	61	Not Available																								Not Available	TCGA-AG-A023-F38514	22A4EA99-88E0-4117-9F6A-46BEE8B92076	16	1581	Not Available	Scheduled Follow-up Submission	Progressive Disease	NO	12	Unknown	Unknown	Not Available	822	Unknown	NO	Not Available	Not Available	YES	WITH TUMOR	NO	Not Available	NO	Dead	2012	FEMALE	Not Available	Rectal Adenocarcinoma	NO	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	12	YES	Not Available	6									Not Available	Not Available	Not Available	1	Not Available	6	Not Available	Yes	A023	Not Available	WITH TUMOR	Not Available	1.88	YES	Not Available	Not Available	Not Available																			R2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M1	N2	T4	NO	NO	YES	AG	Rectum	YES	Alive	Not Available	2011	2005
TCGA-DC-6682	57	MALE	184	762	172.4	50.92155009451796	Rectal Adenocarcinoma	Rectum	Alive	T3	N0	M0	Stage IIA	0	762			TUMOR FREE		57	Rectosigmoid Junction	TCGA-DC-6682	26964b56-583f-46cc-ab2e-a948bf3e5432	NO	Not Available	45	NO	Not Available	-21062	Not Applicable	0	122	Not Available																								NOT HISPANIC OR LATINO	TCGA-DC-6682-F15649;TCGA-DC-6682-F30873;TCGA-DC-6682-F44769	b62802e1-65da-4682-913b-a28b0f2c7e33;e6b4da6e-5734-4424-89a7-ee9a84543bdf;791588E2-F159-47E4-B4E2-7A65CD7BF924	Not Available;17;26	Not Applicable;Not Applicable;Not Applicable	122;397;762	Scheduled Follow-up Submission;Scheduled Follow-up Submission;Scheduled Follow-up Submission	Not Available;Not Available;Not Applicable	Not Available;Not Available;NO	8;4;6									NO;NO;NO	TUMOR FREE;TUMOR FREE;TUMOR FREE	NO;NO;NO	Not Available;Not Available;Not Applicable	NO;NO;NO	Alive;Alive;Alive	2011;2012;2013	MALE	184	Rectal Adenocarcinoma	NO	No	C19	8140/3	C19.9	YES	NO	Not Available	Not Available	NO	Not Available	24	NO	Not Available	8									Not Available	NO	Not Available	0	Not Available	0	Not Available	No	6682	NO	TUMOR FREE	Not Available	13.8	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	YES	NO	DC	Rectum	NO	Alive	172.4	2011	2011
TCGA-AG-4001	74	FEMALE	Not Available	1096	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N0	M0	Stage IIA	0	1096			WITH TUMOR		74	Rectum	TCGA-AG-4001	d846228f-67af-4b3b-9796-dbc263c2054c	NO	Not Available	Not Available	Not Available	18	-27302	Not Applicable	0	31	Not Available																								Not Available	TCGA-AG-4001-F38309	8E956586-D2C3-4499-80E4-62A975087484	12	Not Applicable	1096	Scheduled Follow-up Submission	Complete Remission/Response	NO	12									NO	TUMOR FREE	NO	Not Available	NO	Alive	2012	FEMALE	Not Available	Rectal Adenocarcinoma	NO	No	C19	8140/3	C19.9	YES	NO	Not Available	Not Available	NO	Not Available	29	NO	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	No	4001	Not Available	WITH TUMOR	Not Available	Not Available	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	NO	YES	AG	Rectum	NO	Alive	Not Available	2010	2009
TCGA-DT-5265	51	MALE	Not Available	384	Not Available		Rectal Mucinous Adenocarcinoma	Rectum	Alive	T3	N0	M0	Stage II	0	384			TUMOR FREE		51	Rectum	TCGA-DT-5265	3f10de1e-c8ce-415e-b4e1-e50901686a2f	Not Available	Not Available	Not Available	Not Available	9	-18669	Not Applicable	0	8	Not Available																								NOT HISPANIC OR LATINO	TCGA-DT-5265-F20335;TCGA-DT-5265-F71902	dbb7e402-4f8a-4699-9784-7ba6ea15c8fa;FCD1BF2E-EC38-4BD0-9B8A-B9500AC8BDEF	9;31	Not Applicable;Not Applicable	161;384	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Not Available;Complete Remission/Response	Not Available;NO	1;3									NO;NO	Not Available;TUMOR FREE	NO;NO	Not Available;Complete Remission/Response	YES;YES	Alive;Alive	2012;2015	MALE	Not Available	Rectal Mucinous Adenocarcinoma	Not Available	No	C20	8480/3	C20.9	YES	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8									Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5265	Not Available	TUMOR FREE	Not Available	Not Available	NO	Not Available	ASIAN	Not Available																			RX	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	Not Available	YES	NO	DT	Rectum	Not Available	Alive	Not Available	2011	2010
TCGA-AG-A036	71	MALE	Not Available	3562	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N2	M0	Stage III	0	3562			WITH TUMOR		71	Rectum	TCGA-AG-A036	f2a8deb2-0e2c-4bbd-8fa1-99b7abb2f3aa	NO	Not Available	1	Not Available	15	-26206	Not Applicable	0	31	Not Available	TCGA-AG-A036-D37689	5C971E83-8B85-45AE-86A7-2658BC205B5F	n/a	5	215	92	5-Fluorouracil	Complete Response	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2012	Not Available	TCGA-AG-A036-F38517	056C033F-17DB-419C-AC3A-3A1DB7F3971A	16	Not Applicable	3562	Scheduled Follow-up Submission	Complete Remission/Response	NO	12									NO	TUMOR FREE	YES	Complete Remission/Response	YES	Alive	2012	MALE	Not Available	Rectal Adenocarcinoma	NO	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	30	Not Available	Not Available	6									Not Available	Not Available	Not Available	0	Not Available	18	Not Available	No	A036	Not Available	WITH TUMOR	Not Available	2.2	YES	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-AG-A036-R38369	681D02A8-5853-43DB-892B-D2EDE71E2AE6	Not Available	13	215	92	Complete Response	12	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage III	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T3	NO	NO	YES	AG	Rectum	Not Available	Alive	Not Available	2011	2002
TCGA-AG-3582	75	MALE	Not Available	1096	Not Available		Rectal Adenocarcinoma	Rectum	Dead	T3	N1	M1	Stage IV	0	1096			WITH TUMOR		75	Rectum	TCGA-AG-3582	db1e3104-8bfd-4353-854a-c478ba1f7d07	NO	Not Available	Not Available	Not Available	18	-27636	Not Applicable	0	31	Not Available																								Not Available	TCGA-AG-3582-F37958	A1610969-6DFF-40FE-815E-81B303261EE9	6	1096	Not Available	Scheduled Follow-up Submission	Unknown	NO	12									Unknown	Unknown	NO	Not Available	NO	Dead	2012	MALE	Not Available	Rectal Adenocarcinoma	NO	No	C18.9	8140/3	C18.9	YES	NO	Not Available	Not Available	NO	Not Available	28	NO	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	1	Not Available	No	3582	Not Available	WITH TUMOR	Not Available	612.1	YES	Not Available	Not Available	Not Available																			R2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M1	N1	T3	NO	NO	YES	AG	Rectum	NO	Alive	Not Available	2010	2007
TCGA-EI-6514	59	FEMALE	Not Available	496	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N0	M0	Stage IIA	0	496			TUMOR FREE		59	Sigmoid Colon	TCGA-EI-6514	40974ab3-e532-4d6e-9c98-ee640f3976d6	NO	Not Available	Not Available	NO	13	-21618	Not Applicable	0	216	Not Available	TCGA-EI-6514-D28631	139796C1-BFC0-4707-9CF2-52A9843422B6	Not Available	27	88	27	5-FU + LEULOV	Not Available	2	Not Available	Not Available	mg	ADJUVANT	Not Applicable	Not Available	IV	NO	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2012	NOT HISPANIC OR LATINO	TCGA-EI-6514-F28630	50212526-646E-40D5-92DD-80EDF761190F	27	Not Applicable	496	Scheduled Follow-up Submission	Not Available	Not Available	2									NO	TUMOR FREE	YES	Not Available	NO	Alive	2012	FEMALE	Not Available	Rectal Adenocarcinoma	NO	No	C20	8263/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	8	NO	Not Available	5									Not Available	NO	Not Available	Not Available	Not Available	0	0	No	6514	NO	TUMOR FREE	Not Available	5.5	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	Not Available	YES	NO	EI	Rectum	NO	Alive	Not Available	2011	2010
TCGA-DC-6683	43	MALE	183	762	82.6	24.664815312490667	Rectal Adenocarcinoma	Rectum	Alive	T3	N1b	M0	Stage IIIB	0	762			TUMOR FREE		43	Rectosigmoid Junction	TCGA-DC-6683	16a9e1c5-85c2-4930-a16c-af59114bac9a	NO	Not Available	70	NO	Not Available	-15918	Not Applicable	0	153	Not Available	TCGA-DC-6683-D16997;TCGA-DC-6683-D16998;TCGA-DC-6683-D16996;TCGA-DC-6683-D17000	7b26e472-0f10-4ca1-9bb1-4dbd2a4852e9;102d8593-ffff-4a1e-8f0d-0d8e1dac97af;c35d6f62-4fe4-460c-9ca1-eef4461e775d;d212da89-e3a1-4588-ab55-5f0513443f06	Not Available;Not Available;Not Available;Not Available	18;18;18;18	214;214;214;214	50;50;50;50	Fluorouracil;Oxaliplatin;Fluorouracil;Leucovorin Calcium	Not Available;Not Available;Not Available;Not Available	4;4;4;4	12;12;12;12	2400;170;800;800	mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;1	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Other, specify in notes	Not Available;Not Available;Not Available;Ancillary	28800;1980;9600;9600	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012	NOT HISPANIC OR LATINO	TCGA-DC-6683-F15652;TCGA-DC-6683-F30877;TCGA-DC-6683-F44770	129f3071-ccf1-429c-a6f9-fb410ce1cd32;7389f972-ac7f-48a5-9216-3e559772ec96;612F090F-CF93-4239-B18D-1FDE3FD329D8	Not Available;18;26	Not Applicable;Not Applicable;Not Applicable	153;306;762	Scheduled Follow-up Submission;Scheduled Follow-up Submission;Scheduled Follow-up Submission	Not Available;Not Available;Not Applicable	Not Available;Not Available;NO	8;4;6									NO;NO;NO	TUMOR FREE;TUMOR FREE;TUMOR FREE	YES;YES;YES	Not Available;Not Available;Not Applicable	NO;NO;NO	Alive;Alive;Alive	2011;2012;2013	MALE	183	Rectal Adenocarcinoma	NO	No	C19	8140/3	C19.9	YES	NO	Not Available	Not Available	YES	MLH1-Not Expressed;MSH2-Not Expressed;PMS2-Not Expressed;MSH6-Not Expressed	27	NO	Not Available	8									Not Available	NO	Not Available	0	Not Available	3	Not Available	No	6683	YES	TUMOR FREE	Not Available	11.1	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1b	T3	NO	YES	NO	DC	Rectum	YES	Alive	82.6	2011	2011
TCGA-CI-6623	44	MALE	Not Available	1443	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T1	N0	M0	Stage I	0	1443			TUMOR FREE		44	Rectum	TCGA-CI-6623	acccb105-6439-4b30-a0b9-bb94c7873d4a	Not Available	Not Available	Not Available	Not Available	30	-16177	Not Applicable	0	285	Not Available																								NOT HISPANIC OR LATINO	TCGA-CI-6623-F69598	20B550ED-D0CF-403D-BC5D-AEB7B98AAD72	14	Not Applicable	1443	Scheduled Follow-up Submission	Unknown	NO	1									Unknown	Unknown	Unknown	Unknown	Unknown	Alive	2015	MALE	Not Available	Rectal Adenocarcinoma	Not Available	No	C20	8140/3	C20.9	YES	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	11									Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6623	NO	TUMOR FREE	Not Available	5.9	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	Not Available	NO	YES	CI	Rectum	NO	Alive	Not Available	2011	2011
TCGA-AG-A01W	67	FEMALE	Not Available	0	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N0	M0	Stage II	0	0			WITH TUMOR		67	Rectum	TCGA-AG-A01W	74543fa4-ce73-46e4-9c59-224e8242b4a2	NO	Not Available	Not Available	Not Available	15	-24745	Not Applicable	0	0	Not Available	TCGA-AG-A01W-D37677	E11038FD-3C7C-46DA-A03B-2AB5352DCDD5	n/a	5	184	62	5-Fluorouracil	Complete Response	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2012	Not Available																									FEMALE	Not Available	Rectal Adenocarcinoma	NO	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	20	YES	Not Available	6									Not Available	Not Available	Not Available	2	Not Available	0	Not Available	No	A01W	Not Available	WITH TUMOR	Not Available	2.07	YES	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-AG-A01W-R38370	E84AABE3-40C3-4825-B4B7-7DAE74BD1409	Not Available	13	92	31	Complete Response	12	Not Available	50	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	NO	YES	AG	Rectum	YES	Alive	Not Available	2011	2004
TCGA-AG-3583	66	MALE	Not Available	610	Not Available		Rectal Mucinous Adenocarcinoma	Rectum	Dead	T3	N2	M1	Stage IV	0	610			WITH TUMOR		66	Rectum	TCGA-AG-3583	5af7b4eb-8314-41ce-ab2b-f98054a78a8b	NO	Not Available	Not Available	Not Available	18	-24107	Not Applicable	0	61	Not Available																								Not Available	TCGA-AG-3583-F37959	F861BB3F-7736-4CDE-B4C6-00496512B52A	6	610	Not Available	Scheduled Follow-up Submission	Unknown	NO	12									Unknown	Unknown	NO	Not Available	NO	Dead	2012	MALE	Not Available	Rectal Mucinous Adenocarcinoma	NO	No	C19	8140/3	C19.9	YES	NO	Not Available	Not Available	NO	Not Available	34	YES	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	9	Not Available	No	3583	Not Available	WITH TUMOR	Not Available	90.73	YES	Not Available	Not Available	Not Available																			R2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M1	N2	T3	NO	NO	YES	AG	Rectum	NO	Alive	Not Available	2010	2008
TCGA-AF-2687	57	MALE	163	1427	68.2	25.669012759230682	Rectal Adenocarcinoma	Rectum	Alive	T3	N2	M0	Stage IIIC	1	1267.0			TUMOR FREE		57	Rectum	TCGA-AF-2687	f9204a59-6877-4d06-a20e-fd7ab0859ed5	NO	Not Available	Not Available	NO	8	-21098	Not Applicable	0	595	Not Available	TCGA-AF-2687-D7471;TCGA-AF-2687-D7475;TCGA-AF-2687-D7476;TCGA-AF-2687-D7474;TCGA-AF-2687-D7473	3041c9c2-446a-4fd8-a6b7-b4ea72dda4fd;e024567d-988f-4c5f-b624-b18ee2d0bc40;0d0a7050-6694-40d7-8087-f5ea54967092;b1351850-ce3f-4280-8c28-f967e6a594a3;66493de1-960a-4d78-abdb-ad820db8bfc4	Not Available;Not Available;Not Available;Not Available;Not Available	9;9;9;9;9	97;259;261;259;259	55;133;133;133;133	Xeloda;5 FU;5 FU;Leucovorin;Oxaliplatin	Not Available;Not Available;Not Available;Not Available;Not Available	2;2;2;2;2	Not Available;9;9;9;9	1500;605-684;3629-4104;600-700;129-145	mg;mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;2;2;2;2	PO;IV;IV;IV;IV	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Other, specify in notes;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	93,000;5699;34193;5750;1211	mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011;2011	NOT HISPANIC OR LATINO	TCGA-AF-2687-F7364;TCGA-AF-2687-F10487;TCGA-AF-2687-F40084	51a01fae-9805-48d0-bcb6-843afc405026;dfbfbfb7-e06b-4970-8711-cc78885b37d8;FD8BE15C-49BE-4B72-AAC4-1816B383712D	8;19;13	Not Applicable;Not Applicable;Not Applicable	595;734;1427	Not Available;Not Available;Scheduled Follow-up Submission	Not Available;Not Available;Complete Remission/Response	Not Available;Not Available;NO	2;4;2	None;None;NO	None;None;NO	None;None;Not Available	None;None;1267	None;None;Unknown	None;None;NO	None;None;Not Available	None;None;Not Available	NO;NO;YES	TUMOR FREE;TUMOR FREE;TUMOR FREE	YES;Not Available;YES	Not Available;Not Available;Complete Remission/Response	YES;Not Available;YES	Alive;Alive;Alive	2011;2011;2013	MALE	163	Rectal Adenocarcinoma	NO	No	C19	8140/3	C19.9	YES	NO	Not Available	Not Available	Not Available	Not Available	16	YES	Not Available	2									Not Available	YES	Not Available	0	Not Available	6	Not Available	No	2687	Not Available	TUMOR FREE	Not Available	5.3	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-AF-2687-R7361	7e39a0da-bc40-44e9-97c5-63bd6ef3d102	1	9	97	56	Not Available	2	28	5040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	M0	N2	T3	NO	YES	NO	AF	Rectum	NO	Alive	68.2	2011	2009
TCGA-DY-A1H8	77	FEMALE	160	992	40	15.625	Rectal Adenocarcinoma	Rectum	Dead	T2	N1	M0	Stage IIIA	0	992			Not Available		77	Rectum	TCGA-DY-A1H8	c2395f04-e248-4091-855d-802b1b871f29	NO	Not Available	Not Available	Not Available	Not Available	-28459	992	0	992	992																								NOT HISPANIC OR LATINO	TCGA-DY-A1H8-F19088	3B7C3CF1-2960-4E6F-B34C-DCC36970CBF5	2	992	992	Scheduled Follow-up Submission	Not Available	Not Available	12									NO	Not Available	Not Available	Not Available	Not Available	Dead	2011	FEMALE	160	Rectal Adenocarcinoma	Not Available	No	C20	8140/3	C20.9	YES	YES	12	YES	Not Available	Not Available	7	Not Available	Not Available	5									Not Available	Not Available	0	0	0	1	Not Available	No	A1H8	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2	NO	NO	YES	DY	Rectum	Not Available	Dead	40	2011	2000
TCGA-AG-4022	59	FEMALE	Not Available	1400	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N0	M0	Stage II	0	1400			WITH TUMOR		59	Rectum	TCGA-AG-4022	9084b672-8e65-4b7f-a256-32fd35aa8ab5	NO	Not Available	Not Available	Not Available	18	-21823	Not Applicable	0	30	Not Available	TCGA-AG-4022-D37665	BA0BE627-3B95-403A-954D-635201C79CD6	Not Available	5	153	61	5-Fluorouracil	Complete Response	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2012	Not Available	TCGA-AG-4022-F38320	C27D26C8-5EE2-4623-855A-329C85715A5B	12	Not Applicable	1400	Scheduled Follow-up Submission	Complete Remission/Response	NO	12									NO	TUMOR FREE	YES	Complete Remission/Response	YES	Alive	2012	FEMALE	Not Available	Rectal Adenocarcinoma	NO	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	12	YES	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	0	Not Available	No	4022	Not Available	WITH TUMOR	Not Available	1.03	YES	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-AG-4022-R38364	22465234-5910-4156-97D3-DB3DC8195628	Not Available	13	153	122	Complete Response	12	Not Available	50	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	NO	YES	AG	Rectum	YES	Alive	Not Available	2010	2006
TCGA-DY-A1DE	56	FEMALE	160	3932	70	27.34375	Rectal Adenocarcinoma	Rectum	Alive	T3	N0	M0	Stage IIA	1	3316.0			Not Available		56	Rectum	TCGA-DY-A1DE	5555fbdd-962f-4d79-b36c-ae3c3cc4aff4	YES	Normal	Not Available	Not Available	Not Available	-20504	Not Applicable	0	3667	3667	TCGA-DY-A1DE-D30446;TCGA-DY-A1DE-D30447	D369621F-ABAD-4DC9-B8ED-BAC84CF0BFB5;2B357047-E9A9-473A-9D6C-0DFD7D0DE8C8	Not Available;Not Available	10;10	78;379	46;291	Mayo 425-20;Mayo 425-20	Complete Response;Complete Response	4;4	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2012	NOT HISPANIC OR LATINO	TCGA-DY-A1DE-F19046	EB9A942F-CF37-4E8D-98D9-791973F9D383	5	Not Applicable	3932	Scheduled Follow-up Submission	Not Available	Not Available	12	Not Available	Not Available	Not Available	3316	Unknown	NO	Not Available	Not Available	YES	Not Available	Not Available	Not Available	Not Available	Alive	2011	FEMALE	160	Rectal Adenocarcinoma	NO	No	C20	8140/3	C20.9	YES	YES	61	YES	Not Available	Not Available	14	NO	NO	5									Not Available	Not Available	0	0	5	0	Not Available	No	A1DE	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-DY-A1DE-R30540	D500ADD4-8062-4D6A-B9B6-10509272BC16	Not Available	12	174	75	Not Available	4	Not Available	Not Available	NO	Not Available	Not Applicable	ADJUVANT	Not Available	Not Available	2012	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	NO	YES	DY	Rectum	NO	Alive	70	2011	2001
TCGA-AG-A00C	49	FEMALE	Not Available	183	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T3	N1	M0	Stage IIIB	0	183			WITH TUMOR		49	Rectum	TCGA-AG-A00C	ff004403-8cc5-43e6-bd1c-dde4eb1e6193	NO	Not Available	6	Not Available	15	-18201	Not Applicable	0	0	Not Available	TCGA-AG-A00C-D37666;TCGA-AG-A00C-D37667;TCGA-AG-A00C-D37668	0480C952-95AB-4119-B285-88C9B48B46CF;AB4C44C6-717B-46CA-8881-BCDB2B3C9D28;66F94F54-0A6F-4BA1-8050-01A385AB66F3	Not Available;Not Available;Not Available	5;5;5	213;213;213	92;61;92	Folinic acid;5-Fluorouracil;Oxaliplatin	Complete Response;Complete Response;Complete Response	12;12;12	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2012;2012;2012	Not Available	TCGA-AG-A00C-F38313	B2E6175A-488F-4340-8048-4EF3DC25477D	12	Not Applicable	183	Scheduled Follow-up Submission	Complete Remission/Response	NO	12									NO	TUMOR FREE	YES	Complete Remission/Response	YES	Alive	2012	FEMALE	Not Available	Rectal Adenocarcinoma	NO	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	NO	Not Available	24	YES	Not Available	6									Not Available	Not Available	Not Available	0	Not Available	1	Not Available	No	A00C	Not Available	WITH TUMOR	Not Available	4.31	YES	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-AG-A00C-R38312	ACD5E3F1-5863-4451-B18E-A113DE5709D1	Not Available	13	92	61	Complete Response	12	Not Available	50	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T3	NO	NO	YES	AG	Rectum	NO	Alive	Not Available	2011	2007
TCGA-DC-4745	49	FEMALE	165	639	93.8	34.45362718089991	Rectal Adenocarcinoma	Rectum	Alive	T3	N1a	M0	Stage IIIB	0	639			Not Available		49	Rectosigmoid Junction	TCGA-DC-4745	644571e9-b8e6-42f3-a2e4-33bad0fac661	NO	Not Available	30	NO	9	-17958	Not Applicable	0	334	Not Available	TCGA-DC-4745-D16789;TCGA-DC-4745-D16792;TCGA-DC-4745-D16795;TCGA-DC-4745-D16798;TCGA-DC-4745-D16799	56e97bd0-ae1f-4321-9da2-1c4fcebd711d;3ba36058-d0eb-40b6-b5b6-1a57dc54e5ef;2e038d05-efc6-45e4-b011-af9a6669eda3;abf58812-4c12-4734-ba99-80b3e107572f;5935d581-743c-4b5e-892c-f90ab7754666	Not Available;Not Available;Not Available;Not Available;Not Available	26;26;26;26;26	216;216;216;132;204	62;62;62;62;122	Fluorouracil;Fluorouracil;Leucovorin Calcium;Oxaliplatin;Pegfilgrastim	Not Available;Not Available;Not Available;Not Available;Not Available	9;9;9;9;9	12;12;12;6;6	800;2400-2500;800;170;6	mg;mg;mg;mg;mg	ADJUVANT;ADJUVANT;OTHER, SPECIFY IN NOTES;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Available;Not Applicable;Not Applicable	1;1;1;1;1	IV;IV;IV;IV;SC	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Other, specify in notes;Chemotherapy;Other, specify in notes	Not Available;Not Available;Ancillary;Not Available;Ancillary	9600;29000;9600;1020;36	mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011;2011	NOT HISPANIC OR LATINO	TCGA-DC-4745-F12832;TCGA-DC-4745-F33823	7fa7a007-05f3-49e2-b899-eded752702d1;F7B5E69F-CC72-493B-B369-945E761D0BD0	9;19	Not Applicable;Not Applicable	334;639	Not Available;Scheduled Follow-up Submission	Not Available;Complete Remission/Response	Not Available;NO	6;7									NO;NO	TUMOR FREE;TUMOR FREE	YES;YES	Not Available;Complete Remission/Response	NO;NO	Alive;Alive	2011;2012	FEMALE	165	Rectal Adenocarcinoma	YES	No	C19	8140/3	C19.9	YES	NO	Not Available	Not Available	YES	MLH1-Not Expressed;MSH2-Not Expressed;PMS2-Not Expressed;MSH6-Not Expressed	22	NO	Not Available	6									Not Available	NO	Not Available	1	Not Available	1	Not Available	No	4745	NO	Not Available	Not Available	1.6	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1a	T3	NO	NO	YES	DC	Rectum	NO	Alive	93.8	2011	2010
TCGA-DC-6157	48	MALE	185	1581	116	33.89335281227173	Rectal Adenocarcinoma	Rectum	Alive	T2	N0	M0	Stage I	0	1581			TUMOR FREE		48	Rectosigmoid Junction	TCGA-DC-6157	634d542b-a72f-408b-9fef-65ef6c45f882	NO	Not Available	3	NO	26	-17807	Not Applicable	0	850	Not Available																								NOT HISPANIC OR LATINO	TCGA-DC-6157-F14258;TCGA-DC-6157-F21435;TCGA-DC-6157-F44763	359a768b-2515-4207-93cf-ddcf6785d26d;ea0ef720-c662-4555-bf4c-bf07955cab84;AC62B632-9414-49DC-9008-D51B00393253	26;13;26	Not Applicable;Not Applicable;Not Applicable	850;1095;1581	Scheduled Follow-up Submission;Scheduled Follow-up Submission;Scheduled Follow-up Submission	Not Available;Not Available;Not Applicable	Not Available;Not Available;NO	7;2;6									NO;NO;NO	TUMOR FREE;TUMOR FREE;TUMOR FREE	NO;NO;NO	Not Available;Not Available;Not Applicable	NO;NO;NO	Alive;Alive;Alive	2011;2012;2013	MALE	185	Rectal Adenocarcinoma	NO	No	C19	8140/3	C19.9	YES	NO	Not Available	Not Available	NO	Not Available	21	NO	Not Available	7									Not Available	NO	Not Available	1	Not Available	0	Not Available	No	6157	NO	TUMOR FREE	Not Available	2.2	YES	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	NO	YES	DC	Rectum	NO	Alive	116	2011	2009
TCGA-AG-3586	72	FEMALE	Not Available	31	Not Available		Not Available	Rectum	Alive	T3	N2	M0	Stage III	0	31			WITH TUMOR		72	Rectum	TCGA-AG-3586	a8b974f4-aabf-484d-bfa2-a286b39681e0	NO	Not Available	Not Available	Not Available	18	-26542	Not Applicable	0	31	Not Available																								Not Available																									FEMALE	Not Available	Not Available	NO	No	C19	8480/3	C19.9	YES	NO	Not Available	Not Available	NO	Not Available	19	YES	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	4	Not Available	No	3586	Not Available	WITH TUMOR	Not Available	1.86	YES	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage III	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T3	NO	NO	YES	AG	Rectum	NO	Alive	Not Available	2010	2006
TCGA-G5-6572	56	MALE	185.4	1432	140	40.7294528638042	Rectal Adenocarcinoma	Rectum	Dead					0	1432			TUMOR FREE		56	Rectosigmoid Junction	TCGA-G5-6572	2cf90e4e-b952-4a77-aaa9-39e4e2e5c4b3	NO	Not Available	Not Available	NO	2	-20475	1432	0	Not Available	Not Available																								NOT HISPANIC OR LATINO	TCGA-G5-6572-F15855	d8728ad2-17ed-4ac4-b49d-7c6aad3c4bf3	2	1432	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	9									NO	TUMOR FREE	NO	Not Available	NO	Dead	2011	MALE	185.4	Rectal Adenocarcinoma	NO	No	C19	8140/3	C19.9	YES	NO	Not Available	Not Available	NO	Not Available	22	NO	Not Available	9									Not Available	NO	Not Available	0	Not Available	0	Not Available	No	6572	NO	TUMOR FREE	Not Available	1.7	YES	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	NO	NO	YES	G5	Rectum	NO	Dead	140	2011	2004
TCGA-AF-2690	76	FEMALE	160	524	54.5	21.2890625	Rectal Adenocarcinoma	Rectum	Dead	T3	N2	M0	Stage IIIC	0	524			TUMOR FREE		76	Rectum	TCGA-AF-2690	368fd5c9-cd4b-4326-a47b-4d72938cfb8f	NO	Not Available	Not Available	NO	3	-28119	Not Applicable	0	358	Not Available																								NOT HISPANIC OR LATINO	TCGA-AF-2690-F7026;TCGA-AF-2690-F13123	2490a4e1-7e5b-4858-bffe-e1302ccc2937;3fd6b428-d0ee-43ee-aaf2-75ad6733a537	3;20	Not Applicable;524	358;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2;6									NO;Not Available	TUMOR FREE;Not Available	NO;Not Available	Not Available;Not Available	NO;Not Available	Alive;Dead	2011;2011	FEMALE	160	Rectal Adenocarcinoma	NO	No	C20	8140/3	C20.9	YES	NO	Not Available	Not Available	Not Available	Not Available	24	YES	Not Available	2									Not Available	YES	Not Available	1	Not Available	3	Not Available	No	2690	Not Available	TUMOR FREE	Not Available	4.2	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T3	NO	YES	NO	AF	Rectum	YES	Alive	54.5	2011	2009
TCGA-AH-6903	46	MALE	183	592	74.8	22.33569231688017	Rectal Mucinous Adenocarcinoma	Rectum	Alive	T3	N1b	M0	Stage IIIB	0	592			TUMOR FREE		46	Rectosigmoid Junction	TCGA-AH-6903	1e89c189-7c8a-44c9-9b0f-2f625a285003	NO	Not Available	45	NO	26	-17030	Not Applicable	0	55	Not Available	TCGA-AH-6903-D45595;TCGA-AH-6903-D45596;TCGA-AH-6903-D45597	0136A943-A156-450D-89CE-22B658D58AED;3AC71EE5-4B1E-4DBE-856A-2B4841E4EDEE;A49CFDD2-967B-4FC3-8902-594DAA1A2F3A	Not Available;Not Available;Not Available	17;17;17	228;228;228	70;70;70	5-FU;Oxaliplatin;Leucovorin	Complete Response;Complete Response;Complete Response	7;7;7	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Ancillary	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;Not Available	2013;2013;2013	NOT HISPANIC OR LATINO	TCGA-AH-6903-F45564	F7DEF277-33CB-4D2A-8EBC-A4BD9699894B	17	Not Applicable	592	Scheduled Follow-up Submission	Complete Remission/Response	NO	7									NO	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2013	MALE	183	Rectal Mucinous Adenocarcinoma	NO	No	C19	8480/3	C19.9	YES	NO	Not Available	Not Available	NO	Not Available	18	NO	Not Available	7									Not Available	NO	Not Available	0	Not Available	3	0	No	6903	NO	TUMOR FREE	Not Available	3.51	YES	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1b	T3	NO	YES	NO	AH	Rectum	NO	Alive	74.8	2011	2010
TCGA-AG-3601	68	MALE	Not Available	0	Not Available		Rectal Adenocarcinoma	Rectum	Alive	T4	N1	M0	Stage IIIB	0	0			WITH TUMOR		68	Rectum	TCGA-AG-3601	ba902e78-752f-4248-9a59-ea08475c961b	NO	Not Available	Not Available	Not Available	18	-24837	Not Applicable	0	0	Not Available																								Not Available																									MALE	Not Available	Rectal Adenocarcinoma	NO	No	C19	8140/3	C19.9	YES	NO	Not Available	Not Available	NO	Not Available	17	YES	Not Available	5									Not Available	Not Available	Not Available	0	Not Available	2	Not Available	No	3601	Not Available	WITH TUMOR	Not Available	47.92	YES	Not Available	Not Available	Not Available																			R2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T4	NO	NO	YES	AG	Rectum	NO	Alive	Not Available	2010	2007
